Summary
Seaweeds contain a rich nutritional composition and various bioactive components including polysaccharides, proteins, pigments, fatty acids, polyphenols, and phlorotannins. Recent studies have highlighted the therapeutic potential of seaweed bioactives, demonstrating their functional efficacy as anti-oxidant, anti-inflammatory, anti-microbial, anti-cancer, anti-obesity, and anti-diabetic agents in different models. Owing to those bioactive properties, the integration of seaweeds into food, feed, pharmaceutical and nutraceutical industries is expanding rapidly. However, the lack of robust large-scale processing technologies and limited understanding of biocompatibility and bioavailability remain significant barriers to their wider utilization. This review delivers a comprehensive overview of the nutritional, bioactive, and therapeutic potentials of seaweeds and their major bioactive compounds and further highlights how molecular structure, processing, and food matrix influence their bioactivity and absorption. It also examines downstream processing strategies and evaluates their impact on product quality, safety, and scalability. Finally, the review discusses future research directions, including the development of multiproduct biorefineries, optimization of bioactive delivery in functional foods, and the need for human pharmacokinetic studies. Collectively, these developments position seaweeds as sustainable foundation in health and wellness, with vast potential to address global nutritional and therapeutic needs through innovative, technology-driven approaches.
Subject areas: health sciences, medicine, nutrition, natural product chemistry, natural product biochemistry
Graphical abstract

Health sciences; medicine; nutrition; natural product chemistry; natural product biochemistry
Introduction
Seaweeds or macroalgae have gained global interests due to their high ecological productivity and ability to address major challenges related to human health, nutrition, and environmental sustainability. Seaweeds are a renewable marine resource with low agricultural inputs, which make them a sustainable future candidate for food systems.1 Marine macroalgae or seaweeds are classified into three major groups based their photosynthetic pigments, namely Phaeophyceae (brown seaweeds), Rhodophyta (red seaweeds), and Chlorophyceae (green seaweeds).2 These classifications were based upon their ecological adaptations to light availability in marine environments. Among them, the green algae cover the shallow regions of coastal waters due to the presence of light-harvesting pigments like chlorophyll a and b, whereas red and brown algae possess pigments such as fucoxanthin and phycoerythrin, which make them well adapted to deeper waters and waters with less-light availability.3
Beyond their ecological significance, seaweeds are rich sources of structurally diverse bioactive compounds, including polysaccharides, polyphenols, phlorotannins, peptides, sterols, and pigments, many of which are uncommon or absent in terrestrial plants.3 These compounds have demonstrated a wide range of biological activities, including anti-oxidant, anti-inflammatory, anti-cancer, anti-microbial, anti-viral, anti-coagulant, and immunomodulatory effects in in vitro and in vivo models.4 Subsequently, seaweeds are increasingly being recognized as valuable raw materials for the development of functional foods and nutraceuticals targeting chronic conditions such as cardiovascular diseases, obesity, diabetes, and certain cancers.5
Seaweeds can be processed at different levels, each conferring distinct nutritional and functional benefits. Whole seaweed biomass, consumed directly as food, provides all essential nutrients such as proteins, dietary fibers, minerals, vitamins, and bioactive polysaccharides that contribute to metabolic health and gut function.4,5,6 In contrast, seaweed extracts, obtained using aqueous, enzymatic, chemical, or emerging green extraction technologies are commonly incorporated into nutraceutical and pharmaceutical formulations. These seaweed extracts contain higher concentrations of certain functional molecules than raw biomass. Further downstream processing allows the isolation of purified compounds and peptide fractions, which have gained attention for targeted therapeutic applications.7,8 This distinction between whole biomass, extracts, and isolated products is critical because the biological activity, bioavailability, and efficacy of seaweed-derived compounds are strongly influenced by the extraction methods, chemical structure, and molecular composition.
Among the seaweed-derived bioactives, sulfated polysaccharides such as fucoidans, carrageenans, and ulvans have been most extensively studied. These compounds have exhibited diverse biological activities, including anti-oxidant, anti-tumor, anti-viral, anti-coagulant, and immunomodulatory effects.4,5,6 Polyphenolic compounds, particularly phlorotannins from brown seaweeds, also exhibit strong anti-oxidant properties and have shown promising potential toward anti-cancer, anti-inflammatory, and neuroprotective activities.7,8 Additionally, proteins and bioactive peptides derived from marine algae have demonstrated anti-oxidant, anti-hypertensive, anti-diabetic, and anti-microbial activities, highlighting seaweeds as emerging sources of alternative protein and functional ingredients.3,9 Marine pigments such as fucoxanthin from brown seaweeds, phycobiliproteins from red seaweeds, and chlorophylls from green seaweeds further contribute to the biofunctional properties of seaweeds in metabolic regulation, anti-obesity effects, and cancer-related pathways.6
Historically, seaweed consumption dates back thousands of years, particularly in Asian countries such as Japan, China, and Korea, where seaweeds were traditionally valued for both nutritional and medicinal purposes.8 Edible seaweeds such as Porphyra, Pyropia, Neopyropia (Rhodophyta), and Saccharina and Undaria (Phaeophyceae) have long been used to address dietary deficiencies, including iodine deficiency and goiter.6 Modern scientific research has substantiated many of these traditional uses, identifying seaweeds as important sources of biologically active compounds.5,6 Epidemiological and dietary studies have further suggested that regular consumption of seaweeds is associated with reduced incidence of lifestyle-related disorders such as obesity, type 2 diabetes, cardiovascular diseases, and certain cancers.6 For instance, population-based studies in Japan and Korea have reported inverse associations between seaweed intake and diabetes prevalence, while consumption of brown seaweeds such as Undaria has been linked to reduced risks of breast cancer.6 In addition, seaweeds rich in polysaccharide and fiber content have gained attention as prebiotic ingredients, promoting gut microbiota modulation, colonic fermentation, and immune regulation.3,9,10
Despite these promising attributes, the health effects of seaweed-derived compounds are influenced by multiple factors, including species variability, processing methods, chemical structure, bioavailability, and metabolism. Moreover, while numerous in vitro and animal studies support the therapeutic potential of seaweed bioactives, human clinical evidence remains limited for many compounds and species. Therefore, a critical and balanced synthesis of nutritional composition, bioactive compounds, extraction strategies, and therapeutic outcomes is essential.
In this context, the present review systematically summarizes the nutritional profile of seaweeds, key bioactive compounds, extraction and processing strategies, and their pharmacological properties, with particular emphasis on anti-oxidant, anti-diabetic, anti-cancer, and anti-inflammatory activities. Where available, human intervention studies are critically discussed, and areas lacking clinical evidence are clearly identified. This integrated approach aims to highlight the opportunities, limitations, and future prospects of seaweeds as valuable biomasses for functional foods, nutraceuticals, and therapeutic applications. Recent reviews have emphasized the functional value of seaweed-derived compounds, but most of them have focused on biological activities specific to seaweed types. Unlike previous reviews, this review integrates the compositional, mechanistic, regulatory, and translation perspectives to highlight both the potential and current limitations of seaweeds as functional food ingredients.
The literature includes recent review articles, compositional analyses, and preclinical and human intervention studies, where human evidence remains limited or absent, as explicitly stated in this review. Further, this review aims to provide a critical synthesis of current knowledge on edible seaweeds by consolidating and discussing the reported data on their nutritional composition and relevance to human health. It evaluates the therapeutic potential of seaweed-derived compounds by distinguishing the mechanistic evidence from preclinical findings and available human studies. The review further examines the functional applications of edible seaweeds in the development of value-added functional foods and nutraceutical formulations.
In addition, it discusses the therapeutic potential of seaweed proteins and peptides and highlights various analytical approaches used for the quantification of seaweed proteins. It also summarizes the safety, regulatory, and toxicological considerations associated with dietary seaweed consumption. In addition, the sustainability aspects and global supply chains of seaweed production are assessed. Finally, key challenges, research gaps, and future perspectives related to compositional variability, consumer acceptance, and the translation of seaweed-based products into functional health applications are highlighted.
Nutritional composition of seaweeds
Macronutrients
Lipids and carbohydrates
Seaweeds or macroalgae differ significantly in their biochemical composition. Seaweed biomass is composed mainly of water (up to 85%) with the dry matter including a rich mix of carbohydrates (21%–61%), proteins (3%–50%), lipids (0.5%–3.5%) and minerals (12%–46%).6 In general, the lipid levels of red, brown, and green seaweeds are generally low, as summarized in Table 1, ranging from 0.3% to 5.21%. Although, lipid levels are low, seaweeds comprise higher proportions of polyunsaturated fatty acids, particularly omega-3 fatty acids such as eicosapentaenoic acid (EPA), which are essential for cardiovascular and neurological health.8
Table 1.
Nutritional composition of major seaweed species
| Seaweed | Protein | Carbohydrate | Lipid | Ash | Vitamins | Fiber | Minerals | Reference |
|---|---|---|---|---|---|---|---|---|
| Ulva intestinalis (formerly Enteromorpha intestinalis) | 3.32 ± 0.14 | 5.185 ± 0.04 | 0.04 ± 0.01 | 5.62 ± 3.20 | B1, B2, B3, B6, C | 1.01 ± 0.13% | K, Mg, Fe, Zn | Farzanah et al.11 |
| Ulva Lactuca | 10.0 ± 0.01 | 61.83 ± 0.01 | 0.13 ± 0.01 | 17.86 ± 0.87 | NR | NR | NR | Pangestuti et al.12 |
| Caulerpa racemosa | 7.60 ± 0.01 | 38.62 ± 0.01 | 0.71 ± 0.01 | 38.41 ± 1.90 | NR | NR | NR | Pangestuti et al.12 |
| Caulerpa lentilifera | 12.56 | 13.63 | 1.70 | 63.83 | NR | 8.28 | Ca, P, K, Na, Mn, Mg, I, Zn, Fe | Kasmiati et al.13 |
| Caulerpa racemosa | 19.61 | 38.18 | 1.22 | 34.44 | NR | 6.55 | Cu, P, Fe, Na, Ca, K, I, Mg, Mn | Kasmiati et al.13 |
| Turbinaria decurrens | 4.34 | 61.44 | 1.71 | 16.73 | NR | NR | NR | Rasyid et al.14 |
| Polycladia myrica | 22.54 | 45.2 | 5.21 | NR | C, E | 37.53 | NR | Ismail et al.15 |
| Sargassum polycystum | 9.51 ± 0.06 | 52.31 ± 0.85 | 1.30 ± 0.05 | 28.07 ± 0.22 | NR | 16.20 ± 0.52 | NR | Widyaswari et al.16 |
| Sargassum ilicifolium (formerly Sargassum cristaefolium) | 8.55 ± 0.04 | 42.64 ± 0.13 | 1.30 ± 0.05 | 38.07 ± 0.22 | NR | 12.80 ± 0.06 | NR | Widyaswari et al.16 |
| Padina australis | 3.06 ± 0.09 | 4.80 ± 1.11 | 1.82 ± 0.21 | 15.89 ± 0.02 | NR | 71.02 ± 2.74 | Ca, Mg, K, Na, Cu, Fe, Zn | Chin et al.17 |
| Garcilaria changgi | 5.42 ± 0.17 | 38.03 ± 1.75 | 0.05 ± 0.03 | 8.83 ± 0.16 | NR | 76.97 ± 9.14 | Ca, Mg, K, Na, Cu, Fe, Zn | Chin et al.17 |
| Chondrus crispus | 24.4 ± 0.5 | 47.7 ± 0.6 | 0.4 ± 0.1 | 19.4 ± 0.1 | NR | NR | NR | Amaro et al.18 |
| Gracilariopsis longissimia (formerly Gracilaria verrucosa) | 12.36 ± 1.48 | 55.99 ± 2.78 | 0.61 ± 0.22 | 15.51 ± 1.39 | NR | 1.35 ± 0.13 | P, Na, K, Mg, Al, Zn, Si, Cl, Ca, Mn, Fe, Sr, S, Br, | Windarto et al.19 |
| Halymenia durvillei | 12.83 ± 1.19 | 39.07 ± 3.11 | 0.30 ± 0.23 | 35.48 ± 2.42 | NR | 2.47 ± 0.22 | Fe, Mg, Al, Si, P, Sr, Cl, K, Ca, Cu, Zn, Br, S, Na, | Windarto et al.19 |
| Sargassum spp. | 4.78 | 80.35 | 0.59 | 2.86 | Vitamin C | 11.34 | NR | Indriyawati et al.20 |
| Padina spp. | 4.84 | 74.03 | 0.63 | 3.3 | Vitamin C | 17.18 | NR | Indriyawati et al.20 |
| Mastocarpus stellatus | 18.62 ± 0.04 | 60.43 ± 0.59 | 0.14 ± 0.03 | 20.81 ± 0.61 | NR | NR | NR | Carpena et al.21 |
| Chondrus crispus | 17.00 ± 0.26 | 53.43 ± 0.01 | 0.12 ± 0.01 | 29.46 ± 0.26 | NR | NR | NR | Carpena et al.21 |
| Gigartina pistillata | 14.35 ± 0.26 | 53.72 ± 0.75 | 0.11 ± 0.04 | 31.82 ± 0.54 | NR | NR | NR | Carpena et al.21 |
| Ulva rigida | 16.3 | 11.68 | 0.42 | 28.7 | NR | 42.9 | Ca, Fe K, Mg, Mn, P, Zn, As I, | Echave et al.22 |
| Codium tomentosum | 15.4 | 4.77 | 0.7 | 38.9 | NR | 39.1 | Ca, Fe K, Mg, Mn, P, Zn, As I, | Echave et al.22 |
| Palmaria palmata | 21.5 | 7.78 | 0.1 | 23.8 | NR | 46 | Ca, Fe K, Mg, Mn, P, Zn, As I, | Echave et al.22 |
All values are expressed as % (dry weight), unless otherwise stated. Data were compiled from different studies, using various analytical methods, seasons, and conditions; therefore, values should be interpreted as indicative ranges, rather than directly comparable values.
NR, not reported.
Carbohydrates are the abundant macromolecules present in seaweeds, and their proportion can even reach up to 81% on dry weight basis. Specifically, the carbohydrate levels of seaweeds summarized in Table 1, vary between 4.80% and 61.44% of their dry weight. Depending upon their complexity and length of molecules, carbohydrates can be classified as monosaccharides, disaccharides, oligosaccharides, and polysaccharides. Glucose, mannose, galactose, fructose, rhamnose, fucose, xylose, and arabinose are some of the commonly found monosaccharides in seaweeds. Significant polysaccharides found in seaweeds are fucoidans, alginates, and laminarins in brown algae; carrageenans and agars in red algae; and ulvans in green algae,4 as illustrated in Figure 1. Polysaccharides are formed by the linkages of monosaccharides together by glycosidic bonds. Depending on the composition of monosaccharides, they can be classified as homopolymers or heteropolymers. Homopolysaccharides comprise repeated units of a single type of monosaccharide linked together to form the structural component of cell walls of plants and most of the seaweeds such as cellulose derivatives, whereas heteropolysaccharides are composed of repeated units of different types of monosaccharides to form polymers such as carrageenans and ulvans.3 These polysaccharides serve not only as structural components but also as dietary fibers, which exhibit various health-promoting bioactivities including anti-oxidant, anti-inflammatory, anti-coagulant, and prebiotic functions.4
Figure 1.
Classification of seaweeds and their bioactive compounds
Proteins
Proteins are chains of amino acids that are bound together by peptide bonds. The protein content of seaweeds varies considerably among taxonomic groups. Green and brown seaweeds usually contain lower protein proportions, approximately 20% and 10% of dry weight, respectively, whereas red seaweeds such as Palmaria palmata, Porphyra spp., Gracilaria spp. contain higher protein levels ranging from 19 to 44% of dry weight.5 However, the protein content of macroalgae is comparatively high than that of terrestrial plant sources like soybean, pulses, etc.5 Due to their high protein content, edible seaweeds are increasingly being recognized as promising alternative protein sources and novel functional ingredients for human nutrition.3 Recent studies have demonstrated the successful incorporation of seaweed-derived ingredients into meat products, meat analogues, and low-salt formulations, underscoring the technological functionality and nutritional potential of seaweed proteins in reformulated food systems.23,24
Protein quantification in macroalgae is challenging due to the presence of various non-proteinaceous compounds like nitrate, free amino acids, pigments, and other nitrogenous compounds, which may interfere with analytical measurements and lead to an overestimation of protein content. In addition, high salt content, recalcitrant cell wall structures, and the presence of phycocolloids can affect the efficiency of protein extraction and interfere with analytical reactions during protein quantification.25 Among the different methods of protein quantification, calorimetric methods such as Lowry’s and BCA assays still tend to be commonly used due to low costs and ease of use. Both of these assays estimate the concentration of protein by measuring color changes from copper reduction but differ in terms of their detection reagents. In Lowry’s assay, the Folin-Ciocalteu reagent is reduced, producing blue color, which is measured at 650–750 nm, whereas the BCA chelates the reduced Cu+ ion, forming a purple complex measurable at 562 nm.26,27 Although these methods are rapid and easy to use, their efficacy may be limited when applied to macroalgae. Precise quantification of proteins in both the plant and algal samples can be difficult due to the presence of various bioactive substances including polyphenols, polysaccharides, and pigments. These substances may get co-extracted along with proteins and cause interference with the measurements.25,28,29
Spectroscopic techniques such as Fourier transform infrared (FTIR) and near-infrared (NIR) spectroscopy have recently been explored as rapid and non-destructive approaches for protein quantification in seaweeds. Unlike colorimetric assays, these methods rely on molecular vibrational signatures rather than chemical reactions, thereby reducing interference from phenolic compounds, polysaccharides, pigments, and salts commonly present in macroalgal biomass.25,30 In FTIR spectroscopy, proteins are identified through characteristic peptide absorption bands, particularly the amide I band (∼1,650 cm−1) associated with C=O stretching and the amide II band (∼1,540 cm−1) corresponding to N–H bending and C–N stretching vibrations, respectively. Protein quantification is achieved by correlating spectral intensities with reference protein values, using statistical models such as linear regression or partial least-squares regression (PLSR).25,30,31
Similarly, NIR spectroscopy utilizes overtone and combination vibrations of N–H, C–H, and O–H bonds within the 700–2500 nm wavelength range, where protein-related signals are typically detected between 1400 and 2500 nm. Spectral data are commonly analyzed using chemometric approaches such as PLSR models to predict protein content.25,32 However, reliable implementation requires the development of robust calibration datasets, as the biochemical composition of seaweeds can vary significantly with species, environmental conditions, and seasonal fluctuations.25,30 The quantification of protein using colorimetric and spectroscopic methods can be affected by spectral interferences arising from interactions with non-protein compounds present in the extracts. So, protein precipitation or purification steps may also be employed prior to the colorimetric and spectroscopic analyses to improve measurement accuracy by reducing matrix interferences. However, the efficiency of protein precipitation and removal of non-proteinaceous compounds from the extracts can be influenced by several factors including the choice of precipitation method, solvent, and extraction conditions.25
Protein content in seaweeds is most commonly estimated indirectly from total nitrogen determined using elemental analysis through Kjeldahl or Dumas combustion methods, with crude protein calculated using a nitrogen-to-protein conversion factor (N× factor). The Kjeldahl method involves digestion of the sample with concentrated H2SO4 in the presence of catalyst CuSO4, which converts organic nitrogen into ammonia that is sequentially quantified by titration.33 This method has been widely applied in food and algal analysis due to its reliability and relatively simple instrumentation. Alternatively, the Dumas method is a combustion-based dry technique in which the sample is burned at high temperatures in the presence of oxygen, leading to the conversion of nitrogen into nitrogen oxides that are subsequently reduced to molecular nitrogen (N2). The resulting gases are separated from combustion by-products quantified using a thermal conductivity detector.34 Compared with the Kjeldahl method, the Dumas technique is faster, safer, and highly automated, enabling analysis of each sample within minutes, which makes it suitable for high-throughput laboratories. In some seaweed studies, Dumas analysis has also been reported to produce slightly higher nitrogen values with improved analytical precision compared with the Kjeldahl method.35 Both methods are, therefore, widely employed as nitrogen-based protein estimation in seaweed biomass.
In nitrogen-based protein estimation, crude protein is typically calculated using the conventional nitrogen-to-protein conversion factor N× 6.25. However, this factor assumes that proteins contain approximately 16% nitrogen and that all nitrogen present in the sample originates from proteins. However, this assumption may not be valid for macroalgae because seaweeds contain significant amounts of non-protein nitrogen (NPN) compounds, including free amino acids, nitrates, pigments, and other nitrogenous metabolites. So, the conversion factor 6.25 likely overestimates the true protein content in seaweeds.29 Recent studies, therefore, recommend lower conversion factors, typically ranging from 4.59 to 5.7.36 In cases where species-specific factors are not available, a generalized seaweed conversion factor of around 5.0 has been proposed as a practical approximation.37 However, there is a need for standardized, macroalgae-specific conversion factors to improve the reliability of protein quantification in seaweed biomass.
Amino acid analysis followed by acid hydrolysis is widely regarded as the gold standard for determining true protein content in seaweeds. Unlike nitrogen-based methods or colorimetric assays, this approach directly quantifies protein-bound amino acids while excluding non-protein nitrogen sources such as nitrates, free amino acids, and other nitrogenous compounds that may lead to overestimation of protein content.34,38 In this method, proteins are hydrolyzed to their constituent amino acids through the cleavage of peptide bonds, and the total protein content is calculated as the sum of the individual amino acid residues.
Typically, protein hydrolysis is performed using 6 M hydrochloric acid (HCl) at 110°C for approximately 24 h. This treatment effectively breaks most peptide bonds and releases free amino acids for subsequent quantification.34 The liberated amino acids are commonly analyzed chromatographically, using techniques such as reverse-phase high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC), or automated amino acid analyzers.38 Because this method quantifies proteins based solely on amino acid residues, it is considered a direct measurement of true protein. During protein hydrolysis, peptide bonds incorporate a molecule of water, resulting in a mass gain of approximately 18 Da per peptide bond. Therefore, protein estimation based on amino acid analysis requires correction for this water gain, as the measured amino acid residues correspond to the molecular fraction of amino acids after the loss of water during peptide bond formation in proteins. As a result, true protein content is calculated as the sum of amino acid residues after subtracting the molecular mass contribution of water, ensuring accurate representation of the protein fraction.29,34
Despite its high accuracy, certain amino acids such as tryptophan, cysteine, and methionine may be partially degraded during acid hydrolysis and may require alternative hydrolysis.39 In addition, hydrolysis procedures can sometimes result in a slight underestimation of the total protein content due to amino acid losses, which may require correction factors during calculation.38 Nevertheless, amino acid analysis remains the most reliable method for determining true protein content, as it directly measures protein-derived amino acids without interference from non-proteinaceous substances. For this reason, it is often recommended as a reference method for validating nitrogen-based protein estimation approaches and for calibrating spectroscopic prediction models in seaweed research.34,40
Micronutrients (vitamins and minerals)
Seaweeds are a rich source of vitamins (A, B-complex, C, D, E, and K) and contain essential minerals including iodine, calcium, magnesium, iron, and zinc (Figure 1), which contribute to their nutritional and functional food value41 (Table 1). Seaweeds have been reported to contain a high mineral content of up to 40% of the whole biomass. These elevated levels of minerals are due to the absorption of metal ions from seawater and accumulation of mineral salts in their thallus as carbonate salts.3
Seaweeds contains both the water-soluble and fat-soluble vitamins, which include vitamin B complex, vitamin C, and vitamins A, D, E, and K.42 The proportion of vitamin A (carotenoids) in seaweeds varies from 2% to 10% of the reference nutrient intake (RNI). Briefly, brown and green seaweeds are rich sources of vitamin A (carotenoids), containing average levels between 500 and 3,000 mg/kg of dry weight, whereas vitamin A concentration in red seaweeds ranges from 100 to 800 mg/kg dry weight.3 Similarly, vitamin C content ranges from 1% to 23% of RNI, whereas vitamin B12 level ranges from 107% to 446% of RNI.43 Seaweeds contain higher levels of vitamin B12, which can be substituted as an alternative natural source of vitamin B12 for vegetarians. Vitamin B12 cannot be synthesized by most of the terrestrial plants and are only synthesized by certain prokaryotes. Prokaryotes share a symbiotic association with seaweeds, and their interconnection promotes the production of vitamin B12 in seaweeds.44 Discovery of the presence of vitamin B12 in seaweeds was considered a breakthrough because previously it was believed that vitamin B12, considered as most essential for the brain development and functions of the human body, is present only in animal-based foods.42
Dietary fibers and bioactive compounds
Seaweeds possess biologically active compounds with various therapeutic potentials. They have also been utilized as ingredients in functional food components, nutraceuticals, and dietary supplements due to their notable dietary fiber content. Dietary fibers are carbohydrate polymers and are non-absorbable in the small intestine, which enables their interaction with gut microbes and synthesis of beneficial metabolites These fibers are believed to have significant health benefits. Specifically, the dietary fiber derived from seaweeds has tremendous potential in human health and could be used as food supplements.45 Seaweeds contain varying concentrations of dietary fibers ranging from 1% in green algae to the highest 76.97 g/100 g in red algae (Gracilaria changii), as summarized in Table 1. Other studies have also revealed that red seaweeds contain varying and higher levels of dietary fiber, from 5.7 g/100 g (in G. cervicornis) to 64.7 g/100 g (in G. changii). These proportions of soluble dietary fiber in seaweeds are higher than those in fruits and vegetables and are considered advantageous for health, as it reduces the blood cholesterol and postprandial glucose levels and increases satiety.
Pharmacological applications of seaweed-derived compounds
Fucoidans
Fucoidans are fucose-containing sulfated polysaccharides found in many brown seaweed species. They are species specific and do not have a universal chemical structure. Yet, fucoidans are the primary cell wall constituent, present along with the alginate and cellulose in brown seaweeds.46 They are mainly composed of L-fucose units linked by α-(1→3) or alternating α-(1→4) and α-(1→3) glycosidic bonds. They also comprise sulfate ester groups at the C-2 and/or C-4 positions of fucose residues, along with other sugar constituents including glucose, galactose, mannose, xylose, acetyl groups, and uronic acids.47 Fucoidan content in brown seaweed varies from 10% to 20%, with the highest content 46.6% reported in Laminaria digitata (Phaeophyceae).4 Fucoidans possess a high molecular weight of around 20–2,000 kDa and are water soluble. These anionic polysaccharides are negatively charged due to their sulfate content. Presence of sulfate groups enhances their interactions with proteins and lipids, contributing to diverse bioactives. Fucoidans exhibit a wide range of biological activities including anti-oxidant, anti-inflammatory, anti-viral, anti-bacterial, anti-coagulant, anti-thrombotic, anti-tumor, immunoregulatory, anti-obesity, and anti-diabetic (Table 2).47,83 These distinct biological characteristics of fucoidans are due to the degree of sulfation, molecular weight, and sugar composition. Highly sulfated, low-molecular weight fucoidans are associated with several biological properties, whereas highly branched or high-molecular weight fucoidans exhibit other distinct properties.84
Table 2.
Therapeutic application of seaweed-derived bioactive compounds
| Seaweed | Bioactivity | Target system/disease model | Outcomes/observations | Reference |
|---|---|---|---|---|
| Fucoidans | ||||
| Stoechospermum polypodioides (formerly Stoechospermum marginatum) | anti-cancer | liver cancer: hepatocellular carcinoma (HepG2) | potent cytotoxicity against HepG2 cells (IC50 = 24.4 ± 1.5 μg/mL); induced necrotic death: no toxicity to Vero cells | Chandimali et al.48 |
| Sargassum aquifolium (formerly Sargassum echinocarpum) | anti-cancer | breast cancer cells (MCF-7) | cytotoxic to MCF-7 breast cancer cells (IC50 = 297.58 ± 2.40 ppm), induced apoptosis; increased oxidative stress; SI = 7.62; safe to normal cells | Yunianta et al.49 |
| Fucus vesiculosus | anti-cancer | cholangiocarcinoma cells (CL-6) | induction of apoptosis, mitochondrial disruption, and G0/G1 cell cycle arrest; IC50 = 196.27 μg/mL; non-toxic to normal cells | Chantree et al.50 |
| Undaria pinnatifida | anti-cancer | colorectal cancer cells (CaCo-2, HT-29) | fucoidan-curcumin-selenium nanocomposite showed strong cytotoxicity (IC50 = 10.35 mg/L), DNA damage, apoptosis, and autophagy, better than cisplatin | Al-Duais et al.51 |
| Padina pavonica | anti-viral | herpes simplex cirus type 1 (HSV-1) | inhibition of HSV-1 by 30.89%, EC50: 49.89 μg/mL, SI: 4.21, moderate efficacy | Akl et al.52 |
| Sargassum henslowianum | anti-viral | HSV-1 and HSV-2 | inhibition of HSV-1 with IC50 = 0.89 μg/mL and HSV-2 with IC50 = 0.48 μg/mL; blocks viral adsorption at early infection stages | Sun et al.53 |
| Padina pavonica | anti-diabetic | postprandial hyperglycemia | inhibition of α-amylase by 75.69% at 1,000 μg/mL: IC50 = 117.56 μg/mL | Akl et al.52 |
| Ecklonia maxima | anti-diabetic | type 2 diabetes | potent mixed-type inhibition of α-glucosidase (IC50 = 0.27–0.31 mg/mL); stronger than acarbose (standard) | Daub et al.54 |
| Padina pavonica | anti-oxidant | N/A | FRAP assay: 81.82% activity at 1,000 μg/mL; IC50 = 113.21 μg/mL | Akl et al.52 |
| Saccharina japonica (formerly Laminaria japonica) | anti-oxidant | N/A | strong ABTS = 1.02 mg Trolox equivalents/g; FRAP = 5.39 mg TE/g activity; linked to sulfated L-fucp residues | Yue et al.55 |
| Laminarins | ||||
| Padina pavonica | anti-cancer | colon cancer (HT-29) | selective cytotoxicity to HT-29 colon cancer cells (IC50 = 57 ± 1.2 μg/mL), induced apoptosis and necrosis; safe on Vero cells | Sanniyasi et al.56 |
| Saccharina cichorioides | anti-cancer | breast cancer cells (MDA-MB-231) | selective inhibition of MDA-MB-231 cells; enhanced radiosensitivity with X-ray; induced apoptosis and DNA damage | Malyarenko et al.57 |
| Saccharina japonica (formerly Laminaria japonica) | anti-cancer | liver cancer: hepatocellular carcinoma (Bel-7404 and HepG2) | inhibited proliferation and induced apoptosis in Bel-7404 and HepG2 cells; suppressed tumor growth in mice; effect linked to SMP-30 upregulation | Tian et al.58 |
| Laminaria hyperborea | anti-oxidant | N/A | hydrothermal-assisted laminarin showed the highest anti-oxidant activity (DPPH = 38.62%, FRAP = 56.45 mg TE/g); anti-oxidant potency decreased with purification steps | Rajauria et al.59 |
| Sargassum mcclurei | anti-oxidant | N/A | showed high anti-oxidant activity (TAA: 19.66 mg ascorbic acid equivalent/g) | Xuan Cuong60 |
| Carrageenans | ||||
| Chondrus armatus | anti-cancer | human gastrointestinal cancers (colon: HCT-116 and RKO; esophagus: KYSE-30 and FLO-1) | selectively inhibited (IC50 = 184–405 μg/mL) gastrointestinal cancer cells by inducing apoptosis and cell cycle arrest, with minimal toxicity to normal cells | Tiasto et al.61 |
| Gigartina pistillata | anti-cancer | colorectal cancer stem cell-enriched tumor spheres (HT29, SW620, SW480, HCT116) | suppressed colorectal cancer stem cell growth at sub-micromolar doses, particularly from the tetrasporophyte stage | Cotas et al.62 |
| Kappaphycus alverzii | anti-oxidant, anti-inflammatory, anti-coagulant, and cytotoxic | alloxan induced diabetic Wistar albino rats, human blood cells, brine shrimp | safe up to 2,000 mg/kg in rats; enhanced anti-oxidant enzyme levels; reduced lipid peroxidation; showed better cytotoxic and lower hemolytic activity than commercial carrageenans and also had strong anti-inflammatory and anti-coagulant effects | Sanjivkumar et al.63 |
| Eucheuma onii | anti-oxidant | N/A | NaOH-extracted carrageenan showed strong anti-oxidant activity (60.7% DPPH scavenging); IC50 = 0.2–30 ppm | Setyopratomo and Sapei64 |
| Polyphenols and phlorotannins | ||||
| Padina tetrastromatica | anti-diabetic | inhibition of α-amylase and α-glucosidase | α-amylase, IC50 = 47.2 μg; α-glucosidase, IC50 = 28.8 μg; significant inhibitory effect | Naveen et al.65 |
| Padina tetrastromatica | anti-oxidant | N/A | DPPH, IC50 = 58.85 μg/mL; ABTS, IC50 = 10.83 μg/mL; high reducing and anti-oxidant power | Naveen et al.65 |
| Costaria costata | anti-cancer | duodenal adenocarcinoma cells (HuTu 80), melanoma cells (SK-MEL-28) | inhibited α-N-acetylgalactosaminidase (α-NaGalase) activity (IC50 = 0.12–0.14 mg/mL); reduced intracellular enzyme levels; non-toxic up to 40 μg/mL | Bakunina et al.66 |
| Eisenia bicyclis | anti-diabetic | C2C12 myotubes (glucose uptake model) | increased glucose uptake by 51.09% under insulin-stimulated and 16.08% under basal condition, comparable to metformin; upregulated expression of Glut4 (10-fold), IRS1, IRS2, and Akt; activated both IRS/Akt and AMPK pathways | Raja et al.67 |
| Cystoseira compressa | anti-diabetic | STZ-induced diabetic rats (in vivo) | significantly reduced serum glucose, α-amylase, and α-glucosidase; increased insulin, hepatic glutathione, AMPKα2 expression; improved liver anti-oxidants; protected pancreatic β-cells; non-toxic in normal cell assays | Gheda et al.68 |
| Eisenia bicyclis | anti-oxidant | N/A | high total phenolic content; strong reducing power (263 ± 3.02 mg TE/g DW); DPPH radical-scavenging activity with IC50 = 47.36 ± 2 μg/mL; presence of zeaxanthin (0.5 mg/kg) contributes to the anti-oxidant profile | Raja et al.67 |
| Eisenia bicyclis | anti-melanogenesis | mouse B16 melanoma cells (in vitro, α-MSH-induced) | suppressed melanin production; FF-A downregulated Mitf and Tyr expression, both inhibited TRP-2; non-toxic up to 50 μM; | Ohno et al.69 |
| Cystoseira compressa | anti-oxidant | N/A | showed high anti-oxidant capacity (DPPH, IC50 = 22.4 μg/mL; ABTS, IC50 = 1.89 μg/mL); total anti-oxidant activity, 64.7 ascorbic acid eq/g; non-toxic to normal cells | Gheda et al.68 |
| Sargassum tenerrimum | anti-diabetic, anti-inflammatory | High-fat diet- and low-dose STZ-induced diabetic Wistar rats | reduced fasting blood glucose, insulin, resistance, and TNMF-α; improved serum insulin, lipid, liver, and renal profiles; protected pancreatic and liver tissues | Godlaveti Vijay and Vellapandian70 |
| Alkaloids | ||||
| Caulerpa cylindracea | anti-cancer | colorectal cancer cell lines (HCT-116, HT-29) | reduced cell viability in HCT-116 (IC50: 119 μM) and HT-29 cells (IC50: 179 μM) in a dose-dependent manner; inhibited colony formation; induced apoptosis | Mert-Ozupek et al.71 |
| Sargassum platycarpum | anti-cancer | human liver cancer cells (HepG2) | dose-dependent inhibition of HepG2 cells (IC50 = 24.6 ± 2.1 μg/mL); low cytotoxicity | Abdelrheem et al.72 |
| Caulerpa cylindracea | anti-SARS-CoV-2, anti-cancer | SARS-CoV-2 spike-ACE2 binding assay; breast cancer cells (MCF-7, MDA-MB-231) | inhibited spike-ACE2 binding (IC50 = 190.2 nM); mild main protease reduction at high dose; strong cytotoxicity effect against MCF-7 and MDA-MB-231 (IC50 = 13.0–17.3 μM); non-toxic to normal cells at tested doses | Zayed et al.47 |
| Caulerpa recemosa | anti-viral (anti-HSV-1) | Vero cells (African green monkey kidney), HSV-1 infection | low cytotoxicity (CC50 = 687.9 μM); moderate cytotoxic activity in colorectal cancer cells (IC50 = 20–31 μM); significantly inhibited HSV-1 replication, targeting alpha and beta phases of viral replication | Abílio et al.73 |
| Carotenoids | ||||
| Sargassum aquifolium (formerly Sargassum echinocarpum) | anti-cancer | caspase-3 protein (apoptosis target) | showed strong binding affinity to caspase-3, indicating high apoptosis-induction potential; formed multiple H-bonds and hydrophobic interactions stabilizing caspase-3 | Mualimin and Arum74 |
| Hijikia fusiformis, Undaria pinnatifida, Sargassum fulvellum | anti-cancer | ovarian cancer cells (PA-1) | induced apoptosis dose dependently in PA-1 cells; reduced cell viability better than tamoxifen at low concentrations after 24 h; IC50 of 5.9 μM at 24 h | Saxena et al.75 |
| Sargassum angustifolium | anti-diabetic, anti-obesity | STZ-nicotinamide-induced type 2 diabetic mice | prevented weight gain, improved blood glucose and insulin levels comparable to metformin, enhanced lipid profile, and promoted pancreatic beta cell regeneration in diabetic mice | Oliyaei et al.76 |
| Proteins and bioactive peptides | ||||
| Porphyra yezoensis | anti-coagulant | in vitro coagulation assays using human plasma; thrombosis | dose-dependent prolongation of activated partial thromboplastin time (APTT) from 35 s to 320 s; IC50 = 0.3 μM; no effect on prothrombin or thrombin time; purified 1.77 kDa peptide (NMEKGSSSVVSSRMKQ) selectively inhibited the intrinsic coagulation pathway | Indumathi and Mehta77 |
| Ulva lactuca | anti-oxidant | in vitro anti-oxidant and enzyme-based assays; cell-free systems; RAW 264.7 cells (cytotoxicity) | increased protein recovery along with phenolics and other bioactives; highest anti-oxidant activity observed, with ABTS value of 5.45 ± 0.11 mg (AAE)/g and total anti-oxidant capacity of 8.03 ± 0.06 mg (TE)/g; high recovery of total phenolics (39.82 ± 0.32 mg GAE/g), saponins (13.22 ± 0.33 mg DE/g), and flavonoids (6.5 ± 0.47 mg QE/g) | Pangestuti et al.12 |
| Ulva rigida | anti-diabetic/anti-oxidant | in vitro ACE-I inhibition and anti-oxidant assays (ACE enzyme system; FRAP assay) | protein hydrolysates generated bioactive peptides (Ile-Pro and Ala-Phe-Leu) exhibiting significant ACE inhibitory activity and strong ferric-reducing anti-oxidant power | Paiva et al.78 |
| Palmaria palmata | anti-diabetic |
in vitro DPP-IV inhibition assays; BRIN-BD11 pancreatic β-cells; enteroendocrine STC-1 cells; in vivo glucose regulation in NIH Swiss mice |
protein hydrolysates inhibited DPP-IV activity and enhanced secretion of incretin hormones (GLP-1, GIP) and insulin; bioactive peptides ILAP, LLAP, and MAGVDHI significantly prolonged GLP-1 half-life. ILAP and LLAP stimulated insulin secretion in BRIN-BD11 cells (p < 0.001), with increased cAMP production, and acted as GIP secretagogues in STC-1 cells (p < 0.01); in vivo, ILAP and LLAP elevated plasma insulin (p < 0.01) and reduced blood glucose (p < 0.05) in mice, while MAGVDHI reduced food intake (p < 0.001), indicating strong incretin-mediated anti-diabetic potential | Harnedy-Rothwell et al.79 |
| Palmaria palmata | anti-diabetic and anti-obesity (incretin mediated) |
in vitro pancreatic BRIN-BD11 β-cells, enteroendocrine GLUTag and STC-1 cells; DPP-4 inhibition assays; simulated gastrointestinal digestion (SGID). in vivo glucose tolerance and satiety tests in mice |
protein hydrolysates (0.02–2.5 mg mL−1) exhibited significant insulinotropic activity, DPP-4 inhibition, and stimulated GLP-1 and GIP secretion, with bioactivity largely retained after SGID. The alcalase/flavourzyme hydrolysate produced the strongest response, increasing cAMP levels (1.7-fold) and enhancing intracellular Ca2+ signaling; acute administration improved glucose tolerance and satiety in mice, indicating strong incretin-mediated anti-diabetic and anti-obesity potential | McLaughlin et al.80 |
| Caulerpa sertularioides | anti-inflammatory and anti-oxidant | in vitro anti-inflammatory assays; DPPH anti-oxidant assay; protein characterization (SDS-PAGE, MALDI-MS); inflammation and oxidative stress | exhibited stronger anti-inflammatory and anti-oxidant effects at lower doses; DPPH radical-scavenging IC50 values of 456.1 μg mL−1; protein denaturation IC50 values of 66.78 μg mL−1; membrane stabilization IC50 values of 88.96 μg mL−1; protease inhibition IC50 values of 59.54 μg mL−1; 17 kDa lectin as the active protein was identified by SDS-PAGE; mass fingerprinting revealed a remorin-like protein sharing 65% sequence similarity with plant remorin-like proteins | Sanniyasi et al.81 |
| Various red, brown, and green seaweeds | functional food and techno-functional activity | food prototypes (meat products and meat analog formulations); reformulated foods | incorporation of seaweed ingredients improved nutritional value and contributed techno-functional properties such as binding capacity and texture enhancement in meat and meat analogue products; seaweed proteins, along with other bioactive components, supported functional performance in food matrices | Yesuraj et al.23 |
| Palmaria palmata | anti-obesity and anti-diabetic | in vitro enzyme inhibition assays (pancreatic lipase, α-amylase); peptide identification (LC-MS/MS); molecular docking analysis; obesity and type 2 diabetes | alcalase hydrolysate showed the highest protein content (10.11 ± 0.15%) and degree of hydrolysis (30.36 ± 0.77%); strong pancreatic lipase inhibition, with the lowest IC50 values of 2.29 ± 0.87 mg mL−1 and significant α-amylase inhibition (p < 0.05); ultra-filtrated peptide fractions <1 kDa and 1–3 kDa exhibited the highest inhibitory activity, with IC50 values of 3.25–3.55 mg mL−1 for both enzymes | Ghelichi et al.40 |
| Palmaria palmata | anti-diabetic and anti-obesity | in vivo STZ-induced diabetic mouse model; type 2 diabetes, hyperglycaemia, and metabolic dysfunction | twice-daily oral administration of protein hydrolysate (50 mg kg−1 BW) reduced non-fasting blood glucose from day 9 onward (p < 0.01), with effects sustained until day 18 (p < 0.001); fasting blood glucose reduced to 12 mmol L−1 compared to saline control (27 mmol L−1); HbA1c reduced by 30% vs. saline (metformin: 35%); body weight decreased by 8% (p < 0.01) compared to 5% with metformin (p < 0.05) | McLaughlin et al.82 |
N/A, data not available.
Laminarins
Laminarins are the major storage polysaccharides present predominantly in brown seaweed species such as Laminaria, Saccharina, Ecklonia, and Eisenia and at lower levels in Fucus, Undaria, and Ascophyllum. Laminarins are water soluble and constitute up to 35% of the dry weight.4,85 They have a low molecular weight of approximately 5 kDa, with a degree of polymerization between 20 and 25.86 Structurally, they are made up of the main chain of glucose units linked by β-(1,3) linkages with β-(1,6)-linked side chains.87 Based on the nature of their reducing ends, two structural types of laminarins are found: M chain and G chain. M-chain laminarins have D-mannitol at the reducing end, whereas G-chain laminarins terminate with glucose at the reducing end.88 This short-chain, non-sulfated polysaccharide confer various biological activities, summarized in Table 2, which include anti-cancer, anti-oxidant, anti-inflammatory, anti-coagulant, anti-obesity, anti-diabetic, and anti-viral.85,88 The biological function of laminarins depends on their molecular size, method of extraction, sugar composition, type of linkages, and molecular geometry.56
Carrageenans
Carrageenans are negatively charged sulfated polysaccharides majorly found in red seaweeds. They are anionic polysaccharides, with a molecular weight ranging from 100 to 1,000 kDa. The exact molecular weight can vary based on the type of carrageenan.89 Red seaweeds such as Kappaphycus alvarezii (formerly Euchema cottonii) and Euchema denticulatum contribute to majority of the carrageenan production globally. Carrageenans are long, straight chains of galactose sugars, with sulfate groups attached at various positions. They are built from repeat pairs of galactose units, with one unit of β-D-galactopyranose linked through its third carbon and α-D-galactopyranose or 3,6-anhydro-α-D-galactopyranose linked through its fourth carbon. Based on these structural differences, carrageenans are classified into three types, namely kappa, iota, and lambda. They differ mainly based on the degree and position of sulfation and the presence of 3,6-anhydro bridges.90 They possess a wide range of biological activities such as anti-oxidant, anti-bacterial, anti-viral, anti-hyperlipidemic, anti-coagulant, anti-cancer, and immunomodulatory effects (Table 2), which are attributed to their sulfated nature.91
Polyphenols and phlorotannins
Polyphenols are secondary metabolites derived from seaweeds. They are produced in response to the environmental and ecological stress including UV exposure, herbivore grazing, and other abiotic factors.44 Structurally, polyphenolic compounds consist of one or more hydroxyl groups (–OH), linked directly to an aromatic hydrocarbon (benzene) group.3 The presence of multiple hydroxyl groups makes them highly reactive toward free radicles, which are generated as an integral part of metabolism and can cause cytotoxicity and cellular dysfunction. Each (–OH) group of a polyphenol can donate a hydrogen or electron to neutralize a free radical, after which the radical diffuses its charge across the aromatic ring and becomes non-reactive.92 Seaweed-derived polyphenols include flavonols, catechins, and phlorotannins. Among them, phlorotannins are predominantly present in brown seaweeds, accounting for about 5%–15% of the dry weight. They are polyphenolic compounds formed through the polymerization of phloroglucinol (1, 3, 5-trihydroxybenzene) units via the acetate-malonate pathway.3,92 Marine algal phlorotannins are an extremely heterogeneous group of polyphenolic molecules composed of varying numbers of phloroglucinol units. Depending on their linkage types, phlorotannins are grouped into six structural subclasses, namely fucols, phlorethols and fuhalols, fucophlorethols, eckols and carmalols, and phenoxyphlorotannins. Their molecular weight ranges from 200 to over 650 kDa.10,44 Their multiple phenolic rings and abundant hydroxyl groups contribute to a wide range of potential biological activities,3,92 which are summarized in Table 2.
Marine alkaloids
Alkaloids are secondary metabolites produced in various seaweeds and serve ecological functions like defense and signaling. They are nitrogen-containing organic compounds with a cyclic ring, derived from amino acids or amine precursors such as tryptophan, tyrosine, and lysine. Seaweed alkaloids contain heterocyclic rings with at least one nitrogen atom. They may also incorporate halogen atoms (such as Cl, Br, and I) into their structures, forming halogenated alkaloids. These compounds often possess aromatic or polycyclic skeletal features, which contribute to their structural diversity. Marine alkaloids range from simple amine derivatives to complex halogenated multiring structures. These seaweed-derived alkaloids can be structurally classified into phenylethylamine derivatives, indole and halogenated indole alkaloids, and other alkaloids.93,94 Among them, caulerpin and racemosin are bis-indole alkaloids derived from the green seaweed Caulerpa species. Red seaweeds like Gracilaria species were also reported to contain halogenated indole alkaloids. Their diversity in terms of ring structures and halogenation patterns gives rise to anti-inflammatory, anti-microbial, cytotoxic, anti-oxidant, and other biological activities.94,95
Carotenoids
Carotenoids are naturally occurring pigments found in most fruits, vegetables, plants, algae, and photosynthetic bacteria. They have a wide range of functions in human health. However, humans cannot produce carotenoids and must ingest them through dietary intake or via supplementation.96 Different species of seaweeds contain distinct types of carotenoids, among which beta carotene, fucoxanthin, and tocopherol are important.92 Among these, fucoxanthin is a tetraterpenoid carotenoid that is predominantly found in different species of brown algae.8 Fucoxanthin functions as a light-harvesting pigment for photosynthesis and acts as a photoprotective agent against excess light energy. It absorbs specific wavelengths of blue and green light and transfers that energy to chlorophyll in seaweeds. Additionally, fucoxanthin serves as a potent anti-oxidant, protecting against oxidative damage.97 Most of the anti-oxidants such as beta carotene or ascorbic acid donate protons, whereas fucoxanthin donates electron to quench reactive oxygen species (ROS).41 Fucoxanthin derived from different seaweeds exhibits diverse biological properties including anti-oxidant, anti-cancer, anti-inflammatory, anti-obesity, neuroprotective, photoprotective, and osteoporosis preventive effects.8 Seaweed bioactive compounds, their mode of action, and biological activities are illustrated in Figure 2.
Figure 2.
Seaweed bioactive compounds and their health benefits
Proteins and bioactive peptides
Seaweed proteins contain nutritionally valuable bioactive components, which play a significant role in their structure and metabolism. Seaweed proteins are made of a diverse range of molecules including enzymes, glycoproteins, cell wall-associated proteins, and phycobiliproteins.98 These compounds collectively contribute to the biological functionality of seaweeds and represent an important class of marine bioactives. Seaweed proteins and their derived peptides are nitrogen-containing compounds composed of amino acids and are often associated with complex cell wall polysaccharides such as ulvans, alginate, and carrageenans, which can influence their extractability and functional properties.99
Bioactive peptides from the proteins are typically released through enzymatic, physical, or chemical hydrolysis processes. These processes disrupt native protein folding, resulting in the production of short amino acid sequences with enhanced biological activity.99 These proteins are rich in essential amino acids and also include bioactive peptides with therapeutic properties.77 Seaweed proteins are rich in essential amino acids such as glycine, arginine, glutamic acid, and alanine, with the highest EAAs /NEAAs ratios generally found in red seaweeds (0.98–1.02), followed by green (0.72–0.97) and brown taxa (0.73).5
Several studies have reported diverse strategies for the extraction of seaweed proteins and preparation of bioactive peptides. In general, proteins are subjected to hydrolysis using proteolytic enzymes or physical and chemical treatments that disrupt their native structure and facilitate peptide release. Protein extraction may be carried out as a standalone process or as a combined approach involving two or more sequential or integrated steps.99 Enzymatic hydrolysis remains one of the most widely employed and selective methods for producing peptide-rich fractions from seaweeds.77 Beyond conventional enzymatic approaches, emerging green technologies such as subcritical water hydrolysis have gained increasing attention due to their efficiency and reduced chemical input.12 At a broader scale, biorefinery-oriented strategies integrate protein extraction with the recovery of other valuable seaweed components as a key valorization step within integrated processing frameworks.1 Notably, the protein hydrolysates and peptide-rich extracts derived from seaweeds have been widely reported to exhibit a broad spectrum of biological activities, including anti-oxidant, anti-microbial, anti-inflammatory, anti-hypertensive, anti-diabetic, and anti-tumor.98,99 Owing to these multifunctional bioactive properties, seaweed proteins and peptides have gained increasing interest for potential applications in the nutraceutical, cosmetic, and pharmaceutical sectors.100 The bioactive properties of proteins and peptides are summarized in Table 2.
Therapeutic properties and mechanisms of action
Anti-oxidant and anti-inflammatory activities
Free radicals and Reactive Oxygen Species (ROS) are formed in the body endogenously through metabolic processes and exogenously through environmental exposures. These free radicals cause oxidative stress, which is associated with the development of chronic diseases including cardiovascular diseases, neurodegenerative disorders, cancers, and diabetes. If unmanaged, these free radicals damage lipids, proteins, and DNA, leading to cellular dysfunction.48 Similarly, inflammation is caused by several factors, even without any injury. Factors such as autoimmune disorders, chronic stress, poor sleep, and obesity and external factors including pollution, smoking, and chemical exposure cause chronic inflammation.101 Anti-oxidants play a key role in neutralizing free radicals and alleviating oxidative stress, thus mitigating chronic inflammation,48 whereas anti-inflammatory compounds work by inhibiting pro-inflammatory pathways and reducing the production of inflammatory markers.102 Seaweeds exhibit substantial anti-oxidant and anti-inflammatory properties (Tables 2 and 3) due to the abundance of bioactive compounds such as phlorotannins, flavonoids, carotenoids, sulfated polysaccharides, and vitamins.
Table 3.
Seaweed-derived compounds and their biological activities
| Seaweed | Solvent/extract used | Compound used | Assay | Reference |
|---|---|---|---|---|
| Anti-oxidant activity | ||||
| Laminaria ochroleuca | ethanolic water extract (1:1) | N/A | ABTS, DPPH, NO, O2, and ORAC-FL assays | Amaro et al.18 |
| Grateloupia turuturu | polar lipid extracts | N/A | ABTS and DPPH assays | Da Costa et al.103 |
| Sargassum ilicifolium (formerly Sargassum cristaefolium) | crude lipid extract | N/A | DPPH and FRAP assays | Saraswati et al.104 |
| Champia parvula | aqueous extract | gold nanoparticles (AuNPs) | DPPH, H2O2 scavenging activity, and FRAP assays | Viswanathan et al.105 |
| Caulerpa racemosa, Caulerpa sertularioides | N/A | extracted protein | DPPH assay | Sanniyasi et al.81 |
| Chaetomorpha aerea | acetone extracts | N/A | DPPH and ABTS assays | Hasan et al.106 |
| Sargassum filipendula | UV-treated extracts | N/A | ABTS, DPPH, and FRAP assays | Polo and Chow107 |
| Anti-inflammatory activity | ||||
| Laminaria ochroleuca | ethanolic water extract (1:1) | N/A | human red blood cell assay, cyclooxygenase-2 (COX-2) enzymatic activity | Amaro et al.18 |
| Grateloupia turuturu | polar lipid extracts | N/A | COX-2 enzymatic activity | Da Costa et al.103 |
| Sargassum ilicifolium (formerly Sargassum cristaefolium) | crude lipid extracts | N/A | inhibition of NO production by the LPS-induced RAW 264.7 cells | Saraswati et al.104 |
| Caulerpa racemosa, Caulerpa sertularioides | N/A | extracted protein | protein denaturation inhibition assay, membrane stabilization assay, and trypsin inhibition assay | Sanniyasi et al.81 |
| Padina pavonia and Jania rubens | methanolic extract (1:30) | N/A | functions of liver and kidney assay, malondialdehyde and anti-oxidant assays, and inflammatory cytokine and protein assays | Eman et al.108 |
| Chaetomorpha aerea | acetone extracts | N/A | in vitro protein denaturation assay and carrageenan-induced paw edema test | Hasan et al.106 |
| Anti-cancer activity | ||||
| Padina pavonica, Jania rubens | methanolic extracts (1:30) | N/A | MTT and trypan blue exclusion assays | El-Sheekh et al.109 |
| Caulerpa taxifolia | N/A | zinc oxide nanoparticles | MTT assay, acridine orange and ethidium bromide double staining, and DNA fragmentation assay | Perumal et al.110 |
| Ulva rigida | N/A | silver nanoparticles | anti-cancer activity against human breast cancer cell line (MCF-7) | Algotiml et al.111 |
| Sargassum polycystum | acidic water extracts | water-soluble crude sulfated polysaccharide | MTT assay | Digala et al.112 |
| Champia parvula | aqueous extract | gold nanoparticles (AuNPs) | MTT assay | Viswanathan et al.105 |
| Ulva compressa (formerly Enteromorpha compressa) | methanolic extracts | N/A | MTT assay, clonogenic and scratch assay | – |
| Padina boergesenii | aqueous extract | N/A | MTT assay | Thirupathi et al.113 |
| Halimeda tuna | methanolic extracts | N/A | MTT assay | Husni et al.114 |
| Halimeda gracilis | methanol & ethyl acetate extracts | N/A | in vitro cytotoxic activity, mitochondrial membrane potential assay, nuclear condensation assay, apoptosis assay, and dual staining assay | Ramalingam et al.115 |
| Anti-microbial activity | ||||
| Ulva lactuca | Aqueous extract | N/A | disk diffusion assay | – |
| Amphiroa anceps, Corallina officinalis and Sargassum filipendula | organic extracts | N/A | bacterial inhibition assay | Mofeed et al.116 |
| Kappaphycus alvarezii | N/A | N/A | in vitro anti-bacterial activity assay | Das et al.117 |
| Chondrus crispus, Sarcodiotheca gaudichaudii | aqueous extract | N/A | minimum inhibitory concentration assay | Kulshreshtha et al.118 |
| Anti-viral activity | ||||
| Ulva lactuca | aqueous extract | N/A | virus propagation and anti-viral assay | Maray et al.119 |
| Amphiroa anceps, Corallina officinalis, Sargassum filipendula | organic extracts | N/A | cytotoxicity (MTT) assay | Mofeed et al.116 |
| Sargassum filipendula | methanolic extracts | N/A | retroviral reverse transcriptase (RT) activity | Polo and Chow107 |
| Monostroma nitidum | aqueous extract | N/A | MTT assay | – |
| Anti-obesity activity | ||||
| Grateloupia elliptica | ethanol extract | N/A | cell viability assay, Oil Red O Staining method | Lee et al.120 |
| Gloiopeltis furcata | ethanol extract | N/A | pancreatic lipase inhibition assay (in vitro), animal model of diet-induced obesity (in vivo) | Murakami et al.121 |
| Padina arborescens | enzyme-assisted hydrolysate and crude polysaccharide | N/A | cytotoxicity (MTT) assay and Oil Red O Staining method | Lee et al.122 |
| Bangia fuscopurpurea | N/A | polysaccharide | cell viability (colorimetric) assay, Oil Red O Staining method | Zheng et al.123 |
| Anti-diabetic activity | ||||
| Ulva intestinalis (formerly Enteromorpha intestinalis) | methanolic extracts | N/A | α-amylase and α-glucosidase inhibition assays | Pradhan et al.91 |
| Chaetomorpha aerea | acetone extracts | N/A | in vitro α-amylase inhibitory assay and oral glucose tolerance test | Hasan et al.106 |
| Gloiopeltis furcata | ethanol extract | N/A | glucose tolerance test, serum biochemical analysis | Murakami et al.121 |
| Ulva reticulata | crude extract | N/A | in vitro α-amylase, α-glucosidase, and DPP-IV inhibition assay | Unnikrishnan et al.124 |
DPPH, 2,2-diphenyl-1-picrylhydrazyl assay; ABTS, 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) assay; NO, nitric acid assay; ORAC-FL, oxygen radical absorbance capacity-fluorescein method; FRAP, ferric-reducing anti-oxidant power; COX-2, cyclooxygenase; MTT, 3, (4,5- dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay; DPP-IV, dipeptidyl peptidase-IV assay.
N/A, data not available.
Carrageenans are sulfated polysaccharides derived from red seaweeds and exhibit notable anti-oxidant and anti-inflammatory properties. Native carrageenan isolated from Kappaphycus alvarezii possesses high anti-inflammatory activity up to 84.89% compared with commercial carrageenans.63 Sodium hydroxide-extracted carrageenan from Kappaphycus alvarezii exhibited a high radical-scavenging activity, measured in vitro using DPPH assays, indicating that the extraction chemistry significantly enhances the activity. The NaOH-extracted carrageenan displayed non-Newtonian gel-forming behavior, making it suitable for pharmaceutical use. Mechanistically, carrageenans can suppress nitric oxide and prostaglandin E2 synthesis that contributes to inflammation. They inhibit the activity or expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) enzymes, which make them a potent therapeutic agent against inflammatory conditions.64
Fucoidans, fucose-rich sulfated polysaccharides found in the brown seaweeds Padina pavonica and Saccharina japonica, exhibit strong anti-oxidant and anti-inflammatory properties. The extracted fucoidan showed the highest ferric-reducing anti-oxidant power (FRAP; IC50 = 113.21 μg/mL).86 Similarly, another fraction of fucoidan extracted from Saccharina japonica showed significant radical-scavenging activity, with ABTS (2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) assay) and FRAP values of 1.02 and 5.39 mg Trolox equivalent per gram (TE/g), respectively. This enhanced activity was correlated with its high sulfate content (17.85%) and the presence of (1→3)/(1→4)-linked α-L-fucopyranose (α-L-fucp) residues.55 Similar to fucoidans, laminarins, which are β-glucan polysaccharides present in brown algae, possess potent anti-oxidant activities through hydrogen donation and metal ion reduction.
Laminarins, β-glucan polysaccharides found in brown algae such as Laminaria hyperborea and Sargassum mcclurei, also exhibit anti-oxidant activity through hydrogen donation and metal ion reduction. They have demonstrated strong radical-scavenging, ferric-reducing, and lipoxygenase inhibitory activities (Figure 3). However, excessive purification reduces their bioactivity, likely due to the loss of synergistic co-metabolites.59 Molecular weight and sulfate content further influence their functional potency.60
Figure 3.
In vitro anti-oxidant and anti-inflammatory actions of laminarin
Brown algal phlorotannins, polymeric phenolic compounds composed of phloroglucinol units, show stronger anti-oxidant activity through electron transfer and radical quenching. Extracts of Eisenia bicyclis showed higher total phenolic content and strong radical-scavenging capacity (DPPH), with IC50 values of 47 μg/mL.67 Similarly, phlorotannins from Cystoseira compressa exhibited potent in vitro radical-scavenging activity, with low IC50 values in DPPH and ABTS assays and no cytotoxicity toward normal cells. Their molecular mechanism involves the direct transfer of hydrogen atoms to neutralize ROS and inhibit oxidative stress-induced cytokine formation, which contribute to the anti-inflammatory activity.68
In addition to polysaccharides and phenolics, seaweed proteins and peptides also exhibit pronounced anti-inflammatory potential. Green macroalgae of the genus Caulerpa exhibited notable anti-inflammatory effects mediated by proteinaceous components. Extracts of Caulerpa racemosa and Caulerpa sertularioides significantly inhibited protein denaturation, membrane destabilization, and protease activity in vitro, with Caulerpa sertularioides displaying stronger anti-inflammatory effects at lower concentrations. The activity was attributed to a ∼17 kDa lectin identified as a remorin-like protein, representing the first report of such an anti-inflammatory lectin from Caulerpa sertularioides.56 Similarly, protein- and peptide-rich fractions from Palmaria palmata exhibited significant anti-inflammatory activity. Thermolysin-digested water extracts significantly inhibited TNF-α, IL-6, and nitric oxide production in lipopolysaccharide (LPS)-stimulated macrophages and attenuated carrageenan-induced acute inflammation in vivo.125 Extracts from the green seaweed Ulva lactuca showed strong anti-oxidant potential in various in vitro assays, including ABTS and total anti-oxidant capacity measurements. The extracts exhibited high ABTS radical-scavenging activity (5.45 ± 0.11 mg AAE/g) and total anti-oxidant capacity (8.03 ± 0.06 mg TE/g), accompanied by substantial recovery of bioactive compounds such as phenolics, flavonoids, and saponins.126 Similarly, bioactive peptides derived from the red seaweed Gracilaria gracilis have shown significant anti-oxidant activity in vitro. Short-chain peptides obtained from enzymatic hydrolysis exhibited strong radical-scavenging and reducing capacities, as demonstrated by TEAC, DPPH, FRAP, and ABTS assays. In particular, the peptide fractions displayed Trolox Equivalent AntioxidantCapacity (TEAC) values of up to 60.8% and FRAP values of 4638 μmol TE/g, indicating that lower-molecular weight peptides contribute substantially to the anti-oxidant potential of G. gracilis.127
Gold nanoparticles (AuNPs) derived from the red seaweed Champia parvula exhibited strong radical-scavenging activity, as evidenced by DPPH, FRAP, and H2O2-scavenging assays, and are likely to exert protective cellular effects by neutralizing reactive radicals and maintaining a redox equilibrium.105 Meanwhile, methanolic and aqueous extracts from Caulerpa racemosa and Caulerpa sertularioides have shown strong radical-scavenging activity, validated by DPPH and ABTS assays.81 Furthermore, UV-treated samples of Sargassum filipendula exhibited enhanced anti-oxidant activity, as evaluated by DPPH, ABTS, FRAP, and metal-chelation assays, where light-induced generation of secondary metabolites improved anti-oxidant capacity across multiple assay systems.107 In addition, subcritical water hydrolysates of Ulva lactuca containing protein/peptides exhibited strong anti-oxidant activity, showing the highest ABTS radical-scavenging and total anti-oxidant capacity. The enhanced activity correlated with elevated levels of phenolics (gallic and vanillic acids) and protein/peptide-rich fractions, with no toxicity to RAW 264.7 cells observed.12
Similarly, acetone extracts of Chaetomorpha aerea showed strong anti-oxidant activity in DPPH and ABTS assays. The anti-inflammatory potential was validated using in vitro protein denaturation assays and in vivo carrageenan-induced paw edema models.106 Meanwhile, Padina pavonia (Phaeophyceae) and Jania rubens (Rhodophyceae) were evaluated in a CCl4-induced liver injury model in mice. Both the pre-treatment and post-treatment with these seaweed extracts significantly reduced hepatic necrosis, fibrosis, and inflammation.108 Both native and commercial carrageenans derived from Kappaphycus alvarezii exhibited enhanced anti-oxidant enzyme levels and displayed dose-dependent anti-inflammatory activity up to 2,000 mg/kg in Wistar albino rats. Brine shrimp lethality assay on both the carrageenans also showed LC50 values of 160.41 and 200 μg/mL, respectively. Meanwhile, hemolytic assays of the same also exhibited 38.31% and 65.75% activity, respectively. Although mechanistic and preclinical studies support the anti-oxidant and anti-inflammatory potential of seaweed-derived compounds, clinical studies are still limited.
Anti-cancer activities
Worldwide, cancer has been considered as one of the leading causes of death. It is characterized by abnormal proliferation of cells and invasiveness of abnormal cells that spread to neighboring tissues. Although several anti-cancer drugs have been developed and used widely, they exhibit high toxicity to the tumor as well as normal healthy cells. Additionally, due to the increase in the occurrence of various types of cancers, there is a need for novel anti-cancer drugs. Currently, the search for novel anti-cancer compounds is being carried out using terrestrial plants and in marine environments.128 Seaweeds are a significant source of bioactive compounds with potential therapeutic applications. Bioactive compounds extracted from various seaweeds have shown anti-cancer properties, as summarized in Tables 2 and 3.109
Fucoidans, sulfated polysaccharides found in brown seaweeds, have repeatedly exhibited selective cytotoxicity to cancer cells without affecting normal cells. Fucoidan extracted from Fucus vesiculosus displayed cytotoxic and growth-inhibitory effects toward the cholangiocarcinoma (CL-6) cells. It disrupts the mitochondrial membrane potential (ΔΨm), which leads to mitochondrial dysfunction, resulting in mitochondria-dependent apoptosis. Furthermore, fucoidan was reported to cause G0/G1 phase arrest by downregulating cyclin D1 and CDK4. These effects were accompanied by the upregulation of Bax and downregulation of Bcl-2 proteins, showing both pro-apoptotic and anti-proliferative roles (Figure 4).50 Similar to fucoidan, laminarin extracted from Padina pavonica exhibited cytotoxic activity against human colon adenocarcinoma (HT-29) cells. It triggered both apoptotic and necrotic pathways of cell death without causing any toxicity to normal cells.56 Additionally, aminated laminarin isolated from Saccharina cichorioides has been reported to radiosensitize MDA-MB-231 breast cancer cells to radiation treatment. This radiosensitizing activity enhanced DNA fragmentation and triggered mitochondria-mediated apoptosis.57 Red algal sulfated polysaccharides, κ- and λ-carrageenans from Chondrus armatus, selectively inhibited gastrointestinal cancer cell lines including those of colon cancer (HCT-116 and RKO) and esophageal cancer (KYSE-30 and FLO-1). These bioactives induced apoptosis and cell cycle arrest, with minimal toxicity to normal retinal pigment epithelial (RPE-1) cells.61
Figure 4.
Proposed in vitro anti-cancer mechanism of fucoidan
Fucoidan extracted from Stoechospermum polypodioides (formerly Stoechospermum marginatum), Sargassum aquifolium (formerly Sargassum echinocarpum), and Fucus vesiculosus demonstrated robust anti-cancer effects against liver, breast, and cholangiocarcinoma cell lines. Fucoidan from the brown seaweed Stoechospermum marginatum and Sargassum echinocarpum exhibited substantial inhibition of HepG2 liver cancer cells and MCF-7 breast cancer cells through apoptosis, DNA fragmentation, and oxidative stress. The extracted fucoidan exhibited a selective index of 7.62 against the MCF-7 breast cancer cells. The fucoidan targeted directly only the cancer cells, without causing any toxicity or loss of viability to normal cells.49,129,130 Similarly, laminarin from Saccharina japonica (formerly Laminaria japonica) suppressed the progression of hepatocellular carcinoma through the upregulation of senescence marker protein-30 (SMP-30) in both in vivo and in vitro models.58 Carrageenan extracted from the red seaweed Gigartina pistillata effectively suppressed colorectal cancer stem cell (CSC)-enriched tumor spheres, derived from HT29, SW620, SW480, and HCT116 cell lines. Tetrasporophyte (T) carrageenan extract significantly reduced cellular viability in SW620- and SW480-derived tumor spheres in a dose-independent manner at sub-micromolar levels.44
Caulerpin, a bis-indole alkaloid extracted from Caulerpa species, has been recognized for its selective cytotoxic properties. In particular, caulerpin from Caulerpa cylindracea exhibited potent cytotoxic activity against the colorectal cancer cell lines HCT-116 and HT-29, with IC50 values of 119 and 179 μM, respectively. The compound induced apoptosis and inhibited colony formation in these cancer cell lines.131 Similarly, monomethyl caulerpinate from Caulerpa cylindracea exhibited dual biological activity; it potently inhibited SARS-CoV-2 spike protein and ACE2 receptor interaction, with an IC50 value of 190.2 nM. While exhibiting selective cytotoxicity toward the breast cancer cells MCF-7 and MDA-MB-231, with IC50 values of 13.0–17.3 μM, without affecting normal cells.47 Surprisingly, caulerpin was isolated from a new source, that is, a brown algae Sargassum platycarpum, for the first time. The isolated caulerpin inhibited HepG2 liver cancer cells (IC50 = 24.6 ± 2.1 μg/mL), with low toxicity.72
Fucoxanthin from Sargassum aquifolium (formerly Sargassum echinocarpum) showed a stable in silico binding affinity toward caspase-3, thus inducing apopstosis.74 In vitro studies from Sargassum fusiforme (formerly Hijikia fusiformis), Undaria pinnatifida, and Sargassum fulvellum have shown its inhibitory effect on ovarian cancer (PA-1) cells in a dose-dependent manner. Remarkably, it achieved an IC50 of 5.9 μM within 24 h, outperforming tamoxifen at equivalent concentrations, with fewer or negligible side effects.75
Crude water-soluble sulfated polysaccharides from Sargassum polycystum demonstrated selective cytotoxicity against HeLa cervical cancer cells without affecting the normal cells.112 Similarly, methanolic extracts of the green seaweed Ulva compressa (formerly Enteromorpha compressa) showed promising anti-cancer activity against oral squamous cell carcinoma (OSCC), which was evidenced by clonogenic, scratch, and 3, (4,5- dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays.132 Meanwhile, methanolic extracts from Halimeda tuna were tested for their cytotoxic effects against the A549 lung cancer cells. The extracts exhibited an IC50 value of 2,771 μg/mL, which inhibited their potential to be used as chemopreventive agents.133
Methanolic extracts from the brown algae Padina pavonica and the red algae Jania rubens exhibited notable cytotoxic effects against human liver cancer Hep-G2 cells in both in vitro and in vivo models. In vitro assays including MTT and trypan blue exclusion confirmed a significant reduction in cell viability. In vivo models using Ehrlich ascites carcinoma (EAC) mice demonstrated reduced tumor cell proliferation and enhanced apoptosis upon treatment with these extracts.109
Integration of nanotechnology with the seaweed-derived bioactives to produce novel nanoparticle formulations represents an advancement over traditional extracts in terms of anti-cancer potential and bioavailability. A nanoformulation, Fu/NCur/SeNPs, consisting of fucoidan from Undaria pinnatifida along with curcumin and selenium nanoparticles, was synthesized. This formulation exhibited enhanced efficacy against colorectal carcinoma cells through synergistic effects on DNA damage and autophagy in a dose-dependent manner, with efficiency superior to that of the standard chemotherapeutic agent cisplatin.51 Zinc oxide nanoparticles (ZnO NPs) biosynthesized from the green seaweed Caulerpa taxifolia exhibited apoptosis-mediated suppression in HeLa cervical cancer cells.110 Similarly, silver nanoparticles (AgNPs) synthesized from Ulva rigida exhibited strong anti-proliferative activity (92.62%) against MCF-7 breast cancer cells, with greater selectivity relative to normal cells (IC50 = 13 μg/mL), with a selective index of 3.2.111 AuNPs synthesized from the red seaweed Champia parvula also exhibited notable cytotoxicity against A549 lung carcinoma cells.105 Additionally, selenium-zinc oxide nanoparticles (Se-ZnO NPs) synthesized from Padina boergesenii induced strong cytotoxic responses in both HepG2 breast cancer and MCF-7 hepatoblastoma cell lines.134
Although available evidence for the anti-cancer role of seaweed-derived compounds remains preclinical, limited human studies have begun to validate the therapeutic potential of these compounds, particularly fucoidan. In a randomized, double-blind trial, low-molecular weight fucoidan (LMF) was tested in patients with metastatic colorectal cancer. The participants received 4 g of LMF twice daily for 6 months alongside standard chemotherapy. The treatment improved disease control and overall response without causing additional side effects and blood, kidney, or liver toxicity.135 In another study, cancer survivors with post-treatment fatigue received fucoidan from Fucus vesiculosus and Undaria pinnatifida orally for 8 weeks. The supplementation was safe, well tolerated, and caused improvements in fatigue, frailty, and inflammation, with no major safety concerns reported.136 These human clinical studies are summarized in Table 5.
Table 5.
Summary of human clinical studies investigating therapeutic effects of seaweed-derived compounds
| Seaweed species/extract | Study design & population | Dose & duration | Primary outcomes | Adverse events | Reference |
|---|---|---|---|---|---|
| Red seaweed-derived mineral complex (AlgaeCal®) | long-term observational follow-up in adult female consumers; prior supplement use for 1–7 years; bone mineral density data (n = 172) and blood chemistry data (n = 30), compared with large external reference databases | daily oral supplementation; continuous or repeated use over 1–7 years (dose as reported in original study) | bone mineral density (DEXA); blood chemistry (45 parameters) | no serious supplement-related adverse effects; no adverse changes in blood lipids or cardiovascular risk markers were observed | Kaats et al.156 |
| Ascophyllum nodosum | randomized dietary intervention in healthy, non-pregnant women of childbearing age with low dairy/seafood intake and mild iodine insufficiency | acute test: 1 g seaweed (∼712 μg iodine); intervention: 0.5 g/day for 2 weeks | urinary iodine concentration; iodine bioavailability; thyroid function (TSH, free thyroxine) | mild increase in TSH was observed; two participants showed greater than normal TSH range post-intervention, but free thyroxine remained normal; no major safety concerns at low dose | Combet et al.160 |
| Fucoidan (low-molecular weight fucoidan) | randomized, double-blind, controlled trial in patients with metastatic colorectal cancer (mCRC); study group (n = 28) vs. control group (n = 26); median follow-up, 11.5 months | 4 g LMF twice daily (BID) as oral powder for 6 months, administered alongside chemotarget agents | disease control rate (primary); overall response rate, progression-free survival, overall survival, and quality of life (secondary) | no significant differences in adverse effects, hematological toxicity, or renal/hepatic safety parameters between the groups | Tsai et al.135 |
| Fucoidan (blend of Undaria pinnatifida and Fucus vesiculosus) | randomized, double-blind, placebo-controlled trial in apparently healthy adults (n = 20; 9 males, 11 females) undertaking a supervised resistance training program | 1 g/day oral fucoidan or placebo during 6 weeks of resistance training | muscle strength (1RM back squat); anaerobic performance (Wingate test peak power); body composition (lean body mass, body fat %) | no adverse events reported; supplementation was well tolerated over 6 weeks | Cousins et al.168 |
| Brown seaweed polyphenol extract (Ascophyllum nodosum +Fucus vesiculosus; InSea2®) | dietary intervention study in overweight prediabetic men and women undergoing a moderate weight-loss program with individualized caloric restriction (∼500 kcal/day) | 500 mg/day (2 capsules) of brown algae extract powder; duration as reported in the study | body weight loss; fasting glucose, insulin, and C-peptide; glucose and insulin responses during 2-h OGTT | no major safety concerns reported; supplement described as well tolerated in metabolic intervention context | Jacques145 |
| Fucoidan (FucoHiQ®) | human dietary intervention study in adults with fatty liver or liver fibrosis | oral capsules; dose and duration as reported in the study | liver metabolism: markers of fatty liver and liver fibrosis | no major safety concerns reported; supplement described as well tolerated | Taipei Medical University WanFang Hospital169 |
| Fucoidan (F. Vesiculosus + U. Pinnatifida) | phase 2 pilot randomized clinical trial in adult cancer survivors experiencing post-treatment fatigue | 8-week oral supplementation | feasibility of intervention; changes in fatigue scores, frailty, and inflammation | safety and tolerability monitored; no major concerns reported | McGuire136 |
Anti-microbial and anti-viral activities
In the last two decades, numerous infectious diseases have emerged or re-emerged, presenting greater threats to global public health. The emergence or re-emergence of pathogenic bacteria and infectious viruses has posed huge global health threats that may be fatal for humans.137 Several pathogens are re-emerging as multidrug-resistant strains due to drug resistance mutations caused by the increased utilization of antibiotics.138 Such challenges in public health have necessitated the development of novel therapeutics.137 Seaweeds contribute to a variety of pharmacological activities including anti-microbial and anti-viral, as summarized in Tables 2 and 3. Multiple studies have demonstrated that seaweed-derived compounds can inhibit the growth of a broad spectrum of bacteria, fungi, and biofilm-forming microbes including multidrug-resistant pathogens while exhibiting notable anti-viral activity or immunomodulatory responses.139
Aqueous extracts from the red seaweeds Chondrus crispus and Sarcodiotheca gaudichaudii, in combination with standard antibiotics such as tetracycline and streptomycin, exhibited enhanced anti-bacterial activity against Salmonella enteritidis. This synergistic activity is likely due to the ability of seaweed components to increase bacterial membrane permeability and downregulate efflux pump genes, thereby promoting the intracellular accumulation of antibiotics. Such combinations could also help reduce the antibiotic usage costs and mitigate the development of resistance in pathogens, particularly within the poultry industry.118 The mechanism of anti-microbial action of seaweed-derived compounds is shown in Figure 5.
Figure 5.
Proposed anti-microbial and anti-viral mechanisms of seaweed-derived bioactive compounds based on in vitro studies
Fucoidan from Padina pavonica showed moderate anti-viral activity against HSV-1, with a selectivity index (SI = 4.21). It acts primarily by interfering with viral adsorption onto host cells, thereby inhibiting cell entry and early replication stages.52 Fucoidans from Sargassum henslowianum blocked HSV-1 and HSV-2 effectively at ultra-low concentrations (IC50 = 0.89 and 0.48 μg/mL, respectively), delaying the early infection stage by preventing virus binding to the cell surface.53 This action is thought to be mediated by the heavily charged sulfate groups in fucoidan, which can mask or neutralize viral glycoproteins responsible for host cell recognition. Ulvan, a sulfated heteropolysaccharide from Ulva lactuca, inhibited viral propagation in HAV-10 cells. This action is due to the ability of its negatively charged sulfate groups to disrupt microbial membranes and viral envelopes.119
Caulerpin from Caulerpa recemosa suppressed HSV-1 replication in Vero cells. It affects the early phase of the viral replication cycle by blocking viral DNA synthesis and interfering with key viral enzymes.107 Similarly, methanol extracts of Sargassum filipendula were found to inhibit HIV-1 reverse transcriptase (RT), exhibiting a distinct anti-retroviral mechanism by interfering with viral genome replication.107 Water-soluble polysaccharide extracted from Monostroma nitidum displayed significant anti-viral activity against enterovirus 71 (EV71) in both in vitro and in vivo studies by modulating host immune responses and blocking viral replication, while exhibiting minimal toxicity.140
Ulvan, from Ulva lactuca, also showed notable anti-bacterial activity against several pathogenic bacteria.119 Organic extracts of Amphiroa anceps, Corallina officinalis, and Sargassum filipendula demonstrated significant anti-bacterial effects against Salmonella typhimurium, Staphylococcus aureus, and Escherichia coli. These extracts were found to suppress the infectivity of rotavirus (RV) and coxsackievirus B3 (CVB3), which were passed through cytotoxicity assays.116 Extracts from Kappaphycus alvarezii (red seaweed) exhibited strong anti-microbial effects against a wide range of human pathogens, including Bacillus subtilis, Vibrio parahaemolyticus, Vibrio alginolyticus, Vibrio harveyi, and Klebsiella pneumoniae. The Kappaphycus extracts exhibited substantial anti-microbial activities, mainly by disrupting the bacterial membranes, inhibiting the efflux pumps, or by interfering with the protein synthesis.117 Despite extensive in vitro and in vivo evidence supporting anti-microbial and anti-viral activities, clinical studies evaluating seaweed-derived compounds for infectious diseases remain limited.
Anti-obesity and anti-diabetic activities
Rapid global urbanization, modernization, and socio-economic growth have improved our living standards. But, these developments have had a negative impact on lifestyle in aspects such as unhealthy eating habits, lack of exercise, increased stress, and environmental factors. These factors have contributed to the alarming growth of obesity and type 2 diabetes worldwide. Although prevention strategies like changes in lifestyle habits and medications have been recommended, they have not been successful in reducing the incidence of these diseases.141 As the recommended medications are also expensive, the need for novel compounds to address obesity and diabetes incidence has increased in recent years due to their low cost and negligible side effects.142 Seaweeds’ bioactive compounds have emerged as promising therapeutic agents due to their enriched composition, which could modulate the key metabolic pathways involved in obesity and diabetes, as summarized in Tables 2 and 3.
Compounds such as phlorotannins enhanced glucose uptake in muscle and adipose tissue by activating insulin signaling pathways, upregulating glucose transporter expression (GLUT4), and stimulating AMP-activated protein kinase (AMPK). Similarly, phlorotannins from Eisenia bicyclis significantly enhanced glucose uptake more than 50% in C2C12 myotubes and upregulated the genes associated with insulin signaling and AMPK pathways, reflecting metformin-like insulin-sensitizing actions.67 Phlorotannin-rich fraction from Sargassum tenerrimum demonstrated comparable effects by lowering fasting glucose levels, reducing inflammatory markers (TNF-α), and improving insulin sensitivity.70 Similarly, phlorotannins from Cystoseira compressa reduced serum glucose and digestive enzyme activity, thereby preserving pancreatic β-cell integrity and elevating anti-oxidant defenses in diabetic rats.68 The simplified mechanism of action of phlorotannins involved in glucose metabolism and their anti-diabetic activity are illustrated in Figure 6.
Figure 6.
Proposed mechanism of action of phlorotannins on glucose metabolism
Fucoidan, a sulfated polysaccharide, has been extensively reported for its enzyme inhibitory and insulin-sensitizing activities. Fucoidan from the brown seaweed Padina pavonica exhibited substantial α-amylase inhibitory activity (IC50 = 117.56 μg/mL), demonstrating its potential to reduce postprandial hyperglycemia and oxidative stress linked to diabetes. Similarly, fucoidan from Ecklonia maxima exhibited potent α-glucosidase inhibitory effect (IC50 = 0.27–0.31 mg/mL), compared to the standard anti-diabetic drug acarbose, through a mixed-type inhibition mechanism.54 These inhibitory activities of fucoidan against carbohydrate-hydrolyzing enzymes delay glucose absorption, thereby aiding glycemic control.
Solvent extracts from seaweeds have also displayed distinct enzyme inhibitory and glucose-regulatory effects. Methanolic extracts of Ulva intestinalis (formerly Enteromorpha intestinalis) exhibited significant inhibition of α-amylase and α-glucosidase, comparable to acarbose.132 Chaetomorpha aerea showed both in vitro and in vivo glucose-lowering activities through α-amylase inhibition and improved oral glucose tolerance.106 Methanolic extract of Ulva reticulata exhibited strong anti-diabetic activity through multitarget enzyme inhibition and insulin secretagogue effects. Ulva reticulata extracts demonstrated pronounced anti-diabetic activity by inhibiting key carbohydrate-metabolizing enzymes and enhancing insulin secretion. The bioactive fraction significantly inhibited α-amylase and α-glucosidase, reducing blood glucose levels in normoglycemic and streptozotocin (STZ)-induced diabetic rats. Furthermore, it showed glucose-dependent insulin secretagogue effects comparable to those of standard anti-diabetic drugs.124 Polyphenols from Padina tetrastromatica showed marked inhibition of α-amylase and α-glucosidase (IC50: 47.2 and 28.8 μg/mL) and a strong anti-oxidant potential, as demonstrated through DPPH and ABTS radical scavenging assays.65 Additionally, Padina arborescens extract showed strong intracellular lipid-reducing activity, implicating its use in functional food formulations targeting obesity.122
In addition to polysaccharides and polyphenols, protein and peptide-rich extracts from the red seaweed Palmaria palmata have demonstrated significant anti-obesity and anti-diabetic potential through enzyme inhibition mechanisms. Alcalase-hydrolyzed extracts with high protein content and degree of hydrolysis yielded low-molecular weight peptide fractions (<3 kDa) that effectively inhibited pancreatic lipase and α-amylase. Liquid chromatography- tandem mass spectrometry (LC-MS/MS) profiling and in silico screening identified multiple non-toxic peptides containing known inhibitory motifs, while molecular docking confirmed strong interactions with both enzymes.40 In addition to enzyme inhibition, protein hydrolysates extracted from the red seaweed Palmaria palmata have demonstrated significant metabolic regulatory effects in experimental models. Oral administration of these hydrolysates improved glycemic control and reduced body weight in STZ-induced diabetic mouse models. Furthermore, the treatment significantly lowered the blood glucose levels and produced a substantial reduction in HbA1c levels, comparable to the observed effects of the standard anti-diabetic drug metformin.82 Mechanistically, peptides obtained from Palmaria palmata modulate the incretin pathway by inhibiting DPP-IV activity and enhancing the secretion of incretin hormones such as glucagon-like peptide-1 (GLP-1) and Glucose-Dependent Insulinotropic Polypeptide (GIP), which subsequently promote insulin release and improve glucose regulation. Bioactive peptides including ILAP, LLAP, and MAGVDHI were identified as key contributors to this activity, as they help prolong the half-life of GLP-1 and support incretin-mediated insulin secretion. Furthermore, acute administration of these hydrolysates improved glucose tolerance and increased satiety in animal models.79,80 Moreover, protein hydrolysates obtained from the green seaweed Ulva rigida have also been reported to play a potential role in the regulation of metabolic disorders. Enzymatic hydrolysis generated peptides such as Ile-Pro and Ala-Phe-Leu, which exhibited significant angiotensin-converting enzyme (ACE) inhibitory activity. In addition to enzyme inhibition, the hydrolysates demonstrated considerable ferric-reducing anti-oxidant capacity, suggesting that Ulva rigida-derived peptides may contribute to metabolic health through combined anti-oxidant and enzyme inhibition mechanisms.78
Fucoxanthin, a carotenoid found abundantly in brown seaweeds such as Sargassum angustifolium, exerted significant anti-obesity and anti-diabetic actions in type 2 diabetic mouse models. Fucoxanthin improved blood glucose levels, insulin secretion, and lipid metabolism in STZ-nicotinamide-induced type 2 diabetic mouse models, while enhancing pancreatic β-cell function and preventing weight gain. Fucoxanthin enhances metabolism by upregulating the uncoupling protein-1 (UCP1) in white adipose tissues, thereby promoting thermogenesis and fatty acid oxidation. It also improves insulin sensitivity by modulating adipokines and oxidative balance.143 Compounds derived from red algae have also significantly contributed to the metabolic regulation. Polysaccharide from Bangia fuscopurpurea substantially reduced body weight and lipid accumulation in the adipose tissue of obese C57BL/6 mice. Furthermore, it effectively lowered lipid levels in both blood and liver, with an efficiency comparable to that of inulin.123 Ethanolic extracts from Grateloupia elliptica suppressed lipid accumulation and adipogenesis in both adipocyte cultures and high-fat diet (HFD)-fed mice, indicating the regulation of lipogenic pathways both in vitro and in vivo.120 Similarly, extracts from Gloiopeltis furcata exhibited both anti-obesity and anti-diabetic effects by inhibiting pancreatic lipase and improved glucose tolerance in obese mice.121 Furthermore, oral administration of enzymatically derived Palmaria palmata hydrolysates significantly reduced non-fasting and fasting blood glucose levels, lowered HbA1c, and decreased food intake in STZ-induced diabetic mouse models, with efficacy comparable to that of metformin. These effects are likely linked to the capability of bioactive peptides in inhibiting DPP-4 and modulating glycemic control pathways. Collectively, these findings support Palmaria palmata-derived peptides as promising functional food ingredients for modulating lipid digestion and postprandial glucose regulation.144
In addition to the preclinical findings, a human study also evaluated brown seaweed extract. The polyphenol extract of Ascophyllum nodosum + Fucus vesiculosus (InSea2) was given at 500 mg/day during a moderate calorie-restricted diet. The extract helped in weight loss and improved fasting glucose, insulin, and C-peptide levels, as well as glucose and insulin responses during a 2-h oral glucose tolerance test (OGTT). The results indicated that the supplement was safe and well tolerated (Table 5).145
Seaweeds in functional foods and nutraceuticals
Edible seaweed varieties
Seaweeds are nutritionally significant and a prolific source of bioactive substances; thus, they can serve as an alternative food source. Seaweeds are conventionally consumed as soups and vegetables; however, they are also used as condiments and incorporated into sauces. Seaweeds are regarded as universally suitable foods due to their low caloric content and the variety of essential nutritional compounds.146 All of the three groups of seaweeds comprise many edible species, which are widely used in various cuisines around the world. On the other hand, edible seaweeds as functional food ingredients have gained recognition due the presence of bioactive compounds.23
Among brown seaweeds, notable edible species include Saccharina japonica (Kombu), Undaria pinnatifida (wakame),147 Himanthalia elongata,148 and Durvillaea antarctica.149 These seaweeds are particularly important because they contain a high proportion of complex polysaccharides like fucoidan, alginate, and laminarin, which have biological properties like anti-oxidant, anti-inflammatory, prebiotic, etc. They are also rich in calcium, iodine, iron, and other essential trace minerals, which render them nutritionally dense and vital for metabolic and thyroid function. Red seaweed-derived compounds such as phycoerythrin and hydrocolloids, like agar and carrageenans, are widely used as coloring, gelling, stabilizing, and thickening agents in food industries. Apart from their industrial use, several species of red seaweeds such as Chondrus crispus, Porphyra spp. (Nori), Gracillaria spp., and Palmaria palmata (Dulse) are used directly as foods due to their rich protein content.100 These seaweeds are often consumed in dried or roasted forms, especially in sushi wraps, soups, and seaweed snacks.150,151 Edible green seaweeds, including Ulva lactuca (sea lettuce) and Caulerpa lentillifera (sea grapes), are characterized by their vibrant green color due to high chlorophyll content.13 They are abundant in ulvans, unusual sulfated polysaccharides with immunomodulatory and anti-oxidant capabilities. These seaweeds are rich in vitamins (A, C, and B-complex), minerals, and phenolic compounds that contribute to their health-promoting potential.152 All edible seaweeds vary in their taste, texture, and culinary application, but they serve as valuable sources of fiber, trace elements, and bioactive compounds, with potential health-promoting effects. Incorporation of edible seaweeds in daily diets can improve overall health and metabolism.
Bioactive extracts and formulated products
Seaweeds serve as a rich source of bioactive compounds such as polysaccharides, peptides, phlorotannins, and essential nutrients including omega-3 fatty acids, vitamins, and minerals. This makes them valuable for developing functional foods and nutraceuticals. Polysaccharides like alginate, carrageenans, and agar are widely used as stabilizers and gelling agents in syrups, desserts, sauces, and dairy products. Apart from commercial seaweed-based products, functional seaweed products are now mainstream. For instance, GimMe organic, Tao Kae Noi, and Simple Truth produce organically certified, low-calorie, nutrient-rich roasted seaweed snacks that combine crisp texture with iodine, vitamins, and minerals. Similarly, sea moss gel, seaweed capsules, and sea moss gummies are produced by Myla’s Doctor Seaweed that provides easy-to-consume nutrition boosters packed with iodine and anti-oxidants. In food and meat innovation, seaweed extracts serve as alternatives that reduce sodium and increase mineral levels (Algysalt, PureSea, and Seagreens), without compromising sensory quality.24
Institutions like ICAR-CMFRI have developed patented nutraceuticals (e.g., Cadalmin ADe, ACe, ATe, AHe, and AOe) targeting conditions such as diabetes, obesity, hypertension, and arthritis by using marine extracts from Sargassum spp., Turbinaria spp., Gracilaria spp., and Kappaphycus spp.153 Furthermore, other seaweed-based commercial products and their specifications are summarized in Table 4. The listed marketed and health claims are supported to varying extents by compositional, pre-clinical, or limited human evidence. Collectively, these products highlight the seaweed’s translational potential in functional health products.
Table 4.
Seaweed-based commercial products
| Product name | Origin | Active ingredients | Marketed claims/health claim | Evidence status | Reference |
|---|---|---|---|---|---|
| Cadalmin® GAe | ICAR-CMFRI | Turbinaria ornata and Turbinaria conoids | marketed as anti-arthritic nutraceutical | preclinical evidence on animal models only | Gopalakrishnan et al.153 |
| Cadalmin® ADe | ICAR-CMFRI | Sargassum wightii and Turbinaria ornata | marketed as anti-diabetic nutraceutical | ||
| Cadalmin® ACe | ICAR-CMFRI | Sargassum wightii | marketed as anti-dyslipidemic nutraceutical | ||
| Cadalmin® ATe | ICAR-CMFRI | Sargassum wightii, Turbinaria ornata, Turbinaria conoids, and Kappaphycus alvarezii | marketed as anti-hypothyroid nutraceutical | ||
| Cadalmin® AHe | ICAR-CMFRI | Sargassum wightii | marketed as anti-hypertensive nutraceutical | ||
| Cadalmin® AOe | ICAR-CMFRI | Gracilaria salicornia and Sargassum wightii | marketed as anti-osteoporotic nutraceutical | ||
| Cadalmin® IBe | ICAR-CMFRI | Turbinaria conoides and Sargassum wightii | marketed as immunity boosting nutraceutical | ||
| Cadalmin® ABe | ICAR-CMFRI | Kappaphycus alvarezii and seaweed-associated Firmicutes | marketed as anti-microbial skin and wound care ointment | ||
| FutureFeed® | CSIRO (Australia) | bromoform from Asparagopsis | reduces livestock methane emissions, improves feed efficiency | peer-reviewed animal studies on ruminants | Ridoutt et al.154; FutureFeed®155 |
| AlgaeCal (Algas calcareas) | Roseolithon superpositum (formerly Lithothamnion superpositum) (South America) | plant-based calcium, magnesium, and trace minerals | improves bone density, better absorption vs. conventional calcium | limited human supplementation study reported | Kaats et al.156 |
| PureSea (Seaweed & Co.) | Seaweed & Co. (UK) | seaweed-derived compounds (alginate, minerals, and microencapsulated forms) | marketed as functional food ingredient, nutrient delivery, flavor enhancement | claims limited to manufacturer and marketing sources | PureSea®157 |
| Tao Kae Noi | Taokaenoi Food & Marketing PLC (Thailand) | seaweed snack sheets with oil, salt, and spices | marketed as a low-calorie, mineral-rich healthy snack | claims limited to manufacturer and marketing sources | Tao Kae Noi158 |
| Doctor Seaweed Supplements | Doctor Seaweed (UK) | organic seaweed blends | thyroid health, immunity, menopause support, brain focus, beauty, pet wellness | claims limited to manufacturer and marketing sources | https://doctorseaweed.com/159 |
| Seagreens® Food Capsules | Ascophyllum nodosum | capsule supplement | thyroid support, metabolic balance, anti-oxidant support | peer-reviewed human intervention study | Combet et al.160 |
| Ocean’s Balance Kelp Granules | Saccharina latissima | granulated food seasoning | natural salt alternative, thyroid function | claims limited to manufacturer and marketing sources | Kelp Granules161 |
| SeaSnax | Porphyra spp. (Nori) | roasted snack | anti-oxidant activity, vegan protein source | claims limited to manufacturer and marketing sources | SeaSnax162 |
| Algotherm Nutricosmetics (France) | Laminaria digitata | oral nutricosmetic | skin hydration, anti-aging, detoxification | claims limited to manufacturer and marketing sources | Algotherm163 |
| Marinova’s Maritech® Extracts | Fucus vesiculosus, Undaria pinnatifida | high-purity fucoidan powder | immunomodulation, gut health, inflammation reduction | claims limited to manufacturer and marketing sources | Maritech164 |
| Blue Evolution Pasta | Macrocystis pyrifera | dried pasta infused with seaweed | digestive health, weight management | claims limited to manufacturer and marketing sources | Blue Evolution seaweed pasta165 |
| PharmaSea Supplements | multiple species | tablet/capsule | anti-obesity, metabolic syndrome, cardiovascular support | claims limited to manufacturer and marketing sources | PharmaSea166 |
| Biosea Health Seaweed Chips | Kappaphycus alvarezii | snack food | marketed to balance gut microbiome, satiety | claims limited to manufacturer and marketing sources | Biosea Health167 |
While extensive in vivo and in vitro studies have demonstrated the therapeutic potential of seaweed-derived bioactive compounds, limited supporting evidence is available from human intervention studies and is essential to substantiate their translational relevance. Several clinical trials and pilot studies have evaluated the effects of seaweed-derived compounds on metabolic health, inflammation, oxidative stress, and cancer-related outcomes. To provide an integrated overview of these findings, we summarize key human studies investigating the therapeutic efficacy of seaweed-derived compounds in Table 5.
Prebiotics and gut health
Whole seaweed and seaweed polysaccharides possess notable prebiotic potential, primarily attributed to their rich nutritional composition, especially the high dietary fiber content.170 These polysaccharides, including carbohydrates, sulfates, and associated proteins, have been shown to favorably modulate the gut microbiota. For instance, the polysaccharide extracted from Bangia fuscopurpurea (BFP) showed anti-obesity activity in HFD-induced C57BL/6 mice. The polysaccharide could more effectively reduce body weight and fat accumulation in obese mice than inulin. BFP modulated the intestinal microbial taxa by inhibiting Clostridium and Aerococcus. Thus, BFP polysaccharide may serve as an effective dietary prebiotic in reducing obesity.123 In a simulated human gut model, Australian seaweeds such as Phyllospora comosa, Ecklonia radiata, and Ulvan ohnoi significantly enhanced the development of butyrate-producing firmicutes and increased the production of short-chain fatty acids (SCFA). Their effects were stronger that those observed with standard prebiotics like inulin, and they also increased the overall microbial diversity, which highlight their potential as functional foods for supporting gut and immune health.171 Further evidence comes from an in vitro colon fermentation model using Himanthalia elongata, which selectively stimulated the growth of Bacteroides ovatus, in contrast to inulin, which promoted Parabacteroides distasonis growth. Although Bifidobacterium and Lactobacillus levels remained largely unchanged, H. elongata yielded a substantial SCFA concentration (56.11 mM at 24 h), suggesting effective fermentability and prebiotic action despite taxonomic differences in the microbiota compositon.120 Likewise, Durvillaea antarctica, a commonly consumed brown seaweed, contains prebiotic polysaccharides such as alginate and fucoidan that enhance beneficial bacteria like Bifidobacteria and stimulate SCFA production. Its bioactive compounds support gut barrier integrity and are linked to metabolic and immune benefits, including anti-inflammatory, anti-obesity, and hypoglycemic effects.149 Similarly, in vitro studies have shown that whole seaweeds like Saccharina japonica and Undaria pinnatifida promote the growth of beneficial microbes, such as Bifidobacterium adolescentis and Parabacteroides distasonis, while boosting the levels of SCFAs, especially acetic and butyric acids. Their effects on microbial composition and fermentation activity were comparable to those of inulin, which reinforce their prebiotic potential.172
Furthermore, aquaculture studies indicate that seaweed-based diets enhance gut health by increasing microbial diversity, stimulating digestive enzymes, and improving intestinal structure, such as villus height and goblet cell count. Sulfated polysaccharides like laminarins, ulvans, and fucoidans also contribute to SCFA production and gut barrier maintenance.173,174 Overall, seaweed-derived polysaccharides and bioactive compounds effectively influence gut microbiota and promote SCFA production, thereby maintaining the intestinal integrity. The mechanism of prebiotic action of seaweed polysaccharides and their role in gut microbiota modulation for SCFA production are illustrated in Figure 7. Due to their ability to improve the gut barrier integrity, seaweeds hold promising potential in the development of functional food for gut and metabolic health.
Figure 7.
Potential role of seaweed-derived compounds as prebiotics in gut health
Bioavailability and biocompatibility of seaweed bioactives
Fucoidans
High-molecular weight fucoidans from brown seaweeds exhibit very limited absorption across the intestinal epithelium, and current evidence indicates that their primary site of action is within the gastrointestinal lumen rather than systemic circulation.84,86,87 In contrast, depolymerized or low-molecular weight fractions of fucoidans demonstrate enhanced biological activity. Molecular weight, degree of sulfation, and position are the key determinants of interactions with gut mucosa, microbiota, and host tissues.47,84 Several studies reporting the anti-cancer, anti-diabetic, and immunomodulatory effects have used purified fucoidans in cell cultures or administered them via non-oral routes in animal models.53,54,56 While these studies provide valuable mechanistic insight, they do not necessarily reflect oral bioavailability or clinically relevant systemic exposure in humans.52,55 Therefore, translating in vitro and in vivo efficacy into human outcomes requires careful consideration of absorption, metabolism, and microbiome-mediated effects.
Laminarins and β-glucans
Laminarins, non-sulfated β-glucans predominantly found in brown seaweeds, largely resist digestion in the upper gastrointestinal tract, reach the colon intact, and undergo microbial fermentation to produce SCFAs. Thus, their biological effects are predominantly microbiome mediated, including modulation of gut immunity and metabolic signaling.85,88 Structural features such as molecular size, degree of polymerization, and branching pattern strongly influence fermentability, SCFA production, and immunomodulatory activity. However, human pharmacokinetic and systemic absorption data remain scarce, limiting the ability to predict in vivo efficacy beyond microbiome-dependent mechanisms.2
Ulvans
Ulvans, sulfated polysaccharides from the genus Ulva, exhibit anti-viral, anti-microbial, anti-oxidant, and metabolic activities, and they have shown good tolerability in preclinical studies.140 However, direct evidence for the systemic bioavailability of intact polymers is limited.119 The majority of reported effects are inferred from changes in immune markers, metabolic parameters, or gut fermentation profiles, rather than measured circulating levels. Structural characteristics, such as high charge density and complex branching, favor colonic fermentation and mucosal immune interactions, suggesting that microbiome-mediated mechanisms largely influence the bioavailability. Current in vitro and in vivo studies do not fully characterize digestion, intestinal absorption, or circulating metabolites; so, oral biocompatibility and systemic exposure remain inferred.91
Phlorotannins and seaweed-derived peptides
Phlorotannins, polyphenolic compounds from brown seaweeds, have exhibited potent anti-oxidant, anti-diabetic, and metabolic activities in vitro models.44,68,70 Seaweed-derived peptides, including anti-coagulant peptides from nori hydrolysates and anti-diabetic peptide fractions, are typically assessed using simulated digestion models or in vitro cell systems, which have provided mechanistic insight, but without any data, into bioavailability.77,124,175 Consequently, while these compounds show promising bioactivity, their oral biocompatibility and systemic exposure in humans remain largely inferred, rather than empirically validated.
Matrix, processing, and microbiome-mediated effects
The food matrix and processing methods strongly influence the release and stability of nutrients in seaweeds. For instance, processing-induced changes can significantly affect the content of minerals, including iodine, and modulate polysaccharide structure, protein availability, and anti-oxidant profiles in edible seaweeds.11,45,176 Furthermore, in vitro colonic fermentation and prebiotic studies indicate that the majority of health effects from seaweed polysaccharides are microbiome mediated. Shifts in the gut microbial composition and the production of SCFAs appear to drive the observed metabolic, immunomodulatory, and anti-inflammatory benefits, rather than the absorption of intact macromolecules.9,41 Together, these findings underscore the absence of robust clinical pharmacokinetic studies across all major classes. Standardized extraction methods, molecular characterization, and dose-exposure relationships are required to bridge the gap between promising preclinical findings and clinically validated applications.
Safety, regulatory, and toxicological considerations
Iodine and heavy metal content
Iodine (I), an essential nutrient found abundantly in seaweeds, regulates metabolism and plays a crucial role in overall growth and development. It is a base component for the synthesis of thyroid hormones, triiodothyronine (T3) and thyroxine (T4).177 Iodine is a key component that regulates various biochemical reactions like protein synthesis and enzymatic activity. Additionally, it aids in the development of brain, pituitary glands, heart, muscle, and kidneys.178 Nearly 30% of the global population is at the risk of iodine deficiency.179 In India, around 23.6% tribal population of Orissa was found to have endemic goiter, which is directly caused by iodine deficiency.180 Other disorders caused by iodine deficiency include cretinism, hypothyroidism, and neurological impairments such as mental retardation, deaf mutism, and neuromotor defects, especially in children.181,182,183
Iodine exists in three forms: iodate (IO3−), iodide (I−), and iodine (I2). Seaweeds contain higher concentrations of iodine than other sources. The concentration of iodine and its available chemical form vary according to the seaweeds. Among them, brown seaweeds, particularly kelp, contain a higher concentration of iodine than other seaweeds.184,185 Brown algae such as Laminaria species have been reported to contain iodine levels ranging from 1,700 to 31,000 μg/g dw, and the species of Saccharina contain iodine in the range 200–7,000 μg/g dw.176 Iodine levels of 5,700 ± 660 mg kg−1 DW were found in Saccharina latissima.186 The highest iodine concentration of 22,911 mg/kg was reported in dried seaweeds by European Union (EU), Rapid Alert System for Food and Feed (RASFF).187 Excessive intake of iodine also results in several disorders such as goiter, thyroid autoimmunity, and hypothyroidism or hyperthyroidism, which was found to be prevalent in populations consuming seaweeds.185,188 Thus, both the insufficient and excessive intake of iodine levels may result in lack of thyroid synthesis and other negative effects.177
Daily prescribed levels of iodine as recommended by the National Institutes of Health are as follows: 110–130 μg for new born and infants, 90–120 μg for children, 150 μg for teens and adults, and 220–290 μg of iodine for pregnant and lactating woman.189 Excessive levels of iodine in algae can be reduced by several processing methods. Simple washing of the fresh biomass of Ascophyllum nodosum and F. vesiculosis and in water reduced 34% and 44% of iodine in the seaweeds, respectively.190 Soaking freshly collected Saccharina latissima in tap water at 30°C–32°C for 5 min significantly reduced iodine levels up to 78%–85%. Blanching the dried Saccharina latissima for 2–5 min in brief intervals reduced 93%–94% of iodine.191
Similar to iodine, other heavy metals can also be readily absorbed by seaweeds due to the accumulation of toxic compounds in the marine ecosystems. External factors such as pH, salinity, water temperature, concentration of toxic elements, and species specificity determine the accumulation of heavy metals in seaweeds.192 Due to the higher biosorption capacity, seaweeds can bind to and concentrate heavy metals multi-folds higher than the levels in seawater, which indicate them as substitutes for biological filters and sinks for the pollutants.192 More specifically, the cell wall of seaweeds containing polysaccharides (agar, alginates, carragenans, etc.) contains binding sites for carboxyl, phosphate, and sulfate groups that attract and bind to the surrounding metal ions.193 These heavy metals may pose risks to both animal and human health.194 Some of the common elements reported in seaweeds include arsenic (As), lead (Pb), mercury (Hg), and cadmium (Cd).176,195
Cd contamination occurs due to the leaching of materials such as paints, fossil fuels, fertilizers, and PVC polymers in the environment.196 Exposure to Cd causes osteoporosis, renal failure, and cancer in vital organs.197 Among heavy metals, Cd poses the highest risk of 1.73 for stroke.198 Seaweed such as Codium fragile have been reported to accumulate 32.8 mg/kg dw of Cd.199
Pb contamination in the environment occurs from battery wastes, paints, mining, metal plating, metal smelting, and from agricultural fertilizers and pesticides. Brown algae such as Turbinaria ornata have higher capacity to absorb Pb due to the presence of a higher polysaccharide content with carboxyl and sulfate groups, which have active metal-binding sites.200 Seaweeds in Malaysia have been reported to contain 3.75–10.85 μg/g of Pb. A study in Italy recorded 3.4 ± 1.9 mg kg dw of Pb in various seaweed species.193 Prevalence of respiratory problems such as asthma in workers have been reported to be caused by higher exposure to Pb. It also interrupts physiological functions and triggers various respiratory problems, such as asthma, lung cancer, and chronic obstructive pulmonary disease (COPD), and also affects other systems like nervous, kidney, and cardiovascular systems.201 Prevalence of Pb exposure also increases the risk of stroke, with risk factor of 1.63, which is next to Cd.198
Hg persists in both organic and inorganic forms in marine environments. Seaweeds such as Codium fragile and Ulva (formerly Enteromorpha) species from Mediterranean Sea have been found to contain Hg levels of 26.1 ± 0.23 μg/kg dw and 336.5 ± 130.9 μg/kg dw, respectively.199 Both forms of Hg are readily absorbed by seaweeds.202 Among these, the inorganic form of Hg is absorbed by the respiratory tract, whereas the organic form, particularly methylmercury, is absorbed by the gastrointestinal (GI) tract.203 Methylmercury, once ingested, readily crosses the blood-brain barrier (BBB) and is accumulated in the brain. This leads to neurotoxic effects and makes a person more vulnerable to cognitive impairments and developmental delays. In contrast, the organic form of Hg tends to affect vital organs such as liver and kidneys.202
As contamination mainly occurs through industrial process. Seaweeds have the ability to absorb As. In seaweeds, As is assimilated via phosphorous pathways and can be converted into various forms. Total As contents vary according to the seaweed type and typically range between 10.7 and 162 mg/kg of dry biomass in brown seaweeds, 10.3–39.4 mg/kg in red algae, and 0.30–1.22 mg/kg in green algae. A brown seaweed, Sargassum fusiforme (formerly Hizikia fusiformis), consumed as food in Japan and Korea, has been reported to contain higher As levels 67. 5 mg/kg.204 Upon exposure, As can be converted into toxic dimethylarsinic acid (DMA) in mammals. 3.75 mg/kg of inorganic As has been reported in Himanthalia elongata, without detectable DMA. This DMA was considered as a potential human carcinogen, which could induce strand breaks in DNA.205 The list of heavy metals reported in seaweeds and its health effects are illustrated in Figure 8. Overall, reports for the presence for higher concentrations of iodine and heavy metal contaminants in seaweeds necessitate robust monitoring, proper processing, and regulatory oversight to ensure consumer safety.
Figure 8.
Iodine and heavy metals in seaweeds and their associated health risks
GRAS status and global regulations
GRAS (generally recognized as safe) designation has been established by the FDA, intended specifically for food ingredients. This recognition exempts certain food ingredients to be marketed without FDA approval. However, GRAS status can be applicable only to the food ingredients and not extended to therapeutic purposes.206 As of now, GRAS listings have not been issued for all individual edible seaweeds. GRAS status has been assigned to numerous seaweed products, particularly phycocolloids such as alginate from brown seaweeds, and carrageenans and agar from red seaweeds. These seaweed polysaccharides are specifically used as emulsifiers, thickeners, stabilizers, and gelling agents in food products.207 Among them, carrageenans have been reported to cause allergic reactions, although such cases are relatively rare. Carrageenans have been associated with rare IgE-mediated allergic reaction. Such allergic reactions are sometimes triggered by dairy products containing carrageenan as a hidden ingredient, and it may cause intestinal inflammation in sensitive individuals, especially those with gut disorders or compromised intestinal barriers.207,208 However, some of the whole seaweed powders, oligosaccharides like ulvans and laminarians, and other seaweed extracts are still under regulatory consideration and can be self-affirmed as GRAS by individual companies with supporting safety data.209 Some of the seaweeds are used as foods in countries like Korea, Japan, and China. These seaweeds are traditionally consumed and are often considered as safe through longer consumption, rather than being recognized as GRAS.210
Currently, there are no technical guidelines or specific international standards established by the Codex Alimentarius Commission to directly address food safety concerns related to seaweeds.211 However, several countries have developed their national regulations, focusing on the control of contaminants like heavy metals such as As and iodine. In Europe, the European Union Commission Regulation (EU) 2023/915 and regulation (EC) no. 396/2005 have established maximum levels (MLs) for certain contaminants and Hg in algae. But, specific standards for contaminants like As, Cd, and Pb in whole seaweed remain limited.212 Furthermore, iodine in seaweed is not regulated under EU legislation, and it is still considered as a nutrient. France was the first country in the European Union to conduct a safety evaluation on seaweeds for human consumption and has established MLs for heavy metals in edible seaweeds.213,214,215 Similarly, Federal Institute for Risk Assessment (BfR), Germany, has imposed regulatory limits on iodine levels of dried seaweeds.216 The United States offers only regulatory limits to iodine content in seaweed products but has not established safety regulations for toxic contaminants and heavy metals in edible seaweeds.217 For Australia, several edible seaweed species are permitted, but the iodine content of those seaweeds alone has been regulated by the FSANZ (Food Standards Australia New Zealand) due to the health risks associated with overconsumption of iodine.218
In Asia, National Food Safety Standard of China (GB 2762-2022) has specified maximum levels for the presence of As and Pb in seaweed products,219 while the feed hygiene standard sets maximum levels for heavy metals like As, Pb, Cd, and Hg in feeds containing seaweed materials.220 Hong Kong has regulated MLs for As in seaweeds under its Food Adulteration (Metallic Contamination) Regulation,221 and Taiwan has regulated standards to include MLs for heavy metals in seaweeds.222 In India, there is no specific limit for heavy metal contaminants or iodine in whole seaweeds. But, specific limits have been set for iodine content in seaweed-derived food additives like agar, alginate, and carrageenans by FSSAI standards.223 While GRAS status and national regulations for certain seaweed-derived ingredients are available, there is no comprehensive international standards available for whole seaweeds. Global limits for iodine and heavy metals in seaweeds across different countries are summarized in Table 6. These variations in contaminant levels across different countries need to be standardized to ensure consumer protection and global compliance.
Table 6.
Regulatory limits or guideline values for iodine and heavy metals in seaweeds across different countries (mg/kg) of dry weight
| Region | Iodine | Lead | Mercury | Arsenic | Cadmium | Reference |
|---|---|---|---|---|---|---|
| France | 2,000 | 5 | 0.1 | 3 | 0.5 | Edible seaweed and French regulation-Synthesis made by CEVA213; Opinion of the French Agency for Food214; Opinion of the French Agency for Food215 |
| Germany | 20∗ | NS | NS | NS | NS | Health risks linked to high iodine levels in dried algae216 |
| China | NS | 0.5 | NS | 0.3∗∗ | NS | National Health Commission of PRC & State Administration for Market Regulation219 |
| Taiwan | NS | 0.5 | 0.5 | 1 | 1 | Sanitation standard for contaminants and toxins in food222 |
| India | NS | 5 | 1 | 3 | 1.5 | Food Safety and Standards (Contaminants, Toxins and Residues) Regulations 2011223 |
| USA | 5,000 | NS | NS | NS | NS | Yeh et al.217 |
| Australia | 1,000 | NS | NS | NS | NS | https://www.legislation.gov.au/Series/F2015L00408218 |
NS, not specified.
∗The iodine levels reported for Germany refer to guideline for seaweed-based food products rather than the maximum limit for edible seaweeds.
∗∗Arsenic values for China refer to inorganic arsenic
∗Regulatory limits may apply to different product categories including dried seaweed, food ingredient, or dietary supplements depending on the jurisdiction. This applies to all values present in the table.
The global seaweed farming industries reached an impressive yield of 35.2 million tons (live weight) in 2021. From 2000 to 2021, its market value increased 3-folds, growing from $5 billion to $17 billion, and is projected to grow by 7-fold and reach $85 billion by 2026.224 The seaweed industries are geographically leaded by Asia.225 In Asia, China alone contributed 61% of the global production, with 99.1% of its output being cultivated. Followed by China, Indonesia is another major producer, contributing 26% to the global supply, while countries like South Korea, North Korea, the Philippines, Japan, and Malaysia also remain as significant players in seaweed production. Outside Asia, countries like Tanzania, Russia, and Chile contribute to seaweed production marginally, together accounting for 0.34% of global production.226 In Africa, seaweed production is largely driven by Tanzania, which peaked around 178,000 tons in 2015 but declined to 81,000 tons by 2021.227
In terms of global trade, seaweed exports were estimated to be approximately $943 million, whereas imports reached $1.2 billion in 2021.228 Asian countries dominated both the exports ($590 million) and imports ($762 million). Followed by Asia, America and Europe have exported around $192 million and $143 million and imported $165 million and $245 million worth of seaweed products, respectively.228 Interestingly, China remains as the largest producer and consumer of seaweeds. It ranked fourth in seaweed exports, next to the Indonesia, South Korea, and Chile due to its high domestic demand. However, China remains as the largest importer, accounting for about 41% of global seaweed imports in 2021, followed by Japan ($193 million) and the United States ($104 million). Other top importing countries include Russia ($51 million), France ($30 million), and Australia ($29 million).226,228
In the global context, India is an emerging key player, with significant untapped potential in seaweed cultivation. As of 2023, India has reported a total seaweed production of 72,385 tonnes (wet weight).229 While this volume remains modest compared to those of other leading Asian producers like China and Indonesia, the country’s seaweed industry is slowly gaining a momentum. Based on the reports of Central Marine Fisheries Research Institute (CMFRI), India has the capacity to cultivate approximately 9.7 million tonnes of seaweeds annually across 342 potentially identified coastal sites, indicating a greater scope for scale-up and commercialization. The Indian seaweed market was valued at $2.03 billion in 2024 and is projected to reach $2.12 billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 3.66% during the forecast period.230
Sustainability and ethical harvesting
In general, seaweed production takes places through two primary methods—cultivation and wild harvesting, with majority of global production now being derived from cultivation. Seaweed farming, which is a key constituent of the circular blue bioeconomy, not only contributes to biomass production but also offers important ecological functions such as carbon sequestration and climatic change mitigation.231 Seaweeds absorb the atmospheric carbon-di-oxide and converts it into polysaccharides, thus playing a major role in reduction of greenhouse gases. Seaweed cultivation was considered a sustainable method that requires no freshwater, fertilizers, or arable land and exerts minimal ecological impact.226 Accordingly, seaweed cultivation has been recognized for its potential to alleviate marine pollution, product biodiversity, and support food security (Figure 9). Cultivation of seaweeds has emerged as a promising source of livelihood, especially for coastal and deprived communities in Zanzibar, Tanzania. Seaweed farming began in Zanzibar in 1989 and grew rapidly, which employed around 15,000–20,000 people, majorly women. This initiative increased the seaweed production from 8,080 tonnes to 176,000 tonnes by 2016.232 Moreover, this woman-led sector not only provided income but also promoted social cohesion, knowledge sharing, and dietary improvements through the use of cultivated seaweeds.233
Figure 9.
Seaweed sustainability, health, and industrial application nexus
Similarly, in India, Pradhan Mantri Matsya Sampada Yojana (PMMSY) scheme, which was launched in 2020 with a budget of ₹640 crores, has encouraged sustainable seaweed cultivation initiatives by approving 46,095 rafts and 65,330 monoline tube nets for the people of coastal and fishing communities. These efforts have enabled coastal women to cultivate seaweeds, mainly Kappaphycus alvarezii, producing over 36,000 tonnes of wet seaweeds, and the initiative was aimed to scale-up the cultivation to 1.12 million tonnes in five years.229 These incidences highlight how the sustainable seaweed practices have contributed to the empowerment of woman and enhancement of livelihoods, while simultaneously addressing the ecological concerns.
Despite its benefits, seaweed cultivation also raises several environmental concerns when not managed properly. Large-scale monoculture farms, especially those located in ecologically sensitive shallow marine zones, could degrade the seagrass ecosystems, thereby reducing the biodiversity and disrupting habitats for several species including fish, turtles, and dugongs.234 Seaweed monocultures are highly prone to diseases and pest invasions, thus acting as reservoirs for pathogens that may affect native seaweed flora.235 In India, red seaweeds such as Gracilaria sp., and Kappaphycus alvarezii are cultivated widely. Among them, Kappaphycus alvarezii, an exotic species cultivated extensively in the Palk Bay region, smothered and caused mortality of coral reefs such as Acropora species in Gulf of Mannar regions.236,237 Such ecological impacts necessitate stricter controls and biodiversity assessments prior to the introduction of non-native species.
Parallel to the cultivation practices, wild harvesting also poses critical sustainability challenges. Seaweeds play crucial ecological roles in marine food webs and serve as foundational species in many coastal habitats. However, unethical harvesting practices pose significant threats to marine biodiversity. Historically, species like Ascophyllum nodosum have been harvested in the North Atlantic for centuries.238 In Tamil Nadu, India, wild harvesting still remains a traditional livelihood activity, especially for coastal women. However, indiscriminate and excessive harvesting of species such as Sargassum, Gracilaria, Gelidiella, and Turbinaria has led to the loss of biodiversity and decline in their population.239,240 Overharvesting has even caused the extinction of seaweed colonies in several regions.241 In response to those degradations, Tamil Nadu government imposed a temporary ban on harvesting Gracilaria spices and has restricted Sargassum collection to promote its conservation.242
In order to support seaweed conservation and provide alternative livelihoods, the government of Tamil Nadu announced the establishment of a multipurpose seaweed park, which focuses on sustainable seaweed cultivation, marine biodiversity protection, and education. This initiative is targeted to promote the cultivation of seaweeds in 136 coastal villages across six districts, which involves over 8,821 people.242,243 The “seaweed park” will also feature aquaria and educational facilities that showcase the ecological role of seaweeds. Global initiatives including the Kelp Forest Challenge aim to restore 1 million hectares of kelp forest and further protect 3 million hectares of kelp forests by 2040. Such initiatives exemplify the growing emphasis on ethical, sustainable seaweed practices supported by international collaborations.244
Seaweed value chain and processing-quality-safety nexus
Beyond sustainable cultivation and ethical harvesting, the downstream processing of seaweeds critically regulates the feasibility, safety, and quality of seaweed-derived products. The seaweed value chain typically follows a series of stages including cultivation or wild collection, harvesting, primary dewatering, stabilization or drying, extraction, and fractionation of target components, further followed by final formulation into food, nutraceutical, feed, or biostimulant products.245
After harvesting of fresh biomass, water is usually drained and pre-cleaned. Stabilization or drying may then be achieved through simple, low-technology methods, such as sun-drying or higher-throughput techniques including hot-air or tunnel dryers. Although less common, freeze drying is sometimes applied for high-value applications.245,246,247 The dried biomass is further processed for the extraction of hydrocolloids, proteins and peptides, pigments, lipids, and mineral-rich fractions. These extracts can then be formulated into a wide range of end products.247,248
At industrial scale, the production process for certain single products, particularly hydrocolloids such as carrageenans, agar, and alginate, is well established. These processes typically involve alkaline or acid treatments, followed by filtration, salt or alcohol precipitation, and drying, which are implemented in commercial plants worldwide.245,247 In contrast, seaweed biorefineries are being developed to move beyond single-product value chains (e.g., carrageenan or alginate only) toward integrated processes that recover multiple product streams from the same biomass. These integrated multiproduct biorefineries sequentially recover polysaccharides, proteins, pigments, and other bioactives from the same biomass, thereby improving resource efficiency, economic returns, and sustainability.249 Yet, they remain largely at pilot or demonstration scale. These approaches often rely on enzyme-assisted extraction, membrane separations, and large-volume aqueous processing.248
In designing such biorefineries, top-down and bottom-up approaches are applied for complementary reasons. Top-down approach starts with the processing of whole seaweed biomass and sequentially fractionate it to extract high-value compounds first, followed by lower-value fractions.250 This method is attractive because it can be aligned with existing large-scale unit operations and is well suited to high-volume, relatively low-margin products. This approach allows utilization of most of the biomass, minimalizing waste and infrastructure costs across several product streams.251
Meanwhile, the bottom-up approach focuses on selectively isolating or synthesizing target compounds from seaweed fractions. This approach is applied when the primary objective is to obtain high-value, functionally tailored ingredients, rather than maximal bulk recovery.250 It involves milder and slower processes like controlled enzymatic hydrolysis and membrane fractionation for the extraction of ingredients with specific bioactivities (anti-oxidant, anti-diabetic, and anti-obesity) or techno-functional properties (emulsifying capacity, gel strength, improved stability, and sensory profile).248,252 This method allows precise control over product composition and supports compliance with food and nutraceutical regulations.253 But, it may involve higher processing costs and lower overall biomass utilization.249,251 Techno-economic analyses indicate that large working volumes, high raw-material costs, and significant utility requirements for heating, mixing, concentration, and drying currently limit the scalability and competitiveness of multiproduct biorefineries, which occupy major operating costs.254 Thus, it primarily reflects the gap between single-product hydrocolloid value chains and emerging, multiproduct biorefinery concepts.
Processing steps along value chains also strongly influence iodine and heavy metal loads in seaweeds. Processes like washing, soaking, blanching, and rehydration can substantially reduce the content of mobile iodine and certain heavy metals, such as inorganic As and Cd.255,256 However, more intensive or harsh treatments can lead to losses or structural changes in the nutrient composition as well as denaturation or aggregation of proteins. These changes may alter both bioactivity profiles and techno-functional properties, including gelling, emulsification, and texture.255 Overall, this highlights the critical need to design processing pipelines that balance contaminant reduction and sensory acceptance with the preservation of key nutritional and bioactive components, ensuring safety, quality, and functional integrity in seaweed-derived products. The integration of top-down and bottom-up strategies provides a conceptual framework for optimizing biomass utilization, product quality, and process efficiency in future seaweed biorefineries.
Challenges and research gaps
Variability in composition and bioactivity
One of the major challenges in utilizing seaweeds for health and functional applications is the significant variation in their biochemical composition and bioactivity. The nutrient and bioactive compound profiles of macroalgae are strongly influenced by environmental, physiological, and geographical factors. Considerable variations have been reported, even within the same species, due to seasonal shifts and site-specific conditions. For instance, Chaetomorpha antennina collected from the intertidal rocks of the Covelong coast, India, between June and March exhibited significant seasonal variations in anti-oxidants, minerals, and metabolites. Amino acid levels in seaweeds were the highest during the post-monsoon season and lowest in summer, while fatty acid concentrations peaked during the monsoon season.257 Similarly, a study on red seaweeds from different coastal regions of Kalpitiya, Sri Lanka, revealed notable differences in mineral content (K, Ca, Mn, Fe, Cu, and Zn) among samples of the same species collected during the same season, which indicated a strong site-specific influence beyond the seasonal variability.258 These fluctuations in nutrient content might have a direct impact on the yield, potency, and overall quality of extracted seaweed compounds. Abiotic factors including sunlight, water temperature, wave motion, pH, salinity, and turbidity influence the chemical composition of seaweeds. For example, a comparative study reported that carrageenan yield in Calliblepharis jubata was the highest in summer (18.73%), alginate content in Sargassum muticum was high in winter (36.88%), and agar yield from Gracilaria gracilis remained relatively constant throughout the year (27.04%).259
In addition to these environmental variations, species-specific metabolic pathways also contribute to differences in composition. Brown algae are typically rich in fucoidans and phlorotannins, whereas red algae are rich in sulfated galactans like agar and carrageenans, and green algae are enriched in ulvans and rhamnans.260 Post-harvest methods such as drying, extraction, and storage could also influence the stability and concentration of these bioactive compounds.261 Such variations in the compositions lower the reproducibility of experimental studies, which present challenges for regulatory approvals. So, there is a need for the development of standard cultivation, harvesting, and processing protocols, followed by the integration of advanced analytical and omics-based approaches to ensure consistency and reliability in seaweed-based health products.
Consumer awareness and product acceptance
Seaweeds have been consumed traditionally in East Asian cultures. Specifically, in countries like Japan, one-fifth of the daily diet incorporates seaweeds in any form, and packaged seaweed foods have also been a part of everyday consumption. In contrast, Western countries have historically shown limited consumption of seaweeds, except in some coastal regions.262 However, over the last decade, seaweeds have gained popularity in Europe and North America, driven by the growing awareness of its nutritional value and potential applications.8 Consumption of seaweed-based products such as nori, wakame, kombu, kelp, and dulse is rapidly increasing in these western regions.226
One of the significant challenges faced in Indian seaweed market is the lack of consumer awareness and acceptance of seaweed-derived products.263 Unlike other countries such as China, South Korea, and Japan where seaweed is a staple dietary food, in India, seaweed consumption is largely confined to certain coastal communities.264 Indian cuisine does not traditionally include seaweeds in diet, and most of the populations, especially vegetarians, are hesitant to consume seaweed due to its strong oceanic aroma, unfamiliar taste, and slimy texture.265 Although edible species like Ulva and Caulerpa are available in Indian waters, their acceptance is very low. Also, there is a perception that seaweeds are exotic or a foreign ingredient. In order to improve their acceptance, increasing public awareness about the health benefits of seaweeds is essential. Strategies such as incorporation of seaweeds into familiar foods, using them as a condiment, or masking their aroma and taste could help integrate seaweeds into mainstream Indian diets.10,265
Future perspectives
Seaweeds demonstrate substantial variations in their nutritional composition. These variations in composition are greatly influenced by several factors including season, genetic makeup, and geographical location. Presently, seaweed cultivation largely depends on wild-type or less-improved strains, which leads to inconsistencies in their nutritional quality. These strains also have limited adaptability to the varying environmental conditions and increased susceptibility to diseases. Genome editing and synthetic biology strategies offer promising approaches at the molecular level to overcome existing barriers in macroalgal research. One of the key bottlenecks in this field is the lack of reliable protocols for the development of transgenic macroalgal strains. Only a few studies have reported transformation protocols and cloning toolkits for certain macroalgal species.266,267 Genome editing has been successfully demonstrated in a limited number of species, including two brown algae Ectocarpus spp268 and Saccharina japonica269 and one green alga, Ulva prolifera,270 using CRISPR technology. This technology has been used to knock-out conserved genes such as adenine phosphoribosyl transferase (APT), with the long-term goal of developing cultivars exhibiting improved disease resistance, stress tolerance, and yield.267 Meanwhile, synthetic biology approaches enable the expression of novel biosynthetic pathways in seaweeds to improve the synthesis of desirable compounds and achieve higher yield.271 However, most of these studies remain at the initial levels. Therefore, additional research is required for the development of species-specific genetic tools and robust transformation protocols for seaweeds.
Recently, artificial intelligence (AI) has emerged as a revolutionary platform to overcome those technological complications in the field of macroalgal research. The combination of AI with synthetic biology facilitates in-depth analysis of the metabolic pathways and gene regulatory networks, which enables a precise control over the biosynthesis of targeted metabolites.272 This symbiotic combination may accelerate rapid optimization of novel biosynthetic pathways in seaweeds. Furthermore, advanced AI models such as QSAR (quantitative structure-activity relationship) and neural networks are already playing critical role in the prediction of bioactivity profiles of novel drug compounds. The QSAR model predicts compounds by determining their chemical structure. The integration of neural networks with this model enhances this process to find the complex molecular structures.273,274 In future, the QSAR and neural networks may play a critical role in predicting the bioactivity profiles such as anti-oxidant, anti-microbial, anti-cancer, or anti-inflammatory properties of seaweed-derived metabolites with greater accuracy.
Abiotic factors, such as pH, temperature, salinity, wave motion, etc., can have a direct impact on yield and chemical composition of seaweeds. The integration of sendor-based systems and IoT technologies with machine learning algorithms, allows for efficient real-time monitoring of cultivation conditions.275 In addition, drone-based monitoring and remote sensing technologies help in estimation of growth and early disease detection. These technologies help in preventing losses due to climate variations caused by temperature rise and cyclones.276
Another key technological innovation that needs to be established well is the development of offshore seaweed farming techniques. This system utilizes floating cultivation structures in deeper waters, rather than relying solely on nearshore harvesting. Suggestions have been proposed for utilizing the offshore wind systems and decommissioned petroleum platforms for seaweed cultivation.277 This enables higher yield potential, reduces environmental degradation, and ensures a steady supply of seaweed biomass for industrial applications.
While there is a vast coastline and expanding ocean available for cultivation, there is need for a land-based cultivation system for seaweeds. Such systems have been established successfully in some regions in Canada, Denmark, and the Netherlands, with focus on cultivating seaweeds such as Chondrus crispus, Ulva, Palmaria palmata, Gracilaria, and Asparagopsis species.278,279,280 This method offers several advantages, including higher control over environmental factors like light, temperature, and nutrient levels, which can lead to higher productivity and the cultivation of specific species. Specifically, this system allows for the cultivation of edible seaweeds and seaweeds with novel therapeutic properties, without any contamination or diseases. The nutrient requirements can also be fortified, which can significantly alleviate stress and increase the yield of biomass. The challenges, research gaps, and limitations in the utilization of seaweeds and seaweed-derived products, along with future directions for their food and healthcare applications, have been discussed in detail and are summarized in Table 7.
Table 7.
Research gaps and future directions in seaweeds for food and healthcare
| Research gap | Description | Future directions | References |
|---|---|---|---|
| Variability in composition | nutritional and bioactive compound profiles vary with species, harvest season, and processing techniques, affecting reproducibility | development of standard cultivation and processing protocols for consistent quality control | Peñalver et al.8; Pangestuti et al.12 |
| Lack of standardization | no unified standards for extract preparation, dosage, and bioactivity evaluation across studies | establishment of global standards for seaweed extract characterization and bioassays | Gomez-Zavaglia et al.9; Rajauria et al.59 |
| Limited clinical evidence | most studies have been conducted in vitro or in animal models; human trials are scarce or inconclusive | conduct multicenter randomized controlled trials to confirm therapeutic efficacy | Shannon et al.171 |
| Safety and toxicology uncertainty | risk of excessive iodine intake, heavy metal accumulation, and allergic responses | define safe consumption thresholds and toxicological limits through longitudinal studies | Maray et al.119 |
| Consumer awareness and acceptance | lack of awareness among general consumers about health benefits and available products | launching awareness campaigns, and promoting seaweed-based foods through functional food labeling | Lomartire et al.10; Gajaria and Mantri265 |
| Regulatory heterogeneity | inconsistent GRAS and labeling regulations across countries hinder global market access | harmonize regulations for food safety, labeling, and marketing of seaweed products | Holdt and Kraan281 |
| Underutilized species | only a limited number of seaweeds are commercially explored, leaving bioactive-rich species untapped | explore bioactivity of lesser-known macroalgae using omics and AI tools | Dong et al.282 |
| Synthetic biology and cultivation challenges | lack of biotechnological tools for engineering high-yield strains or enhancing metabolite production | employ synthetic biology, CRISPR-Cas, and AI-based modeling for trait enhancement and metabolite pathway engineering | Blomme et al.266; Jonas et al.267 |
Today, seaweed cultivation comes with several greater risks, which affects the yield negatively. In parallel, the need for seaweeds in various fields is increasing, particularly in nutrition and healthcare. Future research needs to be focused on integration of seaweed-derived bioactives into personalized diet and nutritional frameworks based on an individual’s genetic, metabolic, and microbiome data. As seaweeds play a major role in achieving the UN Sustainable Development Goals, addressing seaweed-associated challenges from the molecular level to scalable cultivation and processing systems is crucial. So, there is a need for coordinated multidisciplinary effort to utilize the full potential of seaweeds for sustainable health, industry, and environmental benefits.
Conclusion
This review details the multifunctional role of bioactive compounds from seaweeds, which include polysaccharides, proteins, pigments, polyphenols, and essential micronutrients. It further discusses their pharmacological effects that enhance metabolic regulation and disease protection. However, a more integrated and deep approach is required to understand the complete health benefits of seaweeds. Successful innovations in genome editing and synthetic biology can enhance the biochemical value of seaweeds by increasing yield and quality of the desired compounds, while lowering their anti-nutritional components. Furthermore, the construction of off-shore and land-based cultivation systems in an environmentally controlled conditions could provide clean and scalable cultivation of seaweeds for nutritional and therapeutic applications. In addition, integrating advanced systems like IoT-based sensors, remote sensing, and drone-based surveillance with these cultivation systems will enable real-time monitoring of such cultivation systems. Meanwhile, the integration of AI and other emerging technologies with these combined systems could further aid in the optimization of environmental conditions. Combination of these technologies could help mitigate the impacts of climatic change and aid in achieving desirable yield and consistency in nutrient composition. Implementation of such regulations, frameworks, and technologies, along with sustainable practices, will ensure the incorporation of seaweeds as foods and supplements into everyone’s diet. Such initiatives may increase the overall consumption of seaweeds worldwide, thereby improving human health and mitigating diseases.
Acknowledgments
The authors would like to thank Vel Tech Rangarajan Dr. Sagunthala, R&D Institute of Science and Technology for providing necessary facilities and support to carry out this work. No funding was received for this work.
Author contributions
Conceptualization, M.S. and N.R.V.G.; validation, M.S.; investigation, M.S.; writing – original draft, A.C.E. and N.R.V.G.; writing – review & editing, M.S.; visualization, N.R.V.G.
Declaration of interests
The authors declare no competing interests.
Contributor Information
Mugesh Sankaranarayanan, Email: drmugeshs@veltech.edu.in.
Nadana Raja Vadivu Ganapathy, Email: nadana.vadivu@jaipur.manipal.edu.
References
- 1.Baghel R.S. Developments in seaweed biorefinery research: A comprehensive review. Chem. Eng. J. 2023;454 doi: 10.1016/j.cej.2022.140177. [DOI] [Google Scholar]
- 2.Bonanno G., Orlando-Bonaca M. Chemical elements in Mediterranean macroalgae. A review. Ecotoxicol. Environ. Saf. 2018;148:44–71. doi: 10.1016/j.ecoenv.2017.10.013. [DOI] [PubMed] [Google Scholar]
- 3.Choudhary B., Chauhan O.P., Mishra A. Edible Seaweeds: A Potential Novel Source of Bioactive Metabolites and Nutraceuticals With Human Health Benefits. Front. Mar. Sci. 2021;8 doi: 10.3389/fmars.2021.740054. [DOI] [Google Scholar]
- 4.Xie C., Lee Z.J., Ye S., Barrow C.J., Dunshea F.R., Suleria H.A.R. A Review on Seaweeds and Seaweed-Derived Polysaccharides: Nutrition, Chemistry, Bioactivities, and Applications. Food Rev. Int. 2023;40:1312–1347. doi: 10.1080/87559129.2023.2212055. [DOI] [Google Scholar]
- 5.Ganesan A.R., Tiwari U., Rajauria G. Seaweed nutraceuticals and their therapeutic role in disease prevention. Food Sci. Hum. Wellness. 2019;8:252–263. doi: 10.1016/j.fshw.2019.08.001. [DOI] [Google Scholar]
- 6.Baghel R.S., Choudhary B., Pandey S., Pathak P.K., Mishra A., Patel M.K. Rehashing Our Insight of Seaweeds as a Potential Source of Foods, Nutraceuticals, and Pharmaceuticals. Foods. 2023;12:3642. doi: 10.3390/foods12193642. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Cornish M.L., Garbary D.J. Antioxidants from macroalgae: potential applications in human health and nutrition. Algae. 2010;25:155–171. doi: 10.4490/algae.2010.25.4.155. [DOI] [Google Scholar]
- 8.Peñalver R., Lorenzo J.M., Ros G., Amarowicz R., Pateiro M., Nieto G. Seaweeds as a Functional Ingredient for a Healthy Diet. Mar. Drugs. 2020;18:301. doi: 10.3390/md18060301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Gomez-Zavaglia A., Prieto Lage M.A., Jimenez-Lopez C., Mejuto J.C., Simal-Gandara J. The Potential of Seaweeds as a Source of Functional Ingredients of Prebiotic and Antioxidant Value. Antioxidants. 2019;8:406. doi: 10.3390/antiox8090406. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Lomartire S., Marques J.C., Gonçalves A.M.M. An Overview to the Health Benefits of Seaweeds Consumption. Mar. Drugs. 2021;19:341. doi: 10.3390/md19060341. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Farzanah R., Clausen M., Arnspang E., Schmidt J., Bastidas-Oyanedel J.-R. Feasibility of United Arab Emirates Native Seaweed Ulva intestinalis as a Food Source: Study of Nutritional and Mineral Compositions. Phycology. 2022;2:120–131. doi: 10.3390/phycology2010008. [DOI] [Google Scholar]
- 12.Pangestuti R., Haq M., Rahmadi P., Chun B.-S. Nutritional Value and Biofunctionalities of Two Edible Green Seaweeds (Ulva lactuca and Caulerpa racemosa) from Indonesia by Subcritical Water Hydrolysis. Mar. Drugs. 2021;19:578. doi: 10.3390/md19100578. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Kasmiati K., Syahrul S., Badraeni B., Rahmi M.H. Proximate and mineral compositions of the green seaweeds Caulerpa lentilifera and Caulerpa racemosa from South Sulawesi Coast, Indonesia. IOP Conf. Ser. Earth Environ. Sci. 2022;1119 doi: 10.1088/1755-1315/1119/1/012049. [DOI] [Google Scholar]
- 14.Rasyid A., Rachman F., Handayani T., Kotta R. NUTRITIONAL POTENTIAL OF DRIED SEAWEED Turbinaria decurrens: BIOCHEMICAL INSIGHTS AND HEALTH BANEFITS. J. Teknol. 2025;87:785–792. doi: 10.11113/jurnalteknologi.v87.23168. [DOI] [Google Scholar]
- 15.Ismail M.M., El Zokm G.M., Miranda Lopez J.M. Nutritional, bioactive compounds content, and antioxidant activity of brown seaweeds from the Red Sea. Front. Nutr. 2023;10 doi: 10.3389/fnut.2023.1210934. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Widyaswari S.G., Metusalach M., Kasmiati K., Amir N. Bioactive compounds and DPPH antioxidant activity of underutilized macroalgae (Sargassum spp.) from coastal water of Makassar, Indonesia. Biodiversitas. 2024;25 doi: 10.13057/biodiv/d250118. [DOI] [Google Scholar]
- 17.Chin Y.Y., Chang K.A., Ng W.M., Eng Z.P., Chew L.Y., Neo Y.P., Yan S.W., Wong C.L., Kong K.W., Ismail A. A comparative evaluation of nutritional composition and antioxidant properties of six Malaysian edible seaweeds. Food Chem. Adv. 2023;3 doi: 10.1016/j.focha.2023.100426. [DOI] [Google Scholar]
- 18.Amaro H.M., Pagels F., Tavares T.G., Costa I., Sousa-Pinto I., Guedes A.C. Antioxidant and Anti-Inflammatory Potential of Seaweed Extracts as Functional Ingredients. Hydrobiology. 2022;1:469–482. doi: 10.3390/hydrobiology1040028. [DOI] [Google Scholar]
- 19.Windarto S., Herawati V.E., Wijaya Y.J., Indriati D.A., Rachmasari Y., Elfitasari T. Exploring the Physicochemical Properties and Nutritional Value of Abundant Seaweed Species Along the Jepara Coast, Indonesia. Thalassas. 2025;41 doi: 10.1007/s41208-025-00846-y. [DOI] [Google Scholar]
- 20.Indriyawati N., Supriyanto, Nabwiyah N.D.N. Nutritional composition of Sargassum sp. and Padina sp. BIO Web Conf. 2024;127 doi: 10.1051/bioconf/202412703001. [DOI] [Google Scholar]
- 21.Carpena M., Caleja C., Pereira E., Pereira C., Ćirić A., Soković M., Soria-Lopez A., Fraga-Corral M., Simal-Gandara J., Ferreira I.C.F.R., et al. Red Seaweeds as a Source of Nutrients and Bioactive Compounds: Optimization of the Extraction. Chemosensors. 2021;9:132. doi: 10.3390/chemosensors9060132. [DOI] [Google Scholar]
- 22.Echave J., Lourenço-Lopes C., Carreira-Casais A., Chamorro F., Fraga-Corral M., Otero P., Garcia-Perez P., Baamonde S., Fernández-Saa F., Cao H., et al. The 1st International Electronic Conference on Chemical Sensors and Analytical Chemistry. MDPI; 2021. Nutritional Composition of the Atlantic Seaweeds Ulva rigida, Codium tomentosum, Palmaria palmata and Porphyra purpurea; p. 67. [DOI] [Google Scholar]
- 23.Yesuraj D., Deepika C., Ravishankar G.A., Ranga Rao A. In: Sustainable Global Resources of Seaweeds Volume 2. Ranga Rao A., Ravishankar G.A., editors. Springer International Publishing; 2022. Seaweed-Based Recipes for Food, Health-Food Applications, and Innovative Products Including Meat and Meat Analogs; pp. 267–292. [DOI] [Google Scholar]
- 24.Gullón P., Astray G., Gullón B., Franco D., Campagnol P.C.B., Lorenzo J.M. Inclusion of seaweeds as healthy approach to formulate new low-salt meat products. Curr. Opin. Food Sci. 2021;40:20–25. doi: 10.1016/j.cofs.2020.05.005. [DOI] [Google Scholar]
- 25.Niemi C., Mortensen A.M., Rautenberger R., Matsson S., Gorzsás A., Gentili F.G. Rapid and accurate determination of protein content in North Atlantic seaweed by NIR and FTIR spectroscopies. Food Chem. 2023;404 doi: 10.1016/j.foodchem.2022.134700. [DOI] [PubMed] [Google Scholar]
- 26.Noble J.E., Bailey M.J.A. Quantitation of protein. Methods Enzymol. 2009;463:73–95. doi: 10.1016/S0076-6879(09)63008-1. [DOI] [PubMed] [Google Scholar]
- 27.BCA Assay and Lowry Assays. https://www.thermofisher.com/in/en/home/life-science/protein-biology/protein-assays-analysis/protein-assays/bca-protein-assays.html
- 28.Lowry Protein Assay - an overview. https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/lowry-protein-assay ScienceDirect Topics.
- 29.Biancarosa I., Espe M., Bruckner C.G., Heesch S., Liland N., Waagbø R., Torstensen B., Lock E.J. Amino acid composition, protein content, and nitrogen-to-protein conversion factors of 21 seaweed species from Norwegian waters. J. Appl. Phycol. 2016;29:1001–1009. doi: 10.1007/s10811-016-0984-3. [DOI] [Google Scholar]
- 30.Templeton D.W., Laurens L.M.L. Nitrogen-to-protein conversion factors revisited for applications of microalgal biomass conversion to food, feed and fuel. Algal Res. 2015;11:359–367. doi: 10.1016/j.algal.2015.07.013. [DOI] [Google Scholar]
- 31.Vandanjon L., Burlot A.-S., Zamanileha E.F., Douzenel P., Ravelonandro P.H., Bourgougnon N., Bedoux G. The Use of FTIR Spectroscopy as a Tool for the Seasonal Variation Analysis and for the Quality Control of Polysaccharides from Seaweeds. Mar. Drugs. 2023;21:482. doi: 10.3390/md21090482. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Jeong H., Cho J., Han J., Yoon Y.-S., Kim H.G., Kim J., Chung H. Large-area coverage–transmission near-infrared measurement of dried laver to determine crude protein content. Food Control. 2025;168:110934. doi: 10.1016/j.foodcont.2024.110934. [DOI] [Google Scholar]
- 33.Hayes M. Measuring Protein Content in Food: An Overview of Methods. Foods. 2020;9:1340. doi: 10.3390/foods9101340. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Mæhre H.K., Dalheim L., Edvinsen G.K., Elvevoll E.O., Jensen I.-J. Protein Determination—Method Matters. Foods. 2018;7:5. doi: 10.3390/foods7010005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.O’ Connor J., Meaney S., Williams G.A., Hayes M. Extraction of Protein from Four Different Seaweeds Using Three Different Physical Pre-Treatment Strategies. Molecules. 2020;25:2005. doi: 10.3390/molecules25082005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Gamero-Vega G., Palacios-Palacios M., Quitral V. Nutritional Composition and Bioactive Compounds of Red Seaweed: A Mini-Review. J. Food Nutr. Res. 2020;8:431–440. doi: 10.12691/jfnr-8-8-7. [DOI] [Google Scholar]
- 37.Angell A.R., Mata L., de Nys R., Paul N.A. The protein content of seaweeds: a universal nitrogen-to-protein conversion factor of five. J. Appl. Phycol. 2016;28:511–524. doi: 10.1007/s10811-015-0650-1. [DOI] [Google Scholar]
- 38.Machado M., Machado S., Pimentel F.B., Freitas V., Alves R.C., Oliveira M.B.P.P. Amino Acid Profile and Protein Quality Assessment of Macroalgae Produced in an Integrated Multi-Trophic Aquaculture System. Foods. 2020;9:1382. doi: 10.3390/foods9101382. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Healy L.E., Zhu X., Pojic M., Poojary M.M., Curtin J., Tiwari U., Sullivan C., Tiwari B.K. Impact of dry, particle-size fractionation on protein and amino acid content of three seaweed species. Int. J. Food Prop. 2022;25:2073–2088. doi: 10.1080/10942912.2022.2120001. [DOI] [Google Scholar]
- 40.Ghelichi S., Hajfathalian M., Helalat S.H., Svensson B., Jacobsen C. Purification, Identification, and In Silico Analysis of Anti-Obesity and Antidiabetic Peptides from the Red Seaweed Palmaria palmata. Mar. Drugs. 2025;23:392. doi: 10.3390/md23100392. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Shannon E., Abu-Ghannam N. Seaweeds as nutraceuticals for health and nutrition. Phycologia. 2019;58:563–577. doi: 10.1080/00318884.2019.1640533. [DOI] [Google Scholar]
- 42.Susanti D., Ruslan F.S., Shukor M.I., Nor N.M., Aminudin N.I., Taher M., Khotib J. Optimisation of Vitamin B12 Extraction from Green Edible Seaweed (Ulva lactuca) by Applying the Central Composite Design. Molecules. 2022;27:4459. doi: 10.3390/molecules27144459. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Hagan M., Anyangwe N. Vitamin content in seaweeds: A systematic review on water-soluble and fat-soluble vitamins for adult daily intake. Funct. Food Sci. 2023;3:305. doi: 10.31989/ffs.v3i12.1273. [DOI] [Google Scholar]
- 44.Cotas J., Leandro A., Monteiro P., Pacheco D., Figueirinha A., Gonçalves A.M.M., da Silva G.J., Pereira L. Seaweed Phenolics: From Extraction to Applications. Mar. Drugs. 2020;18:384. doi: 10.3390/md18080384. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Huang W., Tan H., Nie S. Beneficial effects of seaweed-derived dietary fiber: Highlights of the sulfated polysaccharides. Food Chem. 2022;373 doi: 10.1016/j.foodchem.2021.131608. [DOI] [PubMed] [Google Scholar]
- 46.Zhang X., Thomsen M. Techno-economic and environmental assessment of novel biorefinery designs for sequential extraction of high-value biomolecules from brown macroalgae Laminaria digitata, Fucus vesiculosus, and Saccharina latissima. Algal Res. 2021;60 doi: 10.1016/j.algal.2021.102499. [DOI] [Google Scholar]
- 47.Zayed A., El-Aasr M., Ibrahim A.-R.S., Ulber R. Fucoidan Characterization: Determination of Purity and Physicochemical and Chemical Properties. Mar. Drugs. 2020;18:571. doi: 10.3390/md18110571. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Chandimali N., Bak S.G., Park E.H., Lim H.-J., Won Y.-S., Kim E.-K., Park S.-I., Lee S.J. Free radicals and their impact on health and antioxidant defenses: a review. Cell Death Discov. 2025;11 doi: 10.1038/s41420-024-02278-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Yunianta Y., Laeliocattleya R.A., Wulan S.N., Risjani Y. Fucoidan extract from brown seaweed ( Sargassum echinocarpum ): molecular weight, elemental composition, selectivity and anticancer activity against breast cancer cells. Nat. Prod. Res. 2025;39:3093–3101. doi: 10.1080/14786419.2024.2326978. [DOI] [PubMed] [Google Scholar]
- 50.Chantree P., Na-Bangchang K., Martviset P. Anticancer Activity of Fucoidan via Apoptosis and Cell Cycle Arrest on Cholangiocarcinoma Cell. Asian Pac. J. Cancer Prev. 2021;22:209–217. doi: 10.31557/APJCP.2021.22.1.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Al-Duais M.A., El Rabey H.A., Mohammed G.M., Al-Awthan Y.S., Althiyabi A.S., Attia E.S., Rezk S.M., Tayel A.A. The anticancer activity of fucoidan coated selenium nanoparticles and curcumin nanoparticles against colorectal cancer lines. Sci. Rep. 2025;15:287. doi: 10.1038/s41598-024-82687-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Akl F.M.A., El-Sheekh M.M., Makhlof M.E.M., Ahmed S.I. Antimicrobial, antidiabetic, antiviral, and antioxidant activities of fucoidan extracted from the brown seaweed Padina pavonica. BMC Biotechnol. 2025;25:70. doi: 10.1186/s12896-025-01004-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Sun Q.-L., Li Y., Ni L.-Q., Li Y.-X., Cui Y.-S., Jiang S.-L., Xie E.-Y., Du J., Deng F., Dong C.-X. Structural characterization and antiviral activity of two fucoidans from the brown algae Sargassum henslowianum. Carbohydr. Polym. 2020;229 doi: 10.1016/j.carbpol.2019.115487. [DOI] [PubMed] [Google Scholar]
- 54.Daub C.D., Mabate B., Malgas S., Pletschke B.I. Fucoidan from Ecklonia maxima is a powerful inhibitor of the diabetes-related enzyme, α-glucosidase. Int. J. Biol. Macromol. 2020;151:412–420. doi: 10.1016/j.ijbiomac.2020.02.161. [DOI] [PubMed] [Google Scholar]
- 55.Yue Q., Liu Y., Li F., Hong T., Guo S., Cai M., Zhao L., Su L., Zhang S., Zhao C., Li K. Antioxidant and anticancer properties of fucoidan isolated from Saccharina Japonica brown algae. Sci. Rep. 2025;15:8962. doi: 10.1038/s41598-025-94312-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Sanniyasi E., Gopal R.K., Damodharan R., Arumugam A., Sampath Kumar M., Senthilkumar N., Anbalagan M. In vitro anticancer potential of laminarin and fucoidan from Brown seaweeds. Sci. Rep. 2023;13 doi: 10.1038/s41598-023-41327-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Malyarenko O.S., Usoltseva R.V., Silchenko A.S., Ermakova S.P. Aminated laminaran from brown alga Saccharina cichorioides: Synthesis, structure, anticancer, and radiosensitizing potential in vitro. Carbohydr. Polym. 2020;250 doi: 10.1016/j.carbpol.2020.117007. [DOI] [PubMed] [Google Scholar]
- 58.Tian L., Li C.-M., Li Y.-F., Huang T.-M., Chao N.-X., Luo G.-R., Mo F.-R. Laminarin from Seaweed ( Laminaria japonica ) Inhibits Hepatocellular Carcinoma Through Upregulating Senescence Marker Protein-30. Cancer Biother. Radiopharm. 2020;35:277–283. doi: 10.1089/cbr.2019.3179. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Rajauria G., Ravindran R., Garcia-Vaquero M., Rai D.K., Sweeney T., O’Doherty J. Molecular characteristics and antioxidant activity of laminarin extracted from the seaweed species Laminaria hyperborea, using hydrothermal-assisted extraction and a multi-step purification procedure. Food Hydrocoll. 2021;112 doi: 10.1016/j.foodhyd.2020.106332. [DOI] [Google Scholar]
- 60.Xuan Cuong D. Laminarin (Beta-glucan) of Brown Algae Sargassum mcclurei: Extraction, Antioxidant Activity, Lipoxygenase Inhibition Activity, and Physicochemistry Properties. World J. Food Sci. Technol. 2020;4:31. doi: 10.11648/j.wjfst.20200401.15. [DOI] [Google Scholar]
- 61.Tiasto V.A., Goncharov N.V., Romanishin A.O., Zhidkov M.E., Khotimchenko Y.S. κ- and λ-Carrageenans from Marine Alga Chondrus armatus Exhibit Anticancer In Vitro Activity in Human Gastrointestinal Cancers Models. Mar. Drugs. 2022;20:741. doi: 10.3390/md20120741. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Cotas J., Marques V., Afonso M.B., Rodrigues C.M.P., Pereira L. Antitumour Potential of Gigartina pistillata Carrageenans against Colorectal Cancer Stem Cell-Enriched Tumourspheres. Mar. Drugs. 2020;18:50. doi: 10.3390/md18010050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Sanjivkumar M., Chandran M.N., Suganya A.M., Immanuel G. Investigation on bio-properties and in-vivo antioxidant potential of carrageenans against alloxan induced oxidative stress in Wistar albino rats. Int. J. Biol. Macromol. 2020;151:650–662. doi: 10.1016/j.ijbiomac.2020.02.227. [DOI] [PubMed] [Google Scholar]
- 64.Setyopratomo P., Sapei L. Rheological behavior and antioxidant activity of carrageenan extracted from Green seaweed (Eucheuma cottonii) using alkaline solution at low temperature. AIP Conf. Proc. 2022;2470 doi: 10.1063/5.0080286. [DOI] [Google Scholar]
- 65.Naveen J., Baskaran R., Baskaran V. Profiling of bioactives and in vitro evaluation of antioxidant and antidiabetic property of polyphenols of marine algae Padina tetrastromatica. Algal Res. 2021;55 doi: 10.1016/j.algal.2021.102250. [DOI] [Google Scholar]
- 66.Bakunina I., Imbs T., Likhatskaya G., Grigorchuk V., Zueva A., Malyarenko O., Ermakova S. Effect of Phlorotannins from Brown Algae Costaria costata on α-N-Acetylgalactosaminidase Produced by Duodenal Adenocarcinoma and Melanoma Cells. Mar. Drugs. 2022;21:33. doi: 10.3390/md21010033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Raja R., Hemaiswarya S., Arunkumar K., Mathiyazhagan N., Kandasamy S., Arun A., Ramasamy P. Efficacy of Eisenia bicyclis phlorotannins in the treatment of diabetes and reducing inflammation. Food Biosci. 2023;52 doi: 10.1016/j.fbio.2023.102381. [DOI] [Google Scholar]
- 68.Gheda S., Naby M.A., Mohamed T., Pereira L., Khamis A. Antidiabetic and antioxidant activity of phlorotannins extracted from the brown seaweed Cystoseira compressa in streptozotocin-induced diabetic rats. Environ. Sci. Pollut. Res. 2021;28:22886–22901. doi: 10.1007/s11356-021-12347-5. [DOI] [PubMed] [Google Scholar]
- 69.Ohno Y., Kondo S., Tajima K., Shibata T., Itoh T. Effect of Phlorotannins Isolated From Eisenia bicyclis on Melanogenesis in Mouse B16 Melanoma Cells. Nat. Prod. Commun. 2021;16 doi: 10.1177/1934578X211019264. 1934578X211019264. [DOI] [Google Scholar]
- 70.Godlaveti Vijay N.K., Vellapandian C. Ameliorative effects of phlorotannin-rich fraction of Sargassum tenerrimum in high-fat diet and low dose streptozotocin-induced metabolic changes and oxidative stress in diabetic rats. J. Herbmed Pharmacol. 2023;12:367–379. doi: 10.34172/jhp.2023.40. [DOI] [Google Scholar]
- 71.Mert-Ozupek N., Calibasi-Kocal G., Olgun N., Basbinar Y., Cavas L., Ellidokuz H. An Efficient and Quick Analytical Method for the Quantification of an Algal Alkaloid Caulerpin Showed In-Vitro Anticancer Activity against Colorectal Cancer. Mar. Drugs. 2022;20:757. doi: 10.3390/md20120757. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Abdelrheem D.A., Abd El-Mageed H.R., Mohamed H.S., Rahman A.A., Elsayed K.N.M., Ahmed S.A. Bis-indole alkaloid caulerpin from a new source Sargassum platycarpum : isolation, characterization, in vitro anticancer activity, binding with nucleobases by DFT calculations and MD simulation. J. Biomol. Struct. Dyn. 2021;39:5137–5147. doi: 10.1080/07391102.2020.1784285. [DOI] [PubMed] [Google Scholar]
- 73.Abílio G.M.F., Camilo C.J., Coutinho H.D.M., Costa J.G.M.D., Pena L.J., Silva-Júnior A., Nascimento Y.M.D., Barbosa-Filho J.M., Santos B.V.D.O., Freire K.R.D.L. Cytotoxic and Anti-HSV-1 Effects of Caulerpin Derivatives. Molecules. 2024;29:3859. doi: 10.3390/molecules29163859. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Mualimin L., Arum M. In Silico Study of Bioactive Compounds Fucoxanthin and Fucoidan from Sargassum echinocarpum as Anti-Cancer Agents Targeting Caspase-3 Protein. Aquat Life Sci. 2025;1:45–52. doi: 10.58920/aqlis0102302. [DOI] [Google Scholar]
- 75.Saxena A., Mahajan A., Nagtilak S. Anticancer Efficacy of Fucoxanthin in Targeting Ovarian Cancer Cells. Int. J. Life Sci. Biotechnol. Pharma Res. 2024;13:114–123. doi: 10.69605/ijlbpr_13.6.21. [DOI] [Google Scholar]
- 76.Oliyaei N., Moosavi-Nasab M., Tamaddon A.M., Tanideh N. Antidiabetic effect of fucoxanthin extracted from Sargassum angustifolium on streptozotocin-nicotinamide-induced type 2 diabetic mice. Food Sci. Nutr. 2021;9:3521–3529. doi: 10.1002/fsn3.2301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Indumathi P., Mehta A. A novel anticoagulant peptide from the Nori hydrolysate. J. Funct.Foods. 2016;20:606–617. doi: 10.1016/j.jff.2015.11.016. [DOI] [Google Scholar]
- 78.Paiva L., Lima E., Neto A.I., Baptista J. Isolation and characterization of angiotensin I-converting enzyme (ACE) inhibitory peptides from Ulva rigida C. Agardh protein hydrolysate. J. Funct.Foods. 2016;26:65–76. doi: 10.1016/j.jff.2016.07.006. [DOI] [Google Scholar]
- 79.Harnedy-Rothwell P.A., McLaughlin C.M., Le Gouic A.V., Mullen C., Parthsarathy V., Allsopp P.J., McSorley E.M., FitzGerald R.J., O’Harte F.P.M. In Vitro and In Vivo Effects of Palmaria palmata Derived Peptides on Glucose Metabolism. Int. J. Pept. Res. Ther. 2021;27:1667–1676. doi: 10.1007/s10989-021-10199-8. [DOI] [Google Scholar]
- 80.McLaughlin C.M., Harnedy-Rothwell P.A., Lafferty R.A., Sharkey S., Parthsarathy V., Allsopp P.J., McSorley E.M., FitzGerald R.J., O’Harte F.P.M. Macroalgal protein hydrolysates from Palmaria palmata influence the ‘incretin effect’ in vitro via DPP-4 inhibition and upregulation of insulin, GLP-1 and GIP secretion. Eur. J. Nutr. 2021;60:4439–4452. doi: 10.1007/s00394-021-02583-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Sanniyasi E., Gopal R.K., Raj P.P., Shanmugavel A.K. Anti-inflammatory, remorin-like protein from green marine Macroalga Caulerpa sertularioides (S.G.Gmel.) M.Howe. Heliyon. 2023;9 doi: 10.1016/j.heliyon.2023.e19239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.McLaughlin C.M., Harnedy P.A., Allsopp P.J., McSorley E.M., FitzGerald R.J., O’Harte F.P.M. Administration of protein hydrolysates from Palmaria palmata reduced food intake, improved glycaemic parameters and lipid profile in streptozotocin diabetes induced mice. Proc. Nutr. Soc. 2018;77 doi: 10.1017/S0029665118001209. [DOI] [Google Scholar]
- 83.Wang X., Xia K., Yang X., Tang C. Growth strategy of microbes on mixed carbon sources. Nat. Commun. 2019;10:1279. doi: 10.1038/s41467-019-09261-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Jeong S., Lee S., Lee G., Hyun J., Ryu B. Systematic Characteristics of Fucoidan: Intriguing Features for New Pharmacological Interventions. Int. J. Mol. Sci. 2024;25:11771. doi: 10.3390/ijms252111771. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Karuppusamy S., Rajauria G., Fitzpatrick S., Lyons H., McMahon H., Curtin J., Tiwari B.K., O’Donnell C. Biological Properties and Health-Promoting Functions of Laminarin: A Comprehensive Review of Preclinical and Clinical Studies. Mar. Drugs. 2022;20:772. doi: 10.3390/md20120772. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Li Y., Zheng Y., Zhang Y., Yang Y., Wang P., Imre B., Wong A.C.Y., Hsieh Y.S.Y., Wang D. Brown Algae Carbohydrates: Structures, Pharmaceutical Properties, and Research Challenges. Mar. Drugs. 2021;19:620. doi: 10.3390/md19110620. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Carrasqueira J., Bernardino S., Bernardino R., Afonso C. Marine-Derived Polysaccharides and Their Potential Health Benefits in Nutraceutical Applications. Mar. Drugs. 2025;23:60. doi: 10.3390/md23020060. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Pramanik S., Singh A., Abualsoud B.M., Deepak A., Nainwal P., Sargsyan A.S., Bellucci S. From algae to advancements: laminarin in biomedicine. RSC Adv. 2024;14:3209–3231. doi: 10.1039/d3ra08161c. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Uno Y., Omoto T., Goto Y., Asai I., Nakamura M., Maitani T. Molecular weight distribution of carrageenans studied by a combined gel permeation/inductively coupled plasma (GPC/ICP) method. Food Addit. Contam. 2001;18:763–772. doi: 10.1080/02652030117235. [DOI] [PubMed] [Google Scholar]
- 90.Rupert R., Rodrigues K.F., Thien V.Y., Yong W.T.L. Carrageenan From Kappaphycus alvarezii (Rhodophyta, Solieriaceae): Metabolism, Structure, Production, and Application. Front. Plant Sci. 2022;13 doi: 10.3389/fpls.2022.859635. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Pradhan B., Patra S., Behera C., Nayak R., Jit B.P., Ragusa A., Jena M. Preliminary Investigation of the Antioxidant, Anti-Diabetic, and Anti-Inflammatory Activity of Enteromorpha intestinalis Extracts. Molecules. 2021;26:1171. doi: 10.3390/molecules26041171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Admassu H., Zhao W., Yang R., Gasmalla M.A.A., Alsir E. Development Of Functional Foods: Sea Weeds (Algae) Untouched Potential And Alternative Resource - A Review. Int. J. Sci. Technol. Res. 2015;4:108–115. [Google Scholar]
- 93.Güven K.C., Percot A., Sezik E. Alkaloids in Marine Algae. Mar. Drugs. 2010;8:269–284. doi: 10.3390/md8020269. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Souza C.R.M., Bezerra W.P., Souto J.T. Marine Alkaloids with Anti-Inflammatory Activity: Current Knowledge and Future Perspectives. Mar. Drugs. 2020;18:147. doi: 10.3390/md18030147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Erol E., Orhan M.D., Avsar T., Akdemir A., Okudan E.S., Alim Toraman G.O., Topcu G. Anti-SARS-CoV-2 and cytotoxic activity of two marine alkaloids from green alga Caulerpa cylindracea Sonder in the Dardanelles. RSC Adv. 2022;12:29983–29990. doi: 10.1039/d2ra03358e. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Eggersdorfer M., Wyss A. Carotenoids in human nutrition and health. Arch. Biochem. Biophys. 2018;652:18–26. doi: 10.1016/j.abb.2018.06.001. [DOI] [PubMed] [Google Scholar]
- 97.Kumarasinghe H., Gunathilaka M. A systematic review of fucoxanthin as a promising bioactive compound in drug development. Phytochem. Lett. 2024;61:52–65. doi: 10.1016/j.phytol.2024.03.009. [DOI] [Google Scholar]
- 98.Echave J., Otero P., Garcia-Oliveira P., Munekata P.E.S., Pateiro M., Lorenzo J.M., Simal-Gandara J., Prieto M.A. Seaweed-Derived Proteins and Peptides: Promising Marine Bioactives. Antioxidants. 2022;11:176. doi: 10.3390/antiox11010176. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Echave J., Fraga-Corral M., Garcia-Perez P., Popović-Djordjević J., H. Avdović E., Radulović M., Xiao J., A. Prieto M., Simal-Gandara J. Seaweed Protein Hydrolysates and Bioactive Peptides: Extraction, Purification, and Applications. Mar. Drugs. 2021;19:500. doi: 10.3390/md19090500. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Čmiková N., Kowalczewski P.Ł., Kmiecik D., Tomczak A., Drożdżyńska A., Ślachciński M., Szala Ł., Matić S., Marković T., Popović S., et al. Seaweed Nutritional Value and Bioactive Properties: Insights from Ascophyllum nodosum, Palmaria palmata, and Chondrus crispus. Life. 2024;14:1522. doi: 10.3390/life14111522. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Chavda V.P., Feehan J., Apostolopoulos V. Inflammation: The Cause of All Diseases. Cells. 2024;13 doi: 10.3390/cells13221906. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Khursheed M., Ghelani H., Jan R.K., Adrian T.E. Anti-Inflammatory Effects of Bioactive Compounds from Seaweeds, Bryozoans, Jellyfish, Shellfish and Peanut Worms. Mar. Drugs. 2023;21:524. doi: 10.3390/md21100524. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Da Costa E., Melo T., Reis M., Domingues P., Calado R., Abreu M.H., Domingues M.R. Polar Lipids Composition, Antioxidant and Anti-Inflammatory Activities of the Atlantic Red Seaweed Grateloupia turuturu. Mar. Drugs. 2021;19:414. doi: 10.3390/md19080414. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Saraswati, Giriwono P.E., Giriwono P.E., Iskandriati D., Tan C.P., Andarwulan N. In-vitro anti-inflammatory activity, free radical (DPPH) scavenging, and ferric reducing ability (FRAP) of Sargassum cristaefolium lipid-soluble fraction and putative identification of bioactive compounds using UHPLC-ESI-ORBITRAP-MS/MS. Food Res. Int. 2020;137 doi: 10.1016/j.foodres.2020.109702. [DOI] [PubMed] [Google Scholar]
- 105.Viswanathan S., Palaniyandi T., Rajendran B.K., Sivaji A., Kannaki P., Shanmugam R., Baskar G., Rahaman A.M., Paul L.T.D. Biogenic synthesis of gold nanoparticles using red seaweed Champia parvula and its anti-oxidant and anticarcinogenic activity on lung cancer. Part. Sci. Technol. 2022;41:241–249. doi: 10.1080/02726351.2022.2074926. [DOI] [Google Scholar]
- 106.Hasan M.M., Alim M.A., Momen M.S.H., Islam M.S., Chowdhury S.H., Rashed M., Hoque F., Hossen S.M.M. Harnessing the multidimensional bioactivity of Chaetomorpha aerea: Integrative phytochemical profiling with in vitro, in vivo, and in silico insights. Animal Model. Exp. Med. 2025;8:1416–1427. doi: 10.1002/ame2.70064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.Polo L.K., Chow F. Variation of antioxidant capacity and antiviral activity of the brown seaweed Sargassum filipendula (Fucales, Ochrophyta) under UV radiation treatments. Appl. Phycol. 2022;3:260–273. doi: 10.1080/26388081.2022.2030653. [DOI] [Google Scholar]
- 108.Eman B., El-Sheekh M.M., El Shafay S.M., El-shenody R., Nassef M. Therapeutic anti-inflammatory immune potentials of some seaweeds extracts on chemically induced liver injury in mice. Sci. Rep. 2025;15:4370. doi: 10.1038/s41598-025-87379-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109.El-Sheekh M.M., Nassef M., Bases E., Shafay S.E., El-shenody R. Antitumor immunity and therapeutic properties of marine seaweeds-derived extracts in the treatment of cancer. Cancer Cell Int. 2022;22 doi: 10.1186/s12935-022-02683-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110.Perumal P., Vinayagam J., Loganathan S., Sathakkathulla N.A., Murugesan B.S., Musthafa F., Rathinasamy S., Balaraman A.K. Green synthesis of zinc oxide nanoparticles using green seaweed Caulerpa taxifolia and its anticancer activity on cervical cancer. Chem. Pap. 2025;79:4999–5007. doi: 10.1007/s11696-025-04101-9. [DOI] [Google Scholar]
- 111.Algotiml R., Gab-Alla A., Seoudi R., Abulreesh H.H., El-Readi M.Z., Elbanna K. Anticancer and antimicrobial activity of biosynthesized Red Sea marine algal silver nanoparticles. Sci. Rep. 2022;12 doi: 10.1038/s41598-022-06412-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.Digala P., Saravanan M., Dhanraj M., Pamarthi J., Muralidharan S., Narikimelli A., Dinakaran K.P., Arokiyaraj S., Vincent S. Optimized extraction of sulfated polysaccharide from brown seaweed Sargassum polycystum and their evaluation of anti-cancer and wound healing potential. South Afr. J. Bot. 2022;151:345–359. doi: 10.1016/j.sajb.2022.03.015. [DOI] [Google Scholar]
- 113.Thirupathi B., Pongen Y.L., Kaveriyappan G.R., Dara P.K., Rathinasamy S., Vinayagam S., Sundaram T., Hyun B.K., Durairaj T., Sekar S.K.R. Padina boergesenii mediated synthesis of Se-ZnO bimetallic nanoparticles for effective anticancer activity. Front. Microbiol. 2024;15 doi: 10.3389/fmicb.2024.1358467. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114.Husni A., Gazali M., Nurjanah N., Syafitri R., Matin A., Zuriat Z. Cytotoxic Activity of Green Seaweed Halimeda tuna Methanolic Extract Against Lung Cancer Cells. J. Multidiscip. Appl. Nat. Sci. 2023;4:16–29. doi: 10.47352/jmans.2774-3047.172. [DOI] [Google Scholar]
- 115.Ramalingam V., Narendra Kumar N., Harshavardhan M., Sampath Kumar H.M., Tiwari A.K., Suresh Babu K., Mudiam M.K.R. Chemical profiling of marine seaweed Halimeda gracilis using UPLC-ESI-Q-TOF-MSE and evaluation of anticancer activity targeting PI3K/AKT and intrinsic apoptosis signaling pathway. Food Res. Int. 2022;157 doi: 10.1016/j.foodres.2022.111394. [DOI] [PubMed] [Google Scholar]
- 116.Mofeed J., Deyab M., Mohamed A., Moustafa M., Negam S., El-Bilawy E. Antimicrobial activities of three seaweeds extract against some human viral and bacterial pathogens. Biocell. 2022;46:247–261. doi: 10.32604/biocell.2022.015966. [DOI] [Google Scholar]
- 117.Das D., Arulkumar A., Paramasivam S., Lopez-Santamarina A., del Carmen Mondragon A., Miranda Lopez J.M. Phytochemical Constituents, Antimicrobial Properties and Bioactivity of Marine Red Seaweed (Kappaphycus alvarezii) and Seagrass (Cymodocea serrulata) Foods. 2023;12:2811. doi: 10.3390/foods12142811. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118.Kulshreshtha G., Critchley A., Rathgeber B., Stratton G., Banskota A.H., Hafting J., Prithiviraj B. Antimicrobial Effects of Selected, Cultivated Red Seaweeds and Their Components in Combination with Tetracycline, against Poultry Pathogen Salmonella Enteritidis. J. Mar. Sci. Eng. 2020;8:511. doi: 10.3390/jmse8070511. [DOI] [Google Scholar]
- 119.Maray S.O., Abdel-Kareem M.S.M., Mabrouk M.E.M., El-Halmouch Y., Makhlof M.E.M. In Vitro Assessment of Antiviral, Antimicrobial, Antioxidant and Anticancer Activities of Ulvan Extracted from the Green Seaweed Ulva lactuca. Thalassas. 2023;39:779–790. doi: 10.1007/s41208-023-00584-z. [DOI] [Google Scholar]
- 120.Lee H.-G., Lu Y.A., Li X., Hyun J.-M., Kim H.-S., Lee J.J., Kim T.H., Kim H.M., Kang M.-C., Jeon A.Y.J. Anti-Obesity Effects of Grateloupia elliptica, a Red Seaweed, in Mice with High-Fat Diet-Induced Obesity via Suppression of Adipogenic Factors in White Adipose Tissue and Increased Thermogenic Factors in Brown Adipose Tissue. Nutrients. 2020;12:308. doi: 10.3390/nu12020308. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 121.Murakami S., Hirazawa C., Mizutani T., Yoshikawa R., Ohya T., Ma N., Owaki Y., Owaki T., Ito T., Matsuzaki C. The anti-obesity and anti-diabetic effects of the edible seaweed Gloiopeltis furcata (Postels et Ruprecht) J. Agardh in mice fed a high-fat diet. Food Sci. Nutr. 2022;11:599–610. doi: 10.1002/fsn3.3100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 122.Lee H.-G., Hyun J., Liyanage N.M., Jayawardhana H.H.A.C.K., Nagahawatta D.P., Choi Y.-S., Song K.-M., Kang M.-C., Jeon Y.-J. Investigating in vitro antiobesity properties of enzyme-assisted hydrolysate and its crude sulfated polysaccharide from Padina arborescens. J. Funct.Foods. 2023;108 doi: 10.1016/j.jff.2023.105704. [DOI] [Google Scholar]
- 123.Zheng M., Chao X., Zheng Y., Hong T., Wu W., Zhu Y., Ni H., Jiang Z. A polysaccharide from edible red seaweed Bangia fusco-purpurea prevents obesity in high-fat diet-induced C57BL/6 mice. Int. J. Biol. Macromol. 2024;283 doi: 10.1016/j.ijbiomac.2024.137545. [DOI] [PubMed] [Google Scholar]
- 124.Unnikrishnan P.S., Animish A., Madhumitha G., Suthindhiran K., Jayasri M.A. Bioactivity Guided Study for the Isolation and Identification of Antidiabetic Compounds from Edible Seaweed—Ulva reticulata. Molecules. 2022;27:8827. doi: 10.3390/molecules27248827. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 125.Lee D., Nishizawa M., Shimizu Y., Saeki H. Anti-inflammatory effects of dulse (Palmaria palmata) resulting from the simultaneous water-extraction of phycobiliproteins and chlorophyll a. Food Res. Int. 2017;100:514–521. doi: 10.1016/j.foodres.2017.06.040. [DOI] [PubMed] [Google Scholar]
- 126.Pangestuti R., Haq M., Rahmadi P., Chun B.-S. Nutritional Value and Biofunctionalities of Two Edible Green Seaweeds (Ulva lactuca and Caulerpa racemosa) from Indonesia by Subcritical Water Hydrolysis. Mar. Drugs. 2021;19:578. doi: 10.3390/md19100578. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 127.Enrico T., Aita S.E., Bollati C., Boschin G., Cavaliere C., d’Adduzio L., Montone C.M., Laganá A., Lammi C., Capriotti A.L. Seaweed (G. gracilis) Protein Hydrolyzates: A Valuable Source of Short- and Medium-Chain Peptides with Multifunctional Properties. J. Agric. Food Chem. 2025;73:18783–18794. doi: 10.1021/acs.jafc.5c03547. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 128.Lichota A., Gwozdzinski K. Anticancer Activity of Natural Compounds from Plant and Marine Environment. Int. J. Mol. Sci. 2018;19:3533. doi: 10.3390/ijms19113533. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 129.Sanniyasi E., Gopal R.K., Damodharan R., Arumugam A., Sampath Kumar M., Senthilkumar N., Anbalagan M. In vitro anticancer potential of laminarin and fucoidan from Brown seaweeds. Sci. Rep. 2023;13 doi: 10.1038/s41598-023-41327-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 130.Yunianta Y., Laeliocattleya R.A., Wulan S.N., Risjani Y. Fucoidan extract from brown seaweed (Sargassum echinocarpum): molecular weight, elemental composition, selectivity and anticancer activity against breast cancer cells. Nat. Prod. Res. 2025;39:3093–3101. doi: 10.1080/14786419.2024.2326978. [DOI] [PubMed] [Google Scholar]
- 131.Mert-Ozupek N., Calibasi-Kocal G., Olgun N., Başbınar Y., Çavaş L., Ellıdokuz H. An Efficient and Quick Analytical Method for the Quantification of an Algal Alkaloid Caulerpin Showed In-Vitro Anticancer Activity against Colorectal Cancer. Mar. Drugs. 2022;20:757. doi: 10.3390/md20120757. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 132.Pradhan B., Patra S., Behera C., Nayak R., Patil S., Bhutia S.K., Jena M. Enteromorpha compressa extract induces anticancer activity through apoptosis and autophagy in oral cancer. Mol. Biol. Rep. 2020;47:9567–9578. doi: 10.1007/s11033-020-06010-4. [DOI] [PubMed] [Google Scholar]
- 133.Husni A., Gazali M., Nurjanah N., Syafitri R., Matin A., Zuriat Z. Cytotoxic Activity of Green Seaweed Halimeda tuna Methanolic Extract Against Lung Cancer Cells. J. Multidiscip. Appl. Nat. Sci. 2023;4:16–29. doi: 10.47352/jmans.2774-3047.172. [DOI] [Google Scholar]
- 134.Thirupathi B., Pongen Y.L., Govindarajan R.K., Dara P.K., Rathinasamy S., Vinayagam S., Sundaram T., Hyun B.K., Durairaj T., Suresh Padina boergesenii mediated synthesis of Se-ZnO bimetallic nanoparticles for effective anticancer activity. Front. Microbiol. 2024;15 doi: 10.3389/fmicb.2024.1358467. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 135.Tsai H.-L., Tai C.-J., Huang C.-W., Chang F.-R., Wang J.-Y. Efficacy of Low-Molecular-Weight Fucoidan as a Supplemental Therapy in Metastatic Colorectal Cancer Patients: A Double-Blind Randomized Controlled Trial. Mar. Drugs. 2017;15:122. doi: 10.3390/md15040122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 136.McGuire J.J. Minimizing Fatigue and Inflammation in Survivors of Cancer: A Pilot Randomized Clinical Trial of the Seaweed Supplement Fucoidan. 2025. clinicaltrials.gov
- 137.Gharbi J., Rezza G., Ben M’hadheb M. Editorial: Emerging and re-emerging viral infections: epidemiology, pathogenesis and new methods for control and prevention. Front. Public Health. 2024;12 doi: 10.3389/fpubh.2024.1528163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 138.Ristori M.V., Guarrasi V., Soda P., Petrosillo N., Gurrieri F., Longo U.G., Ciccozzi M., Riva E., Angeletti S. Emerging Microorganisms and Infectious Diseases: One Health Approach for Health Shared Vision. Genes. 2024;15:908. doi: 10.3390/genes15070908. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 139.Cotas J., Lomartire S., Gonçalves A.M.M., Pereira L. From Ocean to Medicine: Harnessing Seaweed’s Potential for Drug Development. Int. J. Mol. Sci. 2024;25:797. doi: 10.3390/ijms25020797. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 140.Wang S., Wang W., Hou L., Qin L., He M., Li W., Mao W. A sulfated glucuronorhamnan from the green seaweed Monostroma nitidum: Characteristics of its structure and antiviral activity. Carbohydr. Polym. 2020;227 doi: 10.1016/j.carbpol.2019.115280. [DOI] [PubMed] [Google Scholar]
- 141.Chandrasekaran P., Weiskirchen R. The role of obesity in type 2 diabetes mellitus—an overview. Int. J. Mol. Sci. 2024;25:1882. doi: 10.3390/ijms25031882. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 142.Magwaza S.N., Chabalala V.N., Hlongwane N.P., Ismail H., Islam M.S. Anti-Obesity Effects of Sulphated Polysaccharides Derived from Marine Macro Algae or Seaweeds: A Systematic Review and Meta-Analysis. Mar. Drugs. 2024;22:528. doi: 10.3390/md22120528. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 143.Oliyaei N., Moosavi-Nasab M., Tamaddon A.M., Tanideh N. Antidiabetic effect of fucoxanthin extracted from Sargassum angustifolium on streptozotocin-nicotinamide-induced type 2 diabetic mice. Food Sci. Nutr. 2021;9:3521–3529. doi: 10.1002/fsn3.2301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 144.McLaughlin C.M., Harnedy P.A., Allsopp P.J., McSorley E.M., FitzGerald R.J., O’Harte F.P.M. Administration of protein hydrolysates from Palmaria palmata reduced food intake, improved glycaemic parameters and lipid profile in streptozotocin diabetes induced mice. Proc. Nutr. Soc. 2018;77 doi: 10.1017/S0029665118001209. [DOI] [Google Scholar]
- 145.Jacques, H. (2022). Efficacy of a Brown Seaweed Extract on Glycemic Control and Body Weight in Overweight Pre-diabetic Subjects. (clinicaltrials.gov).unknown
- 146.Ferrara L. Seaweeds: A Food for Our Future. J. Food Chem. Nanotechnol. 2020;6 doi: 10.17756/jfcn.2020-084. [DOI] [Google Scholar]
- 147.Lopez-Santamarina A., Cardelle-Cobas A., del Carmen Mondragon A., Sinisterra-Loaiza L., Miranda J.M., Cepeda A. Evaluation of the potential prebiotic effect of Himanthalia elongata, an Atlantic brown seaweed, in an in vitro model of the human distal colon. Food Res. Int. 2022;156 doi: 10.1016/j.foodres.2022.111156. [DOI] [PubMed] [Google Scholar]
- 148.Ilyas Z., Ali Redha A., Wu Y.S., Ozeer F.Z., Aluko R.E. Nutritional and Health Benefits of the Brown Seaweed Himanthalia elongata. Plant Foods Hum. Nutr. 2023;78:233–242. doi: 10.1007/s11130-023-01056-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 149.Guerrero-Wyss M., Yans C., Boscán-González A., Duran P., Parra-Soto S., Angarita L. Durvillaea antarctica: A Seaweed for Enhancing Immune and Cardiometabolic Health and Gut Microbiota Composition Modulation. Int. J. Mol. Sci. 2023;24 doi: 10.3390/ijms241310779. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 150.Campos B.M., Ramalho E., Marmelo I., Noronha J.P., Malfeito-Ferreira M., Mata P., Diniz M.S. Proximate Composition, Physicochemical and Microbiological Characterization of Edible Seaweeds Available in the Portuguese Market. Front. Biosci. (Elite Ed) 2022;14:26. doi: 10.31083/j.fbe1404026. [DOI] [PubMed] [Google Scholar]
- 151.Fleurence J. In: Recent Advances in Seaweed Biotechnology. Trivedi N., Reddy C.R.K., Critchley A.T., editors. Springer Nature Singapore; 2025. Seaweeds: A Traditional and an Alternative Source of Proteins for Human and Animal Nutrition; pp. 1–21. [DOI] [Google Scholar]
- 152.Syakilla N., George R., Chye F.Y., Pindi W., Mantihal S., Wahab N.A., Fadzwi F.M., Gu P.H., Matanjun P. A Review on Nutrients, Phytochemicals, and Health Benefits of Green Seaweed, Caulerpa lentillifera. Foods. 2022;11:2832. doi: 10.3390/foods11182832. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 153.Gopalakrishnan A., Ravishankar C.N., Pravin P., Jena J.K. Indian Council of Agricultural Research; 2020. ICAR Technologies: High-Value Nutraceutical and Nutritional Products from Seaweeds. [Google Scholar]
- 154.Ridoutt B., Lehnert S.A., Denman S., Charmley E., Kinley R., Dominik S. Potential GHG emission benefits of Asparagopsis taxiformis feed supplement in Australian beef cattle feedlots. J. Clean. Prod. 2022;337 doi: 10.1016/j.jclepro.2022.130499. [DOI] [Google Scholar]
- 155.FutureFeed® . Commonwealth Scientific and Industrial Research Organisation; 2025. Seaweed-based Feed Additive Containing Bromoform from Asparagopsis to Reduce Livestock Methane Emissions and Improve Feed Efficiency.https://www.future-feed.com/ [Google Scholar]
- 156.Kaats G.R., Preuss H.G., Stohs S., Perricone N. A 7-Year Longitudinal Trial of the Safety and Efficacy of a Vitamin/Mineral Enhanced Plant-Sourced Calcium Supplement. J. Am. Coll. Nutr. 2016;35:91–99. doi: 10.1080/07315724.2015.1090357. [DOI] [PubMed] [Google Scholar]
- 157.PureSea® Organic seaweed ingredients for functional foods, nutrient delivery, and flavor enhancement. 2025. https://www.seaweedandco.com/puresea/
- 158.Tao Kae Noi Seaweed snack sheets seasoned with oil, salt, and spices marketed as a low-calorie, mineral-rich healthy snack. https://www.taokaenoi.co.th/
- 159.All natural, organic seaweed supplements supporting thyroid health, immunity, menopause, brain focus, beauty, and pet wellness. 2025. https://doctorseaweed.com/
- 160.Combet E., Ma Z.F., Cousins F., Thompson B., Lean M.E.J. Low-level seaweed supplementation improves iodine status in iodine-insufficient women. Br. J. Nutr. 2014;112:753–761. doi: 10.1017/s0007114514001573. [DOI] [PubMed] [Google Scholar]
- 161.Ocean’s Balance . Ocean’s Balance; 2023. Kelp Granules.https://oceansbalance.com/products/kelp-granules [Google Scholar]
- 162.SeaSnax Seaweed Snacks | SeaSnax - The Original - Made with Organic Seaweed & 100% Organic Olive Oil! 2025. https://www.seasnax.com/SeaSnax-Sheets_c_1.html
- 163.Algotherm Our History. 2025. https://www.algotherm.com/at_en/our-history-algotherm
- 164.Maritech . Maritech Fucoidan; 2025. Marinova Maritech® Fucus vesiculosus extract | Product portfolio.https://maritechfucoidan.com.au/maritech-fucus-vesiculosus-extract/ [Google Scholar]
- 165.Blue Evolution seaweed pasta Grocery Outlet Ethical Bargains. 2021. https://ethicalbargains.org/2021/07/24/blue-evolution-seaweed-pasta-sustainability-review/
- 166.PharmaSea PharmaSea. 2025. https://www.pharmasea.co.uk/
- 167.Biosea Health . BioSea Health; 2024. Best 100% Organic Seaweed | Food and Supplement.https://bioseahealth.com/#google_vignette [Google Scholar]
- 168.Cousins S.D., Kucewicz S.T.C., Wundersitz D.W.T., Collins B.E.G., Cooke M.B., McKeown N., Figueiredo Galvao H.B., Resciniti S.M., Lyristakis P.M., Gordon B.A., van der Poel C. Investigating fucoidan blend supplementation and resistance training in humans: a parallel randomized controlled trial design. Sci. Rep. 2025;15 doi: 10.1038/s41598-025-24066-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 169.Taipei Medical University WanFang Hospital Fucoidan Improves the Metabolic Profiles of Patients With Non-alcoholic Fatty Liver Disease (NAFLD) 2021. clinicaltrials.gov
- 170.Jagtap A.S., Manohar C.S., Kadam N.S. Relationship between dietary fiber content and prebiotic potential of polysaccharides from the seaweeds of the North west coast of India. Int. J. Biol. Macromol. 2024;269 doi: 10.1016/j.ijbiomac.2024.132225. [DOI] [PubMed] [Google Scholar]
- 171.Shannon E., Conlon M., Hayes M. The Prebiotic Effect of Australian Seaweeds on Commensal Bacteria and Short Chain Fatty Acid Production in a Simulated Gut Model. Nutrients. 2022;14:2163. doi: 10.3390/nu14102163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 172.Lopez-Santamarina A., Sinisterra-Loaiza L., Mondragón-Portocarrero A., Ortiz-Viedma J., Cardelle-Cobas A., Abuín C.M.F., Cepeda A. Potential prebiotic effect of two Atlantic whole brown seaweeds, Saccharina japonica and Undaria pinnatifida, using in vitro simulation of distal colonic fermentation. Front. Nutr. 2023;10 doi: 10.3389/fnut.2023.1170392. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 173.Liu W.-C., Zhou S.-H., Balasubramanian B., Zeng F.-Y., Sun C.-B., Pang H.-Y. Dietary seaweed (Enteromorpha) polysaccharides improves growth performance involved in regulation of immune responses, intestinal morphology and microbial community in banana shrimp Fenneropenaeus merguiensis. Fish Shellfish Immunol. 2020;104:202–212. doi: 10.1016/j.fsi.2020.05.079. [DOI] [PubMed] [Google Scholar]
- 174.Siddik M.A.B., Francis P., Rohani M.F., Azam M.S., Mock T.S., Francis D.S. Seaweed and Seaweed-Based Functional Metabolites as Potential Modulators of Growth, Immune and Antioxidant Responses, and Gut Microbiota in Fish. Antioxidants. 2023;12:2066. doi: 10.3390/antiox12122066. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 175.Unnikrishnan P.S., Animish A., Madhumitha G., Suthindhiran K., Jayasri M.A. Bioactivity Guided Study for the Isolation and Identification of Antidiabetic Compounds from Edible Seaweed—Ulva reticulata. Molecules. 2022;27:8827. doi: 10.3390/molecules27248827. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 176.Blikra M.J., Henjum S., Aakre I. Iodine from brown algae in human nutrition, with an emphasis on bioaccessibility, bioavailability, chemistry, and effects of processing: A systematic review. Compr. Rev. Food Sci. Food Saf. 2022;21:1517–1536. doi: 10.1111/1541-4337.12918. [DOI] [PubMed] [Google Scholar]
- 177.Zimmermann M.B. Iodine deficiency. Endocr. Rev. 2009;30:376–408. doi: 10.1210/er.2009-0011. [DOI] [PubMed] [Google Scholar]
- 178.Estados Unidos . National Academy of Sciences; 2004. Dietary Reference Intakes for Vitamin A, Vitamina K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium and Zinc. [Google Scholar]
- 179.Hatch-McChesney A., Lieberman H.R. Iodine and Iodine Deficiency: a Comprehensive Review of a Re-Emerging Issue. Nutrients. 2022;14:3474. doi: 10.3390/nu14173474. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 180.Bulliyya G., Dwibedi B., Mallick G., Sethy P.G.S., Kar S.K. Determination of Iodine Nutrition and Community Knowledge Regarding Iodine Deficiency Disorders in Selected Tribal Blocks of Orissa, India. J. Pediatr. Endocrinol. Metab. 2008;21:79–87. doi: 10.1515/jpem.2008.21.1.79. [DOI] [PubMed] [Google Scholar]
- 181.Bernal J. Bentham Science Publishers eBooks; 2024. Endemic Goiter and Cretinism: Pathophysiology of Iodine Deficiency; pp. 83–98. [DOI] [Google Scholar]
- 182.Mane V.P., Yenkanaik Y.B., Nimbannavar S.M., Holyachi S., Holyachi S., K. V. C. Prevalence of iodine deficiency disorders and its determinants among school children aged 6 to 12 years in rural areas of Koppal district, Karnataka. Int. J. Community Med. Public Health. 2020;7:573. doi: 10.18203/2394-6040.ijcmph20200429. [DOI] [Google Scholar]
- 183.Preedy V.R., Burrow G.N., Watson R.R. Elsevier/Academic Press; 2009. Comprehensive Handbook of Iodine : Nutritional, Biochemical, Pathological, and Therapeutic Aspects. [Google Scholar]
- 184.Aceves C., Anguiano B., Delgado G. The Extrathyronine Actions of Iodine as Antioxidant, Apoptotic, and Differentiation Factor in Various Tissues. Thyroid. 2013;23:938–946. doi: 10.1089/thy.2012.0579. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 185.Smyth P.P.A. Iodine, Seaweed, and the Thyroid. Eur. Thyroid J. 2021;10:101–108. doi: 10.1159/000512971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 186.Stévant P., Wirenfeldt C.B., Stangeland J., Cohen D., Sloth J.J., Holdt S.L., Duinker A. Iodine reduction and retention of nutrients and flavour-active compounds upon warm seawater treatment of the kelps Alaria esculenta and Saccharina latissima. Algal Res. 2025;86 doi: 10.1016/j.algal.2025.103969. [DOI] [Google Scholar]
- 187.High content of iodine (22911 mg/kg-ppm) in dried seaweed from the Republic of Korea via Germany. 2005. https://webgate.ec.europa.eu/rasff-window/portal/index.cfm?event=notificationDetail&NOTIF_REFERENCE=2005.050
- 188.Farebrother J., Zimmermann M.B., Andersson M. Excess iodine intake: sources, assessment, and effects on thyroid function. Ann. N. Y. Acad. Sci. 2019;1446:44–65. doi: 10.1111/nyas.14041. [DOI] [PubMed] [Google Scholar]
- 189.National Institutes of Health Iodine. 2024. https://ods.od.nih.gov/factsheets/Iodine-Consumer/
- 190.Martinelango P.K., Tian K., Dasgupta P.K. Perchlorate in seawater: bioconcentration of iodide and perchlorate by various seaweed species. Anal. Chim. Acta. 2006;567:100–107. doi: 10.1016/j.aca.2006.02.015. [DOI] [PubMed] [Google Scholar]
- 191.Nielsen S.S. In: Food Analysis Laboratory Manual. Nielsen S.S., editor. Springer US; 2010. Determination of Moisture Content; pp. 17–27. [DOI] [Google Scholar]
- 192.Bricknell I.R., Birkel S.D., Brawley S.H., Van Kirk T., Hamlin H.J., Capistrant-Fossa K., Huguenard K., Van Walsum G.P., Liu Z.L., Zhu L.H., et al. Resilience of cold water aquaculture: a review of likely scenarios as climate changes in the Gulf of Maine. Rev. Aquacult. 2020;13:460–503. doi: 10.1111/raq.12483. [DOI] [Google Scholar]
- 193.Khandaker M.U., Chijioke N.O., Heffny N.A.B., Bradley D.A., Alsubaie A., Sulieman A., Faruque M.R.I., Sayyed M.I., Al-mugren K.S. Elevated Concentrations of Metal(loids) in Seaweed and the Concomitant Exposure to Humans. Foods. 2021;10:381. doi: 10.3390/foods10020381. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 194.Todorov T.I., Wolle M.M., Conklin S.D. Distribution of 26 major and trace elements in edible seaweeds from the US market. Chemosphere. 2022;294 doi: 10.1016/j.chemosphere.2022.133651. [DOI] [PubMed] [Google Scholar]
- 195.Anbazhagan V., Partheeban E.C., Arumugam G., Arumugam A., Rajendran R., Paray B.A., Al-Sadoon M.K., Al-Mfarij A.R. Health risk assessment and bioaccumulation of metals in brown and red seaweeds collected from a tropical marine biosphere reserve. Mar. Pollut. Bull. 2021;164 doi: 10.1016/j.marpolbul.2021.112029. [DOI] [PubMed] [Google Scholar]
- 196.Filippini M., Baldisserotto A., Menotta S., Fedrizzi G., Rubini S., Gigliotti D., Valpiani G., Buzzi R., Manfredini S., Vertuani S. Heavy metals and potential risks in edible seaweed on the market in Italy. Chemosphere. 2021;263 doi: 10.1016/j.chemosphere.2020.127983. [DOI] [PubMed] [Google Scholar]
- 197.Genchi G., Sinicropi M.S., Lauria G., Carocci A., Catalano A. The effects of cadmium toxicity. Int. J. Environ. Res. Public Health. 2020;17:3782. doi: 10.3390/ijerph17113782. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 198.Chowdhury R., Ramond A., O’Keeffe L.M., Shahzad S., Kunutsor S.K., Muka T., Gregson J., Willeit P., Warnakula S., Khan H., et al. Environmental toxic metal contaminants and risk of cardiovascular disease: systematic review and meta-analysis. BMJ. 2018;362 doi: 10.1136/bmj.k3310. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 199.Akcali I., Kucuksezgin F. A biomonitoring study: Heavy metals in macroalgae from eastern Aegean coastal areas. Mar. Pollut. Bull. 2011;62:637–645. doi: 10.1016/j.marpolbul.2010.12.021. [DOI] [PubMed] [Google Scholar]
- 200.Abdullah Al-Dhabi N., Arasu M.V. Biosorption of hazardous waste from the municipal wastewater by marine algal biomass. Environ. Res. 2022;204 doi: 10.1016/j.envres.2021.112115. [DOI] [PubMed] [Google Scholar]
- 201.Raj K., Das A.P. Lead pollution: Impact on Environment and Human Health and Approach for a Sustainable Solution. Environ. Chem. Ecotoxicol. 2023;5:79–85. doi: 10.1016/j.enceco.2023.02.001. [DOI] [Google Scholar]
- 202.James A.K., Dolgova N.V., Nehzati S., Korbas M., Cotelesage J.J.H., Sokaras D., Kroll T., O’Donoghue J.L., Watson G.E., Myers G.J., et al. Molecular Fates of Organometallic Mercury in Human Brain. ACS Chem. Neurosci. 2022;13:1756–1768. doi: 10.1021/acschemneuro.2c00166. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 203.Park J.-D., Zheng W. Human Exposure and Health Effects of Inorganic and Elemental Mercury. J. Prev. Med. Publ. Health. 2012;45:344–352. doi: 10.3961/jpmph.2012.45.6.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 204.Yu Y., Morales-Rodriguez A., Zhou G., Barrón D., Sahuquillo À., López-Sánchez J.F. Survey of arsenic content in edible seaweeds and their health risk assessment. Food Chem. Toxicol. 2024;187:114603. doi: 10.1016/j.fct.2024.114603. [DOI] [PubMed] [Google Scholar]
- 205.Navasumrit P., Chaisatra K., Promvijit J., Parnlob V., Waraprasit S., Chompoobut C., Binh T.T., Hai D.N., Bao N.D., Hai N.K., et al. Exposure to arsenic in utero is associated with various types of DNA damage and micronuclei in newborns: a birth cohort study. Environ. Health. 2019;18 doi: 10.1186/s12940-019-0481-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 206.FDA . U.S. Food and Drug Administration; 2023. Generally Recognized as Safe (GRAS)https://www.fda.gov/food/food-ingredients-packaging/generally-recognized-safe-gras [Google Scholar]
- 207.Liao Y.-C., Chang C.-C., Nagarajan D., Chen C.-Y., Chang J.-S. Algae-derived hydrocolloids in foods: applications and health-related issues. Bioengineered. 2021;12:3787–3801. doi: 10.1080/21655979.2021.1946359. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 208.Borsani B., De Santis R., Perico V., Penagini F., Pendezza E., Dilillo D., Bosetti A., Zuccotti G.V., D’Auria E. The Role of Carrageenan in Inflammatory Bowel Diseases and Allergic Reactions: Where Do We Stand? Nutrients. 2021;13:3402. doi: 10.3390/nu13103402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 209.GRAS Substances (SCOGS) Database . FDA; 2022. Center for Food Safety and Applied Nutrition.https://www.fda.gov/food/generally-recognized-safe-gras/gras-substances-scogs-database [Google Scholar]
- 210.Guo Y., Anne-Katrine L., Li N., Åshild E., Pang S., Jiang Y., Zhu W., Zhao Y., Li X., Yao L., et al. Comparative assessment of food safety regulations and standards for arsenic, cadmium, lead, mercury and iodine in macroalgae used as food and feed in China and Europe. Trends Food Sci. Technol. 2023;141:104204. doi: 10.1016/j.tifs.2023.104204. [DOI] [Google Scholar]
- 211.Report of the expert meeting on food safety for seaweed – current status and future perspectives. 2022. https://www.who.int/publications/i/item/9789240058538
- 212.Commission Recommendation (EU) 2018/464 of 19 March 2018 on the monitoring of metals and iodine in seaweed, halophytes and products based on seaweed. 2018. https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32018H0464
- 213.Edible seaweed and French regulation-Synthesis made by CEVA (31/03/2014) 2014. http://www.d1064431.blacknight.com/sites/default/files/seaweed%20and%20regulation2014.pdf
- 214.Opinion of the French Agency for Food Environmental and Occupational Health & Safety on maximum cadmium levels for seaweed intended for human consumption. 2020. https://www.anses.fr/en/system/files/ERCA2017SA0070EN.pdf Request No 2017-SA-0070.
- 215.Opinion of the French Agency for Food Environmental and Occupational Health & Safety on the risk of excess iodine intake from the consumption of seaweed in foodstuffs. 2018. https://www.anses.fr/en/system/files/NUT2017SA0086EN.pdf Request No 2017-SA-0086.
- 216.Health risks linked to high iodine levels in dried algae. 2004. https://www.bfr.bund.de/cm/349/health_risks_linked_to_high_iodine_levels_in_dried_algae.pdf
- 217.Yeh T.S., Hung N.H., Lin T.C. Analysis of iodine content in seaweed by GC-ECD and estimation of iodine intake. J. Food Drug Anal. 2014;22:189–196. doi: 10.1016/j.jfda.2014.01.014. [DOI] [Google Scholar]
- 218.Food Standards Australia New Zealand; 2016. Australia New Zealand Food Standards Code–Standard 1 Contaminants and Natural Toxicants.https://www.legislation.gov.au/Series/F2015L00408 [Google Scholar]
- 219.National Health Commission of PRC & State Administration for Market Regulation. GB 2762-2022. 2022. https://apps.fas.usda.gov/newgainapi/api/Report/DownloadReportByFileName?fileName=China%20Releases%20the%20Standard%20for%20Maximum%20Levels%20of%20Contaminants%20in%20Foods_Beijing_China%20-%20People%27s%20Republic%20of_CH2023-0040.pdf
- 220.Standardization Administration of China . Standardization Administration of China; 2017. General Administration of Quality Supervision, Inspection and Quarantine. [Google Scholar]
- 221.Food and Environmental Hygiene Department Hong Kong special administrative region of China. 2018. https://www.cfs.gov.hk/english/whatsnew/whatsnew_fstr/whatsnew_fstr_PA_Food_Adulteration_Metallic_Contamination.html
- 222.Sanitation standard for contaminants and toxins in food: Appendix 1. Maximum levels (ML) of metals in foods. 2018. https://db.lawbank.com.tw/Eng/FLAW/FLAWDAT01.aspx?Lsid=FL088408
- 223.Food Safety and Standards (Contaminants, Toxins and Residues) Regulations. 2011. https://www.fao.org/faolex/results/details/en/c/LEX-FAOC119042
- 224.Building a Sustainable and Resilient Ocean Economy. 2022. https://unctad.org/system/files/non-official-document/ditc-ted-06042022-Oceans4-BackgroundNote-v3.pdf
- 225.FAO 2023. https://www.fao.org/3/cc0461en/online/sofia/2022/world-fisheries-aquaculture.html
- 226.UN Trade and Development An Ocean of Opportunities: The Potential of Seaweed to Advance Food, Environmental and Gender Dimensions of the SDGs (United Nations) 2024. [DOI]
- 227.World Bank Global Seaweed New and Emerging Markets Report 2023. 2023. https://www.worldbank.org/en/topic/environment/publication/global-seaweed-new-and-emerging-markets-report-2023
- 228.UNCTADstat unctadstat.unctad.org. 2023. https://unctadstat.unctad.org/
- 229.Seaweed Production 2025. https://www.pib.gov.in/PressReleasePage.aspx?PRID=2112263
- 230.TechSci Research India Seaweed Market Demand, Size and Competitive Analysis | TechSci Research. 2020. https://www.techsciresearch.com/report/india-seaweed-market/14366.html
- 231.Bullen C.D., Driscoll J., Burt J., Stephens T., Hessing-Lewis M., Gregr E.J. Climate benefits of seaweed farming: estimating regional carbon emission and sequestration pathways. bioRxiv. 2023 doi: 10.1101/2023.06.13.544854. Preprint at. [DOI] [Google Scholar]
- 232.Makame M.O., Hamad A.R., Said M.S., Mushi A., Sharif K. Moving Seaweed Farms from Shallow to Deep Seawater to Cope with Warming and Diseases in Zanzibar. Current Socio-Economic and Cultural Barriers. J. Sustain. Dev. 2021;14:29. doi: 10.5539/jsd.v14n5p29. [DOI] [Google Scholar]
- 233.Msuya F.E. 3rd Regional Conference on Innovation Systems and Innovative Clusters in Africa. 2006. The Seaweed Cluster Initiative in Zanzibar, Tanzania. [Google Scholar]
- 234.Jones B.L.H., Eklöf J.S., Unsworth R.K.F., Coals L., Christianen M.J.A., Clifton J., Cullen-Unsworth L.C., de la Torre-Castro M., Esteban N., Huxham M., et al. Risks of habitat loss from seaweed cultivation within seagrass. Proc. Natl. Acad. Sci. USA. 2025;122 doi: 10.1073/pnas.2426971122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 235.Bhuyan M.S. Ecological risks associated with seaweed cultivation and identifying risk minimization approaches. Algal Res. 2023;69 doi: 10.1016/j.algal.2022.102967. [DOI] [Google Scholar]
- 236.Kamalakannan B., Jeevamani J., Arun Nagendran N., Pandiaraja D., Chandrasekaran S. Impact of removal of invasive species Kappaphycus alvarezii from coral reef ecosystem in Gulf of Mannar, India. Curr. Sci. 2014;106:25–2014. [Google Scholar]
- 237.Rameshkumar S., Rajaram R. Experimental cultivation of invasive seaweed Kappaphycus alvarezii (Doty) Doty with assessment of macro and meiobenthos diversity from Tuticorin coast, Southeast coast of India. Reg. Stud. Mar. Sci. 2017;9:117–125. doi: 10.1016/j.rsma.2016.12.002. [DOI] [Google Scholar]
- 238.Mac Monagail M., Cornish L., Morrison L., Araújo R., Critchley A.T. Sustainable harvesting of wild seaweed resources. Eur. J. Phycol. 2017;52:371–390. doi: 10.1080/09670262.2017.1365273. [DOI] [Google Scholar]
- 239.Johnson B., Narayanakumar R., Abdul Nazar A.K., Kaladharan P., Gopakumar G. Economic analysis of farming and wild collection of seaweeds in Ramanathapuram District, Tamil Nadu. Indian J. Fish. 2017;64 doi: 10.21077/ijf.2017.64.4.61828-13. [DOI] [Google Scholar]
- 240.Satpati G.G., Sengupta S., Pal R. Vol. 1. 2022. Seaweeds: The Ecological Roles, the Economic Benefits and the Threats for Changing the Carbon Cycle; pp. 295–311. (Sustainable Global Resources of Seaweeds). [DOI] [Google Scholar]
- 241.Vance C., Pollard P., Maguire J., Sweeney J., Murphy F. Sustainable scale-up of Irish seaweed production: Quantifying potential environmental, economic, and social impacts of wild harvesting and cultivation pathways. Algal Res. 2023;75 doi: 10.1016/j.algal.2023.103294. [DOI] [Google Scholar]
- 242.Tamil Nadu - Way Forward Sustainable Seaweed Farming in Tamil Nadu- Way Forward. 2024. https://spc.tn.gov.in/wp-content/uploads/Seaweed.pdf
- 243.Establishment of Multi-Purpose Seaweed Park in Tamil Nadu. 2023. https://www.pib.gov.in/PressReleaseIframePage.aspx?PRID=1954383
- 244.Eger A., Aguirre J.D., Altamirano M., Nur A.-D., Arroyo N.L., Bauer-Civiello A.M., Beas–Luna R., Bekkby T., Bellgrove A., Bennett S., et al. The Kelp Forest Challenge: A collaborative global movement to protect and restore 4 million hectares of kelp forests. J. Appl. Phycol. 2023;36:951–964. doi: 10.1007/s10811-023-03103-y. [DOI] [Google Scholar]
- 245.Strategy for the Development of seaweed value chain_04062024_compressed.pdf. 2024. https://www.niti.gov.in/sites/default/files/2024-08/Strategy%20for%20the%20Development_04062024_compressed.pdf
- 246.Effective Methods for Harvesting and Drying Seaweeds - Agriculture Notes by Agriculture Institute. 2023. https://agriculture.institute/fish-by-products-waste-utilization/harvesting-drying-seaweeds-methods/
- 247.Crsp A., Hall S. Literature Review of Seaweed Harvest Value Chain. 2012. http://crsps.net/wp-content/downloads/AquaFish/Inventoried%203.19/8-2012-8-77.pdf [Google Scholar]
- 248.Herrera Barragán J.A., Olivieri G., Boboescu I., Eppink M., Wijffels R., Kazbar A. Enzyme assisted extraction for seaweed multiproduct biorefinery: A techno-economic analysis. Front. Mar. Sci. 2022;9 doi: 10.3389/fmars.2022.948086. [DOI] [Google Scholar]
- 249.Álvarez-Viñas M., Flórez-Fernández N., Torres M.D., Domínguez H. Successful Approaches for a Red Seaweed Biorefinery. Mar. Drugs. 2019;17:620. doi: 10.3390/md17110620. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 250.Liu Y., Dar B.N., Makroo H.A., Aslam R., Martí-Quijal F.J., Castagnini J.M., Amigo J.M., Barba F.J. Optimizing Recovery of High-Added-Value Compounds from Complex Food Matrices Using Multivariate Methods. Antioxidants. 2024;13:1510. doi: 10.3390/antiox13121510. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 251.Matos G.S., Pereira S.G., Genisheva Z.A., Gomes A.M., Teixeira J.A., Rocha C.M.R. Advances in Extraction Methods to Recover Added-Value Compounds from Seaweeds: Sustainability and Functionality. Foods. 2021;10:516. doi: 10.3390/foods10030516. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 252.Milić A., Daničić T., Tepić Horecki A., Šumić Z., Teslić N., Bursać Kovačević D., Putnik P., Pavlić B. Sustainable Extractions for Maximizing Content of Antioxidant Phytochemicals from Black and Red Currants. Foods. 2022;11:325. doi: 10.3390/foods11030325. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 253.Cardoso C., Matos J., Afonso C. Extraction of Marine Bioactive Compounds from Seaweed: Coupling Environmental Concerns and High Yields. Mar. Drugs. 2025;23:366. doi: 10.3390/md23090366. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 254.Lindorfer J., Lettner M., Fazeni K., Rosenfeld D., Annevelink B., Mandl M. Technical, Economic and Environmental Assessment of Biorefinery Concepts. 2012. http://crsps.net/wp-content/downloads/AquaFish/Inventoried%203.19/8-2012-8-77.pdf
- 255.van Tuinen S., Faassen E., Gsell A. Processing-mediated reduction of elemental contaminants in seaweed food and feed products: Processing-mediated reduction of contaminant levels in seaweed products. 2023. [DOI]
- 256.Iodecline Ocean Rainforest. https://www.oceanrainforest.com/iodecline
- 257.Vinuganesh A., Kumar A., Korany S.M., Alsherif E.A., Selim S., Prakash S., Beemster G.T.S., AbdElgawad H. Seasonal Changes in the Biochemical Constituents of Green Seaweed Chaetomorpha antennina from Covelong, India. Biomolecules. 2022;12:1475. doi: 10.3390/biom12101475. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 258.Jayakody M.M., Vanniarachchy M.P.G., Wijesekara W.L.I. Mineral Content of Selected Seaweed Varieties in Southern and North Western Sea of Sri Lanka. Vidyodaya J. Sci. 2021;21:31–37. doi: 10.31357/vjs.v24i01.4963. [DOI] [Google Scholar]
- 259.Cotas J., Pacheco D., Gonçalves A.M.M., Silva P., Carvalho L.G., Pereira L. Seaweeds’ nutraceutical and biomedical potential in cancer therapy: a concise review. J. Cancer Metastasis Treat. 2021;7 doi: 10.20517/2394-4722.2020.134. [DOI] [Google Scholar]
- 260.Hentati F., Tounsi L., Djomdi D., Pierre G., Delattre C., Ursu A.V., Fendri I., Abdelkafi S., Michaud P. Bioactive Polysaccharides from Seaweeds. Molecules. 2020;25:3152. doi: 10.3390/molecules25143152. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 261.Wirenfeldt C.B., Hermund D.B., Feyissa A.H., Hyldig G., Holdt S.L. Nutritional value, bioactive composition, physico-chemical and sensory properties of Ulva sp. and Fucus vesiculosus depending on post-harvest processing: a drying comparison study. J. Appl. Phycol. 2024;36:2795–2805. doi: 10.1007/s10811-024-03210-4. [DOI] [Google Scholar]
- 262.Leandro A., Pacheco D., Cotas J., Marques J.C., Pereira L., Gonçalves A.M.M. Seaweed’s Bioactive Candidate Compounds to Food Industry and Global Food Security. Life. 2020;10:140. doi: 10.3390/life10080140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 263.Pandey G., Niladri S.C., Panda S.K., Mohan C.O., Kishore P., Kumar A., Uchoi D., Balasundari S., Anandan R., Mathew S., et al. Scope and challenges of seaweed utilization in food and nutraceutical industry in India: a review. J. Food Sci. Technol. 2023;61:230–241. doi: 10.1007/s13197-023-05676-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 264.Løvdal T., Lunestad B.T., Myrmel M., Rosnes J.T., Skipnes D. Microbiological Food Safety of Seaweeds. Foods. 2021;10:2719. doi: 10.3390/foods10112719. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 265.Gajaria T.K., Mantri V.A. Perspectives and Attitudes towards the Functional and Safety Aspects of Seaweeds for Edible Applications in India. Foods. 2021;10:3026. doi: 10.3390/foods10123026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 266.Blomme J., Liu X., Jacobs T.B., De Clerck O. A molecular toolkit for the green seaweedUlva mutabilis. Plant Physiol. 2021;186:1442–1454. doi: 10.1093/plphys/kiab185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 267.Jonas D.S., Emma C.V., Lee H., Park J., Blomme J. Genome editing in macroalgae: advances and challenges. Front. Genome Ed. 2024;6 doi: 10.3389/fgeed.2024.1380682. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 268.Badis Y., Scornet D., Harada M., Caillard C., Godfroy O., Raphalen M., Gachon C.M.M., Coelho S.M., Motomura T., Nagasato C., Cock J.M. Targeted CRISPR-Cas9-based gene knockouts in the model brown alga Ectocarpus. New Phytol. 2021;231:2077–2091. doi: 10.1111/nph.17525. [DOI] [PubMed] [Google Scholar]
- 269.Shen Y., Motomura T., Ichihara K., Matsuda Y., Yoshimura K., Kosugi C., Nagasato C. Application of CRISPR-Cas9 genome editing by microinjection of gametophytes of Saccharina japonica (Laminariales, Phaeophyceae) J. Appl. Phycol. 2023;35:1431–1441. doi: 10.1007/s10811-023-02940-1. [DOI] [Google Scholar]
- 270.Ichihara K., Yamazaki T., Kawano S. Genome editing using a DNA-free clustered regularly interspaced short palindromic repeats-Cas9 system in green seaweed Ulva prolifera. Phycol. Res. 2021;70:50–56. doi: 10.1111/pre.12472. [DOI] [Google Scholar]
- 271.Goold H.D., Moseley J.L., Lauersen K.J. The synthetic future of algal genomes. Cell Genom. 2024;4 doi: 10.1016/j.xgen.2024.100505. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 272.Guo B., Lu X., Jiang X., Shen X.-L., Wei Z., Zhang Y. Artificial Intelligence in Advancing Algal Bioactive Ingredients: Production, Characterization, and Application. Foods. 2025;14:1783. doi: 10.3390/foods14101783. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 273.Kwon S., Bae H., Jo J., Yoon S. Comprehensive ensemble in QSAR prediction for drug discovery. BMC Bioinf. 2019;20 doi: 10.1186/s12859-019-3135-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 274.Myint K.Z., Xie X.-Q. Ligand biological activity predictions using fingerprint-based artificial neural networks (FANN-QSAR) Methods Mol. Biol. 2015;1260:149–164. doi: 10.1007/978-1-4939-2239-0_9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 275.Iskandar, Samuel C.I., Favitri D., Padlan, Azizi . 2021 15th International Conference on Telecommunication Systems, Services, and Applications (TSSA) 2021. IoT-based of Seaweed Cultivation Employing a Low-cost Autonomous Experimental Buoy; pp. 1–5. [DOI] [Google Scholar]
- 276.Jeroen G., Kooijman D.G., Wieling I.W., Ritchie H., Vanlanduit S. Seaweed Growth Monitoring with a Low-Cost Vision-Based System. Sensors. 2023;23:9197. doi: 10.3390/s23229197. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 277.Ross F.W.R., Malerba M.E., Macreadie P.I. Global potential for seaweed aquaculture on existing offshore infrastructure. Heliyon. 2025;11 doi: 10.1016/j.heliyon.2024.e41248. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 278.Acadian Seaplants . Acadian Seaplants Limited; 2022. Land-Based Seaweed Cultivation Was Pioneered by Acadian Seaplants.https://www.acadianseaplants.com/land-based-seaweed-cultivation/ [Google Scholar]
- 279.Pure Algae Can you grow seaweed on land? Oceans and fisheries. 2024. https://oceans-and-fisheries.ec.europa.eu/news/can-you-grow-seaweed-land-2024-12-19_en
- 280.Seaweedland . Global Seafood Alliance; 2025. Dutch engineer’s land-based seaweed farm gives new meaning to greenhouses - Responsible Seafood Advocate.https://www.globalseafood.org/advocate/dutch-engineers-land-based-seaweed-farm-gives-new-meaning-to-greenhouses/ [Google Scholar]
- 281.Holdt S.L., Kraan S. Bioactive compounds in seaweed: functional food applications and legislation. J. Appl. Phycol. 2011;23:543–597. doi: 10.1007/s10811-010-9632-5. [DOI] [Google Scholar]
- 282.Dong C., Xie C., Lou Z., Lee Z.J., Barrow C.J., Suleria H.A.R. Ecological Characteristics and Nutritional Values of Australia-Native Brown Algae Species. Mar. Drugs. 2025;23:383. doi: 10.3390/md23100383. [DOI] [PMC free article] [PubMed] [Google Scholar]









